{"statement_id": "RN001", "text": "A method for distinguishing agonistic anti-B7-H1 (PD-L1) antibodies from antagonistic anti-B7-H1 antibodies using a functional assay or binding characterization that differentiates antibodies that activate B7-H1 signaling from those that block B7-H1/PD-1 interactions, enabling selection of the appropriate antibody class for treating cancer, infectious disease, or autoimmune conditions.", "source_patent_id": "10302653", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10302653"], "ground_truth": {"tier1_relevant_docs": {"W2105567953": 2, "10259875": 1, "W2131577873": 1, "W2171853585": 2}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "NOVEL", "google": "NOVEL"}}}
{"statement_id": "RN002", "text": "Transgenic mice engineered to be deficient in adenosine deaminase (ADA), resulting in chronically elevated systemic adenosine levels, which serve as an animal model for studying and screening therapeutic compounds against pathological conditions caused by adenosine accumulation.", "source_patent_id": "6207876", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["6207876"], "ground_truth": {"tier1_relevant_docs": {"W2157741965": 1, "W2150598424": 3, "W1981488721": 1, "W1579364872": 1, "W2104052230": 1, "W1555490957": 1, "W2169344912": 3, "W2068147126": 1, "W2103872763": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN003", "text": "Double-stranded RNA molecules between 15 and 21 nucleotides in length that are complementary to a target gene sequence are used to inhibit expression of that target gene.", "source_patent_id": "8202980", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8202980"], "ground_truth": {"tier1_relevant_docs": {"8101584": 3, "8168776": 3, "8119608": 3, "W2045653120": 2, "8114851": 3, "8729037": 3, "10508277": 2, "9994853": 2, "8283329": 2, "8580754": 2, "9102939": 2, "W2002200554": 1, "W1567381189": 1, "10000754": 2, "10351852": 2, "10662428": 2, "10889815": 2, "9181551": 2, "9657294": 2, "9732344": 2, "9738899": 2, "9771588": 2, "9957517": 2, "10041068": 2, "W2087235070": 1, "W1906181797": 1, "W2103392842": 2, "W2038544294": 3, "W2114735542": 3, "W2094253263": 1, "W2056320912": 1, "W2324865838": 2, "W1984251559": 2, "W2113657260": 2, "W2144158368": 2, "W2034046707": 1, "W2021007708": 1, "W147652200": 2, "W1614759083": 1, "8604183": 2, "W1546832385": 1, "W2113513945": 3, "9260471": 3, "9970005": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN004", "text": "Modified mRNA polynucleotides encoding apoptosis inducing factor 1 (AIF1) incorporating chemical modifications to enhance stability and translational efficiency for therapeutic oncology applications.", "source_patent_id": "9301993", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9301993"], "ground_truth": {"tier1_relevant_docs": {"W2058647478": 2, "9220792": 1, "9095552": 1, "9255129": 1, "9114113": 1, "9149506": 1, "9216205": 2, "W1994983564": 1, "9050297": 1, "9107886": 1, "9675668": 1, "W1982010715": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN005", "text": "Small molecule glycomimetic compounds that function as E-selectin antagonists by inhibiting binding of E-selectin to its ligands, useful for treating cancer metastasis by blocking adhesion of cancer cells to bone marrow endothelial cells and inhibiting cancer cell infiltration into bone marrow.", "source_patent_id": "10526361", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10526361"], "ground_truth": {"tier1_relevant_docs": {"10766916": 3, "9109002": 3, "9796745": 3, "9867841": 2, "W1871629237": 3, "W2163318518": 1, "W2047942414": 3, "W2562574582": 2, "W2395243915": 1, "W1725142663": 2, "W2480666200": 2, "W2979826324": 2, "W2035480085": 1, "W2568387171": 2, "W4248903596": 2, "W2557946695": 3, "W2564443150": 3, "11072625": 2, "W2079365541": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN006", "text": "A method for treating viral or virally-induced conditions comprising orally administering a histone deacetylase (HDAC) inhibitor as a viral inducing agent in combination with an antiviral agent, wherein the HDAC inhibitor activates latent virus to render it susceptible to the antiviral agent.", "source_patent_id": "10857152", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10857152"], "ground_truth": {"tier1_relevant_docs": {"W1976555683": 1, "W2147447587": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN007", "text": "An anti-CGRP antagonist antibody (G1) that binds to calcitonin gene-related peptide and blocks its activity, used to prevent or treat CGRP-associated disorders including migraine, cluster headache, tension headache, and vasomotor symptoms such as hot flushes.", "source_patent_id": "9890210", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9890210"], "ground_truth": {"tier1_relevant_docs": {"9890211": 3, "10329343": 3, "9884907": 3, "9884908": 3, "10556945": 3, "9896502": 3, "9708393": 2, "10266587": 2, "11325967": 2, "W2676947678": 1, "W2782073995": 1, "W2040875763": 1, "W1992928272": 1, "W2075728979": 2, "10597448": 2, "W2152386859": 1, "W2607327290": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN008", "text": "Antibodies with high binding affinity specifically targeting the Aβ(20-42) globulomer epitope, wherein the antibodies recognize an epitope present on amyloid-beta globulomer conformational variants comprising residues 20-42 of the amyloid-beta peptide.", "source_patent_id": "9822171", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9822171"], "ground_truth": {"tier1_relevant_docs": {"8987419": 3, "9062101": 3, "10047121": 3, "10538581": 3, "8691224": 3, "9540432": 3, "W2120096591": 3, "8497072": 3, "W2119279113": 1, "W2056092494": 3, "W2126958454": 2, "W2104878642": 1, "W1996037698": 2, "8877190": 3, "9359430": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN009", "text": "An analyte sensing biointerface comprising a sensing electrode embedded within a non-conductive matrix that contains a plurality of discrete passageways extending through the matrix to provide direct fluidic access from tissue to the sensing electrode surface, enabling analyte detection in vivo.", "source_patent_id": "10702193", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10702193"], "ground_truth": {"tier1_relevant_docs": {"10376188": 3, "10667729": 3, "10667730": 3, "8060174": 3, "9788766": 3, "W1999007589": 1, "10143410": 1, "11147483": 1, "8583204": 1, "8682408": 1, "8954128": 1, "9173606": 1, "9173607": 1, "9549699": 1, "9566026": 1, "9572523": 1, "9693721": 1, "7881763": 1, "8277713": 1, "8509871": 2, "9328371": 1, "9804114": 1, "10022078": 3, "W2470426965": 1, "8118877": 2, "W2030153280": 1, "8840552": 2, "11102306": 1, "8229535": 1, "9020572": 1, "9143569": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN010", "text": "A dual-strip lateral flow assay device that simultaneously differentiates viral from bacterial infections by using a first chromatographic test strip to detect MxA protein and low-level C-reactive protein as viral infection markers, and a second chromatographic test strip to detect high-level C-reactive protein as a bacterial infection marker, operating on a fingerstick blood sample.", "source_patent_id": "10379121", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10379121"], "ground_truth": {"tier1_relevant_docs": {"10408835": 3, "10808287": 3, "W1982672647": 1, "W1601324395": 1, "W2089238012": 1, "W2041559574": 1, "W2160132348": 2, "W2322987389": 2, "W1997815596": 1, "W2038330119": 1, "W2112995567": 1, "W4232042142": 2, "W1991577015": 2, "W2110830588": 1, "W2092891003": 1, "W1992612216": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN011", "text": "Opioid antagonists, including peripherally restricted opioid antagonists, are used to attenuate endothelial cell proliferation and migration associated with angiogenesis, thereby inhibiting cancerous tumor growth and metastasis.", "source_patent_id": "8518962", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8518962"], "ground_truth": {"tier1_relevant_docs": {"8524731": 3, "9662325": 3, "9662390": 3, "9675602": 3, "9717725": 3, "W2579523544": 1, "W2735739709": 3, "W2127881618": 2, "W2031848709": 1, "W2095893831": 1, "W2164621617": 1, "W2322614519": 1, "W2074925725": 1, "W1903450321": 1, "W2172074189": 1, "W2095368589": 1, "W2994038732": 2, "W2156405505": 2, "W2123386346": 1, "W2110610344": 1, "W1895036842": 1, "W2406688330": 1, "W1985834247": 2, "W2184879005": 1, "10383869": 2, "8685995": 2, "9526723": 2, "W2552328241": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN012", "text": "A method for assessing immunocompetence by sequencing rearranged TCR and/or immunoglobulin DNA or RNA from a lymphoid sample to quantify adaptive immune receptor diversity and clonal distribution, wherein the resulting repertoire metrics are used to stratify patients by immune status and predict likelihood of response to immunotherapy.", "source_patent_id": "10221461", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10221461"], "ground_truth": {"tier1_relevant_docs": {"11180813": 3, "11047008": 1, "11066705": 2, "W3005826182": 2, "W2043071551": 2, "11214793": 2, "9809813": 2, "W80473510": 2, "W2085156070": 2, "W1551566597": 2, "9824179": 2, "10214770": 2, "9150905": 2, "9371558": 2, "10155992": 2, "10519511": 2, "10760133": 2, "10865453": 2, "11021757": 2, "9512487": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN013", "text": "A microfluidic device comprising a retention member that spatially separates particles from a liquid sample, and a pressure actuator that recombines at least some of the separated particles with a controlled subset of the separated liquid, enabling concentration or dilution of particle-containing samples on-chip, optionally followed by thermal lysis of the particles in an integrated lysing chamber.", "source_patent_id": "10865437", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10865437"], "ground_truth": {"tier1_relevant_docs": {"11078523": 3, "11135584": 1, "W1972867200": 1, "W2160035051": 1, "W2022234108": 1, "W2014512524": 1, "W1985054717": 1, "W2083106700": 1, "W2030235300": 1, "W2404051966": 1, "11084036": 1, "W2125741791": 1, "W2116428607": 1, "W1992057680": 1, "W2150929216": 1, "W2278136502": 1, "W2169868093": 1, "W3153050222": 1, "W2058016311": 1, "W1992723320": 1, "W4245840577": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN014", "text": "A method for identifying DNA methylation state by treating a target nucleic acid with a reagent that modifies nucleotides based on methylation state (e.g., bisulfite conversion), performing methylation-specific amplification of the treated target, fragmenting the amplified products by base-specific cleavage, and detecting the resulting fragments by mass spectrometry to identify the methylation state or precise locus of methylated or unmethylated nucleotides.", "source_patent_id": "9249456", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9249456"], "ground_truth": {"tier1_relevant_docs": {"W2098362718": 3, "W2074628531": 1, "W1970833628": 2, "W2082550660": 1, "W2106401558": 1, "W2117038014": 1, "W1994465394": 2, "W1970668422": 1, "W2089662278": 2, "W2099521252": 1, "W2160372366": 1, "W2130572312": 2, "W2111183991": 2, "W1636055145": 1, "W2106340111": 2, "W1567533051": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN015", "text": "An integrated receiver and hand-held medicament injection pen system wherein a continuous glucose sensor receiver calculates a medicament therapy and automatically sets a bolus dose on the injection pen, with the receiver and pen being either integrally formed or detachably connected via mutually engaging electrical contacts or wireless communication.", "source_patent_id": "9741139", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9741139"], "ground_truth": {"tier1_relevant_docs": {"10278580": 3, "10403012": 3, "10966609": 3, "11373347": 3, "8562558": 3, "8808228": 3, "11564602": 1, "7927274": 2, "8282550": 1, "9538946": 1, "10653835": 3, "10835672": 3, "11246990": 3, "7976492": 3, "8721585": 3, "8882741": 3, "8920401": 3, "8926585": 3, "9050413": 3, "9155843": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN016", "text": "A method of treating neuropsychiatric disorders, including schizophreniform disorder, by administering an effective amount of digestive enzymes (naturally or recombinantly derived) or their derivatives to reduce one or more symptoms of the neuropsychiatric disorder.", "source_patent_id": "10279016", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10279016"], "ground_truth": {"tier1_relevant_docs": {"10940187": 3, "10350278": 1, "11364287": 1, "11016104": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN017", "text": "A biointerface membrane for implantable devices comprising a first domain distal to the device that supports tissue ingrowth and attachment while inhibiting barrier cell layer formation, and a second domain proximal to the device that is resistant to cellular attachment and impermeable to cells, thereby preventing formation of a fibrous barrier that would impede analyte transport to the implanted device.", "source_patent_id": "8840552", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8840552"], "ground_truth": {"tier1_relevant_docs": {"8118877": 3, "10022078": 3, "W1984583685": 2, "7792562": 2, "7835777": 2, "7970448": 2, "7974672": 2, "8527025": 2, "8676288": 2, "9339223": 2, "8527026": 2, "8923947": 2, "9439589": 2, "9931067": 2, "W1988881359": 1, "10610140": 1, "8255030": 1, "8255033": 1, "9597027": 1, "9993186": 1, "W1586651582": 2, "W1974644354": 1, "W2146749893": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN018", "text": "Specific point mutations in NTRK1, NTRK2, and/or NTRK3 genes confer resistance to Trk inhibitors in cancer, and detection of these mutations in patient tumor samples can be used to predict Trk inhibitor efficacy, determine resistance risk, and guide treatment selection away from Trk inhibitor therapy.", "source_patent_id": "10655186", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10655186"], "ground_truth": {"tier1_relevant_docs": {"W2620626563": 2, "W2338990099": 3, "10724102": 3, "10907215": 3, "W2500669545": 2, "W2194998434": 3, "W2148089871": 2, "W2130348198": 1, "W2943991753": 1, "W2180425334": 1, "W2109269285": 1, "W2891473286": 1, "W2169013957": 1, "W4231572578": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN019", "text": "Nucleic acid sequencing method that uses Molecular Index Tags (MITs) attached to adapter sequences to uniquely label and identify individual sample nucleic acid molecules, enabling differentiation of distinct molecules with the same sequence during sequencing workflows.", "source_patent_id": "11519028", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11519028"], "ground_truth": {"tier1_relevant_docs": {"10011870": 3, "10577650": 3, "11530442": 3, "10221436": 1, "10557158": 1, "11414688": 1, "W2009039142": 2, "10077473": 2, "10526650": 2, "9708657": 3, "W2057536116": 1, "10829815": 1, "W987420839": 3, "W2303585199": 3, "11299774": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN020", "text": "An analytical test device comprising a base with a reaction area and visualization area, where analysis chemistry reagents include a nucleic acid substrate with a first label and a nucleic acid reactor that react with an analyte-containing sample to produce a labeled nucleic acid visualization species, which is then captured by a nucleic acid capture species in the visualization area, enabling lateral flow detection through nucleic acid-nucleic acid binding interactions.", "source_patent_id": "7799554", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["7799554"], "ground_truth": {"tier1_relevant_docs": {"W1988220558": 1, "W2135667690": 1, "W2074603803": 2, "11162132": 1, "11299774": 1, "11390912": 1, "11613773": 1, "6551784": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN021", "text": "Stable genetic transformation of maize cells is achieved by introducing the Streptomyces bar gene into embryogenic maize suspension culture cells via microprojectile bombardment, followed by selection of transformed cells using the herbicide bialaphos, and subsequent regeneration of fertile transformed maize plants from the selected cells.", "source_patent_id": "6399861", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6399861"], "ground_truth": {"tier1_relevant_docs": {"6803499": 3, "7705215": 3, "6329574": 3, "6025545": 3, "6777589": 3, "5990390": 3, "W2163621988": 3, "W2091843088": 2, "W1976290254": 1, "W1993993130": 1, "W2063673708": 1, "W2052839443": 1, "W2170434347": 1, "W4243845639": 3, "W2012129665": 2, "W2125582909": 2, "W2146611372": 2, "W1538806497": 1, "W1506529854": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN022", "text": "A truncated thrombomodulin derivative conjugated to polyethylene glycol (PEG) via site-specific pegylation, wherein the pegylation is directed to a defined site on the truncated thrombomodulin protein to produce a thrombomodulin conjugate with preserved protein C pathway regulatory activity.", "source_patent_id": "7833978", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["7833978"], "ground_truth": {"tier1_relevant_docs": {"W2057286297": 1, "W2034097744": 1, "W2051998923": 1, "W1990761369": 1, "W190138522": 1, "W2043817081": 1, "W2501177568": 1, "W1517078815": 2, "W2100513413": 1, "W1966603445": 1, "W2013074637": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN023", "text": "Recombinant microalgal cells engineered with exogenous genes encoding a combination of lipid-pathway enzymes—including fatty acyl-ACP thioesterase, keto acyl-ACP synthase, and sucrose transporter/invertase—to enable heterotrophic cultivation on sucrose while producing triacylglyceride compositions with tailored fatty acid profiles suitable for food, fuel, and oleochemical applications.", "source_patent_id": "9279136", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9279136"], "ground_truth": {"tier1_relevant_docs": {"9255282": 3, "10100341": 3, "9249436": 3, "8852885": 3, "10006034": 3, "10167489": 2, "10344305": 2, "9388435": 2, "9719114": 2, "10053715": 2, "8945908": 2, "9102973": 2, "9200307": 2, "10287613": 2, "10683522": 2, "11401538": 2, "9551017": 2, "9909155": 2, "9068213": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN024", "text": "A multispecific binding molecule comprising at least two polypeptide chains each containing a heavy chain portion and a synthetic connecting peptide, wherein the synthetic connecting peptide is designed to preferentially drive formation of interchain disulfide linkages over intrachain disulfide linkages, such that greater than 50% of the resulting dimers comprise polypeptide chains linked via at least one interchain disulfide bond rather than intrachain disulfide bonds.", "source_patent_id": "8084026", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8084026"], "ground_truth": {"tier1_relevant_docs": {"8603473": 3, "W1998744147": 2, "W1506651516": 1, "W1984670732": 1, "W2092638671": 1, "W2165739023": 1, "W1973382371": 1, "W1571113921": 2, "9889197": 2, "10093738": 2, "10093739": 2, "9284375": 2, "9296816": 2, "9963510": 2, "W1993370938": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN025", "text": "Recombinant human lysosomal acid lipase (LAL) engineered with specific glycosylation patterns that facilitate internalization into target cells via mannose or mannose-6-phosphate receptor-mediated uptake, for use in enzyme replacement therapy of lysosomal acid lipase deficiency conditions such as Wolman disease and cholesteryl ester storage disease.", "source_patent_id": "11560554", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11560554"], "ground_truth": {"tier1_relevant_docs": {"W1578923307": 2, "10407671": 3, "10858638": 3, "W2046407155": 3, "W2160241181": 1, "W1479884104": 2, "W2162765266": 3, "W2173535394": 1, "8945542": 2, "W1632247257": 2, "W2100842605": 1, "W172450680": 1, "W1976651057": 1, "W2462770198": 1, "W2157991447": 2, "W2418548215": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN026", "text": "A method for simultaneously amplifying multiple nucleic acid target loci in a single reaction volume using a library of primers selected to minimize formation of primer dimers and non-target amplicons, wherein the primer library selection process optimizes primer compatibility across all primer pairs to enable highly multiplexed PCR amplification.", "source_patent_id": "10793912", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10793912"], "ground_truth": {"tier1_relevant_docs": {"10316362": 3, "10351906": 3, "10526658": 3, "10538814": 3, "10557172": 3, "10597708": 3, "10597709": 3, "10597723": 3, "10655180": 3, "10731220": 3, "11111545": 3, "11286530": 3, "11312996": 3, "11332793": 3, "11390916": 3, "11519035": 3, "11525162": 3, "W2137167287": 2, "W2118555972": 2, "W2033609627": 2, "W2120335901": 2, "W2318103124": 2, "W2171719398": 2, "W2062837212": 1, "W2168585454": 2, "W2412513069": 2, "10214770": 2, "9150905": 2, "9371558": 2, "W2144175569": 1, "W2046001839": 1, "10894977": 2, "W2120504051": 1, "W2106888005": 2, "10647981": 1, "W2157463520": 2, "11072789": 1, "W2127442514": 1, "W2075922438": 2, "W2029233894": 1, "W2125811524": 1, "W2127082697": 1, "W2173498175": 2, "W2052383391": 2, "W2146351150": 1, "W2118811947": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN027", "text": "A combination therapy comprising an anti-HLA-DR antibody-drug conjugate (ADC) incorporating SN-38 or pro-2PDOX administered at 1-18 mg/kg, combined with a Bruton's tyrosine kinase inhibitor or PI3K inhibitor, wherein the combination produces a synergistic effect on inhibiting tumor growth in hematopoietic cancers, including those resistant to standard therapies.", "source_patent_id": "10058621", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10058621"], "ground_truth": {"tier1_relevant_docs": {"10744129": 1, "10195175": 1, "10206918": 2, "10709701": 2, "W2028681024": 1, "W2741676078": 1, "W2587678059": 1, "W1581978003": 1, "10130718": 1, "10653793": 1, "10849986": 1, "9492566": 1, "W2614143574": 2, "10137196": 1, "W2005504894": 1, "W2065920777": 1, "W2008893511": 1, "W2104028456": 1, "W2405342148": 1, "W2492172102": 1, "W2729256052": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN028", "text": "Antibodies or antibody fragments that bind to an epitope located within the second cysteine-rich subdomain (Cys2, amino acid residues 1575-1725) of MUC5AC with high specificity and selectivity for pancreatic cancer, enabling therapy when conjugated to therapeutic agents such as 90Y and in vivo/in vitro detection and diagnosis of pancreatic cancer.", "source_patent_id": "9452228", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9452228"], "ground_truth": {"tier1_relevant_docs": {"W1544575922": 3, "W2077870908": 1, "W1975433606": 1, "W1982492189": 2, "W2115196893": 1, "W2130301749": 2, "W2038933154": 2, "W2133255804": 1, "W2085055581": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN029", "text": "A method for treating cancer by administering a Btk inhibitor to mobilize a lymphocyte subpopulation into blood, determining the expression profile of one or more biomarkers from that subpopulation via immunophenotyping, and then selecting and administering a second therapeutic agent based on the determined biomarker expression profile.", "source_patent_id": "10004746", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10004746"], "ground_truth": {"tier1_relevant_docs": {"10004745": 3, "10016435": 3, "10478439": 3, "10653696": 3, "10751342": 3, "9814721": 3, "10975442": 1, "11311576": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN030", "text": "A method for diagnosing pervasive developmental disorders (PDDs), dysautonomia, Parkinson's disease, and SIDS by analyzing a stool sample using immunoassay to detect antigens associated with specific pathogens including Giardia, Cryptosporidium, E. histolytica, C. difficile, Adenovirus, Rotavirus, or H. pylori as biological markers indicative of neurological condition risk or presence.", "source_patent_id": "10209253", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10209253"], "ground_truth": {"tier1_relevant_docs": {"W2118956834": 1, "10776453": 1, "7935799": 1, "W2102244140": 1, "W2008853677": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN031", "text": "A lentiviral vector comprising a combination of an inactivated central polypurine tract, a stuffer sequence encoding drug susceptibility genes, and a mutated hairpin in the 5′ leader sequence that substantially abolishes replication, integrated within a self-inactivating vector configuration to enhance biosafety while maintaining efficient transgene expression for gene therapy applications.", "source_patent_id": "9260725", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9260725"], "ground_truth": {"tier1_relevant_docs": {"W2150922307": 1, "W1544190956": 1, "W2154853638": 2, "W2089579355": 2, "W2167523976": 2, "W2112824117": 1, "W2045812968": 1, "W1981449360": 1, "W1835972708": 2, "W2063548487": 1, "W2136355116": 2, "W2047942455": 1, "W2053601402": 1, "W2044474105": 1, "W2026901855": 1, "W2062826915": 1, "W2041709256": 1, "W1983804855": 1, "W2027296526": 1, "W2029727380": 1, "W2029571886": 1, "W2164835084": 1, "W1508974207": 1, "W1988849266": 1, "W2162361061": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN032", "text": "A method for treating metabolic disease by increasing expression of ILDR2 (Immunoglobulin-Like Domain Receptor 2) in a subject, wherein agents that upregulate ILDR2/Ildr2 RNA expression are identified by contacting cells with candidate compounds and comparing Ildr2 RNA expression levels in the presence and absence of the agent.", "source_patent_id": "9682123", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9682123"], "ground_truth": {"tier1_relevant_docs": {"W2117749980": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN033", "text": "Engineered immunostimulatory bacteria encoding RNAi molecules (shRNA or microRNA) that inhibit TREX1 (three prime repair exonuclease 1) expression, formulated for treating HPV-positive tumors or tumors with high tumor mutational burden where TREX1 expression correlates with tumor presence or properties.", "source_patent_id": "11242528", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["11242528"], "ground_truth": {"tier1_relevant_docs": {"W2119681037": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN034", "text": "A uricase-polymer conjugate wherein at least one branched polymer comprising a backbone with a plurality of covalently attached side chains is conjugated to uricase to reduce or eliminate the antigenicity of the uricase molecule.", "source_patent_id": "10392611", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10392611"], "ground_truth": {"tier1_relevant_docs": {"10364451": 3, "W1989411256": 2, "W1943625917": 3, "7815893": 1, "8475765": 1, "W2568016708": 1, "W2073471403": 1, "W2326355551": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN035", "text": "An ultrasound method that simultaneously tracks both vessel wall motion and blood flow velocity using high frame rate pulse-echo ultrasound data combined with speckle tracking applied to both the vessel wall and intraluminal blood, enabling concurrent characterization of vascular wall dynamics and flow patterns from a single acquisition sequence.", "source_patent_id": "11547384", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11547384"], "ground_truth": {"tier1_relevant_docs": {"W2110282218": 2, "W2098486499": 1, "W2544030031": 3, "W2096578443": 2, "W2098349201": 3, "W2153906642": 1, "W2140014467": 1, "W2006656297": 1, "W2072870956": 1, "W2153891623": 2, "W1975573633": 2, "W2112636735": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN036", "text": "Administering carbon monoxide gas to a subject in a therapeutically sufficient amount and duration treats ischemic disorders, with additional methods employing selectin antagonists to prevent white blood cell accumulation or inactivated Factor IX to inhibit coagulation as alternative treatments for ischemic disorders.", "source_patent_id": "8128963", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["8128963"], "ground_truth": {"tier1_relevant_docs": {"W2160800132": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN037", "text": "Aluminum-coated glass slides with a metal oxide surface layer that enables covalent grafting of modified oligosaccharides, providing simultaneous fluorescence-based binding analysis and mass spectrometric characterization of carbohydrates on the same electrically conductive substrate with greater sensitivity than transparent glass slides.", "source_patent_id": "10274488", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10274488"], "ground_truth": {"tier1_relevant_docs": {"W2089319310": 3, "W1965423278": 3, "W2028085557": 1, "W2042650834": 1, "W1978481656": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN038", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with an enzymatically inactive Cas9 polypeptide, enables site-specific modulation of transcription at a target DNA locus without cleaving the DNA, providing RNA-directed transcriptional regulation through a catalytically dead Cas9-guide RNA complex.", "source_patent_id": "11001863", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11001863"], "ground_truth": {"tier1_relevant_docs": {"10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10400253": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3, "10519467": 3, "10526619": 3, "10533190": 3, "10550407": 3, "10563227": 3, "10570419": 3, "10577631": 3, "10597680": 3, "10612045": 3, "10626419": 3, "10640791": 3, "10669560": 3, "10676759": 3, "10774344": 3, "10793878": 3, "10900054": 3, "10982231": 3, "10988780": 3, "10988782": 3, "11008590": 3, "11028412": 3, "11186849": 3, "11242543": 3, "11274318": 3, "11293034": 3, "11332761": 3, "11401532": 3, "11473108": 3, "11479794": 3, "11549127": 3, "10301651": 3, "10752920": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN039", "text": "A continuous analyte sensor comprising a sensing membrane that includes at least one surface-active group-containing polymer configured as a bioprotective layer that substantially blocks the effect of non-constant noise-causing species on the sensing mechanism while allowing target analyte transport to the sensing mechanism.", "source_patent_id": "9693721", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9693721"], "ground_truth": {"tier1_relevant_docs": {"10143410": 3, "11147483": 3, "8583204": 3, "8682408": 3, "8954128": 3, "9173606": 3, "9173607": 3, "9549699": 3, "9566026": 3, "9572523": 3, "10376188": 1, "10667729": 1, "10667730": 1, "10702193": 1, "8060174": 1, "9788766": 1, "11102306": 1, "9020572": 1, "9143569": 1, "8229535": 1, "8277713": 1, "11160926": 1, "11350862": 1, "11382540": 1, "10231654": 1, "10478108": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN040", "text": "A transdermal drug delivery method using an occlusive patch to deliver cannabinoids—including cannabidiol, cannabinol, nabilone, or specific THC derivatives—in combination with specific permeation enhancers (propylene glycol monolaurate, diethylene glycol monoethyl ether, oleoyl macrogolglyceride, caprylocaproyl macrogolglyceride, or oleyl alcohol) to bypass gastrointestinal first-pass metabolism and treat illness symptoms in mammals.", "source_patent_id": "8449908", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["8449908"], "ground_truth": {"tier1_relevant_docs": {"W2127383863": 1, "W2041250042": 1, "W2029366081": 1, "W49359531": 1, "W2133752997": 1, "W2108437852": 1, "W2128542220": 1, "W2095627608": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN041", "text": "An optical coherence tomography system that reduces speckle by using a sample arm arrangement that splits electromagnetic radiation into at least two beams and introduces a path length delay between the beams to irradiate a structure from different angles, enabling angular compounding through path length encoding to reduce speckle noise in the resulting OCT image.", "source_patent_id": "8559012", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8559012"], "ground_truth": {"tier1_relevant_docs": {"8174702": 3, "9226665": 3, "7995210": 1, "W1967985611": 2, "W2089238603": 1, "W2103457061": 2, "W1985263532": 1, "W2047015107": 1, "W2118216040": 1, "W2057535513": 1, "8175685": 1, "W2008322311": 1, "8922781": 1, "W2061240737": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN042", "text": "Poly(beta-amino alcohols) (PBAAs) synthesized via combinatorial polymerization serve as surface coatings that modulate inflammatory response in a structure-dependent manner, inhibiting macrophage activation in vitro and reducing inflammatory cell recruitment and fibrosis in vivo following subcutaneous implantation, and can form polyelectrolyte complex capsules for cellular encapsulation.", "source_patent_id": "9193827", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9193827"], "ground_truth": {"tier1_relevant_docs": {"W1995934164": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN043", "text": "Engineered cytochrome P450 BM-3 mutants (9-10A-A328V and 1-12G) created through directed evolution and site-directed mutagenesis that hydroxylate linear alkanes regioselectively at the 2-position using atmospheric dioxygen, producing opposite enantiomers of 2-octanol (S- and R-configured, respectively) with 40-55% enantiomeric excess and thousands of product turnovers, with activity retained in whole-cell E. coli biotransformations using endogenous cofactor supply.", "source_patent_id": "8741616", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8741616"], "ground_truth": {"tier1_relevant_docs": {"W2083112939": 3, "8343744": 3, "9145549": 3, "7863030": 3, "W2063112093": 2, "W2133834597": 2, "W4235414783": 1, "W2148331201": 1, "W1482005880": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN044", "text": "A T cell in which a recombinant nucleic acid sequence encoding a chimeric antigen receptor (CAR) is integrated at a specific genomic site such that CAR expression is driven by an endogenous T cell promoter, and wherein integration at that site simultaneously reduces or prevents expression of a functional endogenous T cell receptor (TCR) complex at the cell surface.", "source_patent_id": "11377637", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11377637"], "ground_truth": {"tier1_relevant_docs": {"10525083": 1, "W2134422640": 1, "W2047205338": 1, "W1976400767": 2, "11242375": 1, "W2008686180": 1, "W2087414558": 1, "W2105798223": 1, "W1607012924": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN045", "text": "Amino derivatives of EM-138 (a thalidomide-related compound) and their thalidomide precursors, analogs, metabolites, and hydrolysis products inhibit angiogenesis when administered orally, providing treatment for disease states resulting from pathological angiogenesis.", "source_patent_id": "6420414", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["6420414"], "ground_truth": {"tier1_relevant_docs": {"6469045": 2, "7723361": 2, "8143283": 2, "8039488": 3, "6114355": 2, "6518298": 2, "6228879": 2, "W1986847430": 1, "W2979953013": 1, "W2078385611": 1, "W2046965419": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN046", "text": "A blood glucose monitoring unit integrates a calibration unit that eliminates the need for user-entered calibration codes by automatically calibrating in vitro test strips, providing compatibility with codeless test strips within an analyte monitoring system.", "source_patent_id": "10201301", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10201301"], "ground_truth": {"tier1_relevant_docs": {"8346337": 3, "8920319": 3, "8688188": 3, "8915850": 3, "9326716": 3, "8465425": 3, "9078607": 3, "W2101926913": 1, "8160671": 1, "8249684": 1, "8428678": 1, "W2409954223": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN047", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with an enzymatically inactive Cas9 polypeptide, enables site-specific modulation of transcription at a target DNA locus without cleaving the DNA, wherein the RNA-Cas9 complex is directed to a specific genomic site by the targeting sequence to modulate gene expression.", "source_patent_id": "10526619", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10526619"], "ground_truth": {"tier1_relevant_docs": {"10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10400253": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3, "10519467": 3, "10533190": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN048", "text": "A continuous analyte sensor calibration system that uses reference data from a short-term implanted continuous analyte sensor to initially calibrate or update sensor data from a separately implanted long-term continuous analyte sensor, and alternatively uses pre-insertion benchtop testing reference data to provide initial calibration of sensor data without requiring in vivo reference measurements.", "source_patent_id": "10898114", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10898114"], "ground_truth": {"tier1_relevant_docs": {"10610135": 3, "10610136": 3, "10610137": 3, "10617336": 3, "10709364": 3, "10716498": 3, "10743801": 3, "10856787": 3, "10918316": 3, "10918317": 3, "10918318": 3, "10925524": 3, "11000213": 3, "11051726": 3, "7920906": 3, "8560037": 3, "8579816": 3, "8611978": 3, "9078608": 3, "9314196": 3, "9918668": 3, "10786185": 2, "7797028": 2, "7826981": 2, "8052601": 2, "8060173": 2, "8206297": 2, "8394021": 2, "8442610": 2, "8548553": 2, "8622905": 2, "8676287": 2, "8700117": 2, "8761856": 2, "8788006": 2, "8788008": 2, "8801612": 2, "8808182": 2, "9895089": 2, "10980461": 2, "10898113": 1, "8005524": 1, "8216139": 1, "8233958": 1, "8251906": 1, "8257259": 1, "8265725": 1, "8290561": 1, "8374667": 1, "8469886": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN049", "text": "A two-stage microfluidic cartridge that performs nucleic acid amplification in a first stage and then distributes amplified products to a second detection stage, enabling multiplexed detection of multiple target nucleic acids from a single amplification reaction within an integrated device.", "source_patent_id": "11453906", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11453906"], "ground_truth": {"tier1_relevant_docs": {"9598724": 1, "W2089922757": 2, "W2021031313": 1, "W2007192510": 1, "W2114840438": 2, "W2066346928": 1, "W2035285327": 2, "W106927097": 1, "10370705": 2, "9447461": 2, "W2094691790": 1, "W2087828704": 1, "W2016882071": 1, "11266987": 2, "W2145303234": 1, "W2071829817": 1, "W2074603803": 1, "W2123649638": 1, "W2142162336": 1, "W2164952035": 1, "7833708": 1, "8486636": 1, "10131934": 2, "W2137748829": 1, "W2149275456": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN050", "text": "A microfluidic device comprising a retention member that spatially separates particles from liquid in a particle-containing sample, and a pressure actuator that recombines the separated particles with only a subset of the separated liquid, thereby concentrating the particles, followed by thermal lysis of the concentrated particles in a lysing chamber to release their contents.", "source_patent_id": "11078523", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11078523"], "ground_truth": {"tier1_relevant_docs": {"10865437": 3, "W2150929216": 1, "W2404051966": 1, "W2014512524": 1, "W1985054717": 1, "W1992057680": 1, "W2065309676": 1, "W2083106700": 1, "W846227499": 1, "W2125741791": 1, "W2116428607": 1, "W1992723320": 1, "W2117573623": 1, "W2100953371": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN051", "text": "A genetically modified non-human animal whose genome comprises an endogenous EPO gene locus modified to express human erythropoietin (EPO), enabling humanized erythropoiesis modeling and in vivo screening for agents that modulate erythrocyte function or pathogen infection of erythrocytes.", "source_patent_id": "10463028", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10463028"], "ground_truth": {"tier1_relevant_docs": {"10123518": 1, "10785966": 1, "10785968": 1, "9901082": 1, "9986724": 1, "W1990285147": 1, "W154036014": 1, "W2063250903": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN052", "text": "Ligands bearing site-specific conjugated electron-donating substituents that form transition metal catalyst complexes with enhanced ATRP equilibrium constants, enabling atom transfer radical polymerization at low catalyst concentrations while maintaining linear molecular weight growth with monomer conversion and narrow molecular weight distributions.", "source_patent_id": "9533297", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9533297"], "ground_truth": {"tier1_relevant_docs": {"11174325": 1, "W2314034520": 2, "W2076174949": 1, "W2091665035": 1, "W1967812778": 1, "W2014690667": 2, "W2017313815": 2, "W2148804555": 2, "W2087177903": 2, "W2083431697": 1, "W2327846609": 1, "W2039274720": 1, "W1972569526": 1, "10072042": 1, "W2332767535": 1, "W2076910445": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "NOVEL", "google": "NOVEL"}}}
{"statement_id": "RN053", "text": "An optical coherence imaging detector system wherein at least one detector has an electrical integration time during which it receives a signal combining sample and reference electromagnetic radiation, where the signal includes a first portion exceeding a predetermined power threshold and an immediately adjacent second portion with power below the threshold that extends for more than 10% of the electrical integration time, enabling detection of partially illuminated integration periods to improve imaging performance.", "source_patent_id": "RE44042", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["RE44042"], "ground_truth": {"tier1_relevant_docs": {"9060689": 1, "7843572": 1, "8175685": 1, "8081316": 1, "9377290": 1, "9226660": 1, "9364143": 1, "7920271": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN054", "text": "A patient monitor that correlates acoustic breathing sound signals from a respiratory sensor with SpO2 oxygen saturation time series data from a pulse oximeter using a processor to automatically detect and classify multiple SpO2 pattern types associated with respiratory events.", "source_patent_id": "8862196", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8862196"], "ground_truth": {"tier1_relevant_docs": {"9042952": 2, "8932227": 1, "8365730": 2, "10532170": 1, "9044558": 2, "W2414128781": 1, "W2536127515": 1, "W4243470037": 2, "W77398999": 1, "W2005290650": 1, "8398555": 2, "W2408541533": 1, "W2098506383": 1, "W2070901983": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN055", "text": "A client device establishes a secure communication link with a target device by generating an address request, performing an address lookup to determine whether the target device supports secure communications based on whether the requested address is identified in a secure domain name lookup, and then enabling audio/video communications over the established secure link.", "source_patent_id": "9077694", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9077694"], "ground_truth": {"tier1_relevant_docs": {"9077695": 3, "8868705": 3, "10511573": 3, "9374346": 3, "8850009": 3, "8843643": 3, "9860283": 3, "8904516": 3, "9819649": 3, "9100375": 2, "9037713": 3, "9967240": 3, "9038163": 3, "9027115": 3, "9094399": 2, "8943201": 2, "9413766": 2, "9769128": 2, "10187387": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN056", "text": "A peptide amphiphile molecule comprising a peptide sequence that non-covalently binds TGF-β1 and self-assembles into a gel scaffold in situ, which when combined with microfracture surgery localizes and retains chondrogenic growth factors to induce bone marrow mesenchymal stem cell chondrogenic differentiation and enhance articular cartilage regeneration.", "source_patent_id": "8450271", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["8450271"], "ground_truth": {"tier1_relevant_docs": {"W2025439968": 3, "W2068969716": 1, "W2017544519": 1, "W1991415492": 1, "W2047103746": 1, "W2107814037": 1, "W2103765130": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN057", "text": "A continuous analyte sensor calibration system that evaluates sensor data stability over an initial time period before initiating calibration, then builds and updates a calibration set from matched sensor-reference data pairs using inclusion criteria to select optimal calibration pairs, while implementing fail-safe mechanisms that assess clinical acceptability of reference analyte data and calibration quality to validate estimated blood analyte values.", "source_patent_id": "8622905", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8622905"], "ground_truth": {"tier1_relevant_docs": {"10786185": 3, "7797028": 3, "7826981": 3, "8052601": 3, "8060173": 3, "8206297": 3, "8394021": 3, "8442610": 3, "8548553": 3, "8676287": 3, "8700117": 3, "8761856": 3, "8788006": 3, "8788008": 3, "8801612": 3, "8808182": 3, "9895089": 3, "10610135": 3, "10610136": 3, "10610137": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN058", "text": "Tissue culture plastic-adherent placental stem cells (PDAC) are administered systemically to treat neuropathic pain in an individual, leveraging the immunomodulatory and neuroregenerative properties of placenta-derived adherent cells as a cell-based therapeutic approach.", "source_patent_id": "9040035", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9040035"], "ground_truth": {"tier1_relevant_docs": {"W2102726602": 1, "W2126134953": 1, "10195233": 1, "10220059": 1, "10383898": 1, "9579351": 1, "W2923081322": 1, "W2070334783": 1, "W1968668812": 1, "W1501884562": 1, "W2550262023": 2, "W2074379284": 1, "W1990279811": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN059", "text": "A lipid-based transfection compound having a central heteroatom core (N, O, or S) linked via a bivalent organic radical to multiple hydrophobic chains (alkyl, alkenyl, or aryl groups) and polyamine head groups selected from spermiyl, spermidyl, guanidyl, or related polyamine moieties, wherein the linker optionally incorporates ether, ester, amide, or phosphate functionalities, designed to facilitate intracellular delivery of biologically active agents.", "source_patent_id": "9358300", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9358300"], "ground_truth": {"tier1_relevant_docs": {"8058068": 1, "W1988289069": 3, "W2063595779": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN060", "text": "A method for purifying nucleotide sugars from a reaction mixture by sequentially adjusting pH and applying membrane filtration with specific molecular weight cut-offs to selectively remove contaminants including phosphate groups, magnesium sulfate, sodium pyruvate, and tetrasodium pyrophosphate while retaining the desired nucleotide sugar product.", "source_patent_id": "8841439", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["8841439"], "ground_truth": {"tier1_relevant_docs": {"W2030008758": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN061", "text": "A non-naturally occurring microbial organism engineered with both 4-hydroxybutanoic acid (4-HB) and 1,4-butanediol (BDO) biosynthetic pathways, wherein exogenous nucleic acids encoding enzymes including 4-hydroxybutanoate dehydrogenase, α-ketoglutarate decarboxylase, 4-hydroxybutyrate:CoA transferase, and aldehyde/alcohol dehydrogenase are expressed to enable direct microbial fermentation of 1,4-butanediol (BDO) from central metabolic intermediates succinyl-CoA or α-ketoglutarate.", "source_patent_id": "9487803", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9487803"], "ground_truth": {"tier1_relevant_docs": {"11371046": 3, "8357520": 3, "8969054": 3, "8067214": 3, "8889399": 3, "10273508": 3, "8129169": 3, "9434964": 3, "7858350": 3, "8129156": 3, "8178327": 3, "9175297": 3, "11401534": 3, "8129155": 2, "10662451": 2, "8530210": 3, "9222113": 2, "9988656": 3, "7947483": 2, "8048661": 1, "8377666": 3, "8377667": 3, "10087470": 1, "8445244": 1, "8637286": 1, "11085015": 3, "9677045": 3, "10487342": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN062", "text": "A method for synthesizing arrays of polymer sequences on a substrate by selectively exposing regions bearing photoremovable protecting groups to light to activate those regions, then coupling monomers that also carry photoremovable protecting groups, and repeating the cycle with different monomers to build up sequence arrays of desired length.", "source_patent_id": "6660234", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6660234"], "ground_truth": {"tier1_relevant_docs": {"6630308": 3, "6747143": 3, "6403957": 3, "6646243": 3, "6566495": 3, "W2086464766": 3, "6491871": 3, "W2157215461": 3, "W2071451059": 3, "W2029911544": 1, "W2012878989": 2, "W2032429811": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN063", "text": "A method of treating hypertriglyceridemia by administering a pharmaceutical composition comprising eicosapentaenoic acid (EPA) or a derivative thereof as the sole active ingredient, without docosahexaenoic acid (DHA), to reduce triglyceride levels in a subject while minimizing increases in LDL-cholesterol.", "source_patent_id": "8440650", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8440650"], "ground_truth": {"tier1_relevant_docs": {"10537544": 3, "10632094": 3, "11291643": 3, "8293727": 3, "8293728": 3, "8314086": 3, "8324195": 3, "8357677": 3, "8367652": 3, "8377920": 3, "8399446": 3, "8415335": 3, "8426399": 3, "8431560": 3, "8518929": 3, "8524698": 3, "8546372": 3, "10966968": 1, "10561631": 3, "11052063": 3, "10166209": 3, "10265290": 3, "10610508": 3, "10973797": 3, "11185525": 3, "9452151": 3, "10973796": 2, "9827219": 2, "11141399": 1, "10406130": 2, "10842765": 2, "10172818": 2, "11446269": 2, "10016386": 2, "10278935": 2, "10278936": 2, "10278937": 2, "10278938": 2, "10278939": 2, "9603826": 2, "9610272": 2, "9623001": 2, "9693984": 2, "9693985": 2, "9693986": 2, "9918954": 2, "9918955": 2, "10383840": 2, "10555924": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN064", "text": "Azido-BODIPY compounds and cyclooctyne-based fluorogenic probes that undergo azide-alkyne cycloaddition reactions to form triazolyl products, wherein the fluorogenic probes exhibit increased fluorescence upon reaction with azide- or alkyne-containing biomolecules, enabling activity-based detection and imaging of target biomolecules without requiring wash steps.", "source_patent_id": "10119972", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10119972"], "ground_truth": {"tier1_relevant_docs": {"W2062188984": 2, "W2002866108": 3, "W2022634915": 3, "W2030812749": 1, "W2046253638": 2, "W2076529491": 2, "W1980282352": 2, "W2021320094": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN065", "text": "Single-chain polypeptides comprising only the protease domain of a type II transmembrane serine protease (MTSP) are used in methods to identify compounds that modulate MTSP protease activity, along with novel MTSP family members designated MTSP3, MTSP4, and a form of MTSP6.", "source_patent_id": "7700341", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7700341"], "ground_truth": {"tier1_relevant_docs": {"7888092": 3, "W2144185179": 2, "W2119542456": 2, "W2140618597": 2, "W2049831508": 1, "W2102142823": 1, "W1538277030": 1, "W1992681586": 1, "W1969754678": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN066", "text": "A hybridization chain reaction (HCR) method wherein a full initiator sequence is split into two or more partial initiator fragments that individually cannot trigger HCR amplification, but when brought into proximity through target-mediated binding events reconstitute a complete initiator capable of triggering HCR signal amplification.", "source_patent_id": "11214825", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11214825"], "ground_truth": {"tier1_relevant_docs": {"10450599": 3, "W2148304424": 1, "W1561752765": 1, "W2066649475": 1, "W2149270432": 1, "W2594994723": 1, "W2075077797": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN067", "text": "Small molecule glycomimetic compounds that antagonize E-selectin by inhibiting its binding to E-selectin ligands, thereby preventing cancer cell adhesion to bone marrow endothelial cells, reducing metastatic infiltration into bone marrow, and inhibiting thrombus formation.", "source_patent_id": "9109002", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9109002"], "ground_truth": {"tier1_relevant_docs": {"10526361": 3, "10766916": 3, "9796745": 3, "9867841": 2, "W2035480085": 1, "W1871629237": 2, "W2047942414": 3, "W1725142663": 2, "W2979826324": 2, "W2480666200": 2, "W1983774546": 2, "W2568387171": 2, "W4248903596": 2, "W2557946695": 2, "W2109466573": 2, "W2564443150": 2, "W2079365541": 1, "W2562574582": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN068", "text": "Fc region-containing polypeptides (preferably antibodies) comprising at least one amino acid substitution in the Fc region that attenuates post-translational fucosylation, thereby improving binding to activating Fcγ receptors and reducing binding to inhibitory Fcγ receptors to enhance effector cell function.", "source_patent_id": "9096877", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9096877"], "ground_truth": {"tier1_relevant_docs": {"W2127214162": 2, "W2168313542": 2, "W1973718144": 1, "W1989010611": 1, "W2143562636": 2, "W1529809181": 2, "W2036609771": 2, "8674083": 2, "W2053175240": 1, "W2051652916": 2, "W2170516337": 1, "W1969824500": 1, "W2046380830": 1, "8216574": 2, "W2058775948": 1, "9051373": 1, "10711069": 2, "8652466": 2, "9708408": 2, "W2418388414": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN069", "text": "Modified relaxin polypeptides comprising one or more amino acid substitutions with non-naturally encoded amino acids and/or conjugation to a water-soluble polymer such as polyethylene glycol, for use in treating fibrotic disorders or heart failure with improved pharmacological properties compared to native relaxin.", "source_patent_id": "9567386", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9567386"], "ground_truth": {"tier1_relevant_docs": {"11311605": 3, "10751391": 3, "11185570": 3, "8735539": 3, "10266578": 3, "11364281": 3, "10702588": 3, "9488660": 1, "W2030661378": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN070", "text": "Three-dimensional perfunctionalized polyhedral borane and carborane molecular clusters wherein all vertices of the polyhedral cage are substituted with functional groups, enabling manipulation of photophysical properties for use as photooxidants or organic light-emitting diode components.", "source_patent_id": "11479470", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["11479470"], "ground_truth": {"tier1_relevant_docs": {"W2146023678": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN071", "text": "Tocopherol quinone derivatives bearing fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, or amine substituents at the 1,4-benzoquinone core are used to treat oxidative stress disorders including mitochondrial disorders, neurodegenerative diseases, and diseases of aging by modulating, normalizing, or enhancing energy biomarkers.", "source_patent_id": "10703701", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10703701"], "ground_truth": {"tier1_relevant_docs": {"W2185348657": 1, "W1998801948": 1, "W2140075873": 1, "W1983904065": 1, "W2568450381": 1, "W2175835252": 1, "W617988207": 1, "W384863521": 1, "W2105754268": 1, "W2077447747": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN072", "text": "Bifunctional degrader molecules (Degronimers) comprising a glutarimide-based E3 ubiquitin ligase-binding degron linked to a target protein ligand via a carbon-carbon bond at the C3 position of the glutarimide ring, enabling targeted intracellular protein degradation through the ubiquitin-proteasome pathway.", "source_patent_id": "10849982", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10849982"], "ground_truth": {"tier1_relevant_docs": {"W2767426216": 2, "W2559947248": 1, "W2025031463": 1, "W2054746486": 1, "W2585495993": 1, "W2318148969": 2, "W2781383440": 2, "W2090958270": 1, "W1565619051": 2, "W2176682109": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN073", "text": "A therapeutic combination comprising temsirolimus (an mTOR inhibitor), trastuzumab (HER2-targeting monoclonal antibody), and/or HKI-272 (neratinib, an irreversible pan-HER tyrosine kinase inhibitor) for treating metastatic breast cancer, wherein the combination simultaneously targets the mTOR pathway, HER2 receptor, and HER family kinase signaling.", "source_patent_id": "10729672", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10729672"], "ground_truth": {"tier1_relevant_docs": {"W2113762115": 2, "W2124648931": 2, "W2018022997": 1, "W2016506024": 2, "W1965766554": 1, "W2133325068": 3, "W2104239861": 1, "W155262670": 1, "W2089071484": 1, "W2093650262": 2, "W2090648424": 1, "W2114195503": 2, "W2562573190": 1, "W2055831769": 2, "W2417773149": 1, "W2032942530": 1, "W2139135964": 1, "10111868": 1, "9511063": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN074", "text": "A method for measuring protein kinetic parameters (synthesis, breakdown, transport rates) in inaccessible tissues without physical tissue biopsy by administering isotope-labeled molecules in vivo, then collecting body fluid samples to isolate and measure isotopic incorporation patterns of tissue-derived proteins that have escaped into the body fluid via mass spectrometry, using the body fluid protein kinetics as a surrogate for the corresponding tissue protein kinetics.", "source_patent_id": "9134319", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9134319"], "ground_truth": {"tier1_relevant_docs": {"W2274357590": 1, "W2118922221": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN075", "text": "A field effect transistor for RF and microwave circuits incorporates one or more strained channel layers disposed on one or more planarized substrate layers, wherein the strained material configuration produces improved transconductance and noise figure characteristics suitable for use in voltage controlled oscillators, low noise amplifiers, and phase locked loops.", "source_patent_id": "7709828", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["7709828"], "ground_truth": {"tier1_relevant_docs": {"7906776": 3, "7776697": 2, "7846802": 2, "7884353": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN076", "text": "A non-naturally occurring microorganism engineered to produce acrylate via a biosynthetic pathway comprising a decarboxylase enzyme, wherein one or more gene disruptions reduce competing enzymatic activities to confer increased acrylate production, with at least one exogenous nucleic acid encoding the acrylate pathway enzyme expressed in sufficient amount to produce acrylate from fumarate or malate intermediates.", "source_patent_id": "8129154", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["8129154"], "ground_truth": {"tier1_relevant_docs": {"7947483": 1, "10087470": 1, "8445244": 1, "8637286": 1, "10273508": 1, "8129169": 1, "9434964": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN077", "text": "A system for light-directed spatially-addressable parallel chemical synthesis that combines solid-phase chemistry, photolabile protecting groups, and photolithographic binary masking techniques to synthesize large-scale combinatorial chemical libraries on a substrate surface for receptor-ligand binding affinity screening.", "source_patent_id": "6491871", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6491871"], "ground_truth": {"tier1_relevant_docs": {"6566495": 3, "W2159511216": 3, "W2017423606": 1, "W2032429811": 3, "W2012878989": 2, "W2467395778": 1, "W2039492060": 1, "W2034413905": 1, "W2111130831": 1, "W2094850820": 1, "W33352663": 1, "W2142278025": 1, "W2022243850": 1, "W2157215461": 2, "W2086464766": 3, "W2053036921": 1, "W4251565960": 2, "W2036914780": 1, "W2029911544": 2, "W1983646492": 1, "W2166602500": 1, "W2027571016": 1, "W2010630649": 1, "W2899848970": 1, "W2952319396": 1, "W2022942432": 1, "W2035730261": 1, "W2071451059": 3, "10052605": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN078", "text": "Outer membrane vesicles (OMVs) containing polysaccharide A (PSA) are used as a delivery vehicle to mucous membranes, wherein the PSA-containing OMVs induce differentiation of functional regulatory T cells (Tregs) with suppressive activity in a PSA-dependent manner and prevent experimental colitis by suppressing pro-inflammatory cytokine responses in the gut.", "source_patent_id": "11419887", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11419887"], "ground_truth": {"tier1_relevant_docs": {"W2150968312": 2, "W2050259218": 1, "W2111951615": 1, "W1747012886": 1, "W2086454098": 1, "W2049449911": 1, "W1995097896": 1, "W2402098026": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN079", "text": "A method of inhibiting bone resorption comprising administering a sclerostin inhibitor to a human in an amount sufficient to reduce bone resorption marker levels for at least 2 weeks, wherein the sclerostin inhibitor is a sclerostin binding agent that can be monitored by measuring bone resorption markers before and after administration.", "source_patent_id": "9089553", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9089553"], "ground_truth": {"tier1_relevant_docs": {"10273293": 3, "11091537": 3, "W2073558178": 1, "W1970864109": 1, "W2339561542": 1, "W1992159640": 2, "W2075010531": 1, "8563271": 2, "8992911": 2, "9011856": 2, "9657095": 2, "W2108403721": 1, "W2112292482": 1, "7868134": 2, "W2087560312": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN080", "text": "A recombinant Listeria strain that expresses a tumor-specific antigenic polypeptide and optionally an angiogenic polypeptide, wherein a nucleic acid encoding at least one polypeptide is genomically integrated in-frame with a nucleic acid sequence encoding a PEST-containing polypeptide, enabling dual delivery of heterologous antigens to induce an immune response against cancer.", "source_patent_id": "9650639", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9650639"], "ground_truth": {"tier1_relevant_docs": {"9644212": 3, "8128922": 1, "9758551": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN081", "text": "An optical coherence tomography system that extends imaging depth range through optical sub-sampling, wherein a sample is characterized over a plurality of continuous resolvable depth points that exceeds the number of distinct measurements acquired, enabling depth reconstruction beyond the conventional Nyquist-limited imaging range without increasing detector sampling density.", "source_patent_id": "8937724", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["8937724"], "ground_truth": {"tier1_relevant_docs": {"W1973494603": 1, "W2027077159": 2, "W2057925466": 1, "W2062630097": 1, "W2081934600": 1, "W2075929857": 1, "W2066456957": 1, "W2115794463": 1, "W2085637023": 3, "8081316": 1, "9226660": 1, "W2078920062": 1, "W2062786827": 1, "W1989548263": 1, "W2087670896": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN082", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with an enzymatically inactive Cas9 polypeptide, enables site-specific modulation of transcription of a target DNA without cleaving the DNA, wherein the RNA-directed targeting is achieved through a guide RNA that directs the Cas9 polypeptide to a specific genomic locus to activate or repress transcription.", "source_patent_id": "10597680", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10597680"], "ground_truth": {"tier1_relevant_docs": {"10400253": 3, "10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3, "10519467": 3, "10526619": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN083", "text": "A method for directed differentiation of mammalian definitive endoderm cells into gastric fundus tissue or organoids through a defined sequence of signaling pathway manipulations in vitro, producing tissue that recapitulates the cellular composition and organization of the gastric fundus.", "source_patent_id": "11066650", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11066650"], "ground_truth": {"tier1_relevant_docs": {"10174289": 3, "11053477": 3, "10947510": 1, "W1914028229": 1, "10351820": 1, "W2417077905": 1, "10233421": 1, "9593305": 1, "9593306": 1, "9506036": 1, "9528090": 1, "9951314": 1, "W2427010667": 2, "W1653176923": 1, "W2170781656": 1, "W2007260996": 1, "10781425": 1, "W2080741429": 1, "W2139020188": 1, "W2006838330": 1, "W2567003412": 1, "W2147705631": 1, "W1999914688": 1, "W2016093088": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN084", "text": "Bispecific antibodies comprising both a T cell-interacting region and a glycan-interacting region that binds sialyl Tn (STn) antigen expressed on cancer cells, enabling recruitment of T cells to STn-expressing cancer cells to mediate targeted cell killing.", "source_patent_id": "11401330", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11401330"], "ground_truth": {"tier1_relevant_docs": {"W2062675346": 1, "W2111742915": 1, "W2038444690": 1, "W2032185672": 2, "W2887482676": 1, "W1972848082": 1, "W1977743020": 1, "W2116215875": 1, "W1979077811": 1, "W2112689808": 1, "W2145132368": 1, "W2741768127": 3, "W2530534210": 1, "W1544375765": 1, "W1972130286": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN085", "text": "Fully human monoclonal antibodies that cross-reactively bind to both IL-17A and IL-17F, including their homodimeric forms and the heterodimeric IL-17A/IL-17F protein complex, for use in therapeutic, diagnostic, and prophylactic applications.", "source_patent_id": "8771697", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8771697"], "ground_truth": {"tier1_relevant_docs": {"8715669": 3, "9475873": 2, "8137671": 2, "8609093": 2, "W1801000534": 1, "W2091653067": 2, "W1551727579": 1, "W1974228120": 1, "W2132938540": 1, "W2147150779": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN086", "text": "Recombinant microalgal cells engineered with exogenous genes encoding combinations of lipid biosynthesis and modification enzymes—including fatty acyl-ACP thioesterase, keto acyl-ACP synthase, fatty acyl-CoA reductase, and fatty aldehyde decarbonylase—together with sugar utilization genes such as sucrose transporter, sucrose invertase, and fructokinase, enabling heterotrophic cultivation on low-cost sucrose feedstocks to produce tailored oils with specific fatty acid profiles suitable for renewable diesel, biodiesel, and jet fuel.", "source_patent_id": "9255282", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9255282"], "ground_truth": {"tier1_relevant_docs": {"10100341": 3, "9249436": 3, "9279136": 3, "8852885": 3, "10006034": 3, "10167489": 2, "10344305": 2, "9388435": 2, "9719114": 2, "10053715": 2, "8945908": 2, "9102973": 2, "9200307": 2, "10287613": 2, "10683522": 2, "11401538": 2, "9551017": 2, "9909155": 2, "9068213": 2, "8951777": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN087", "text": "A multispecific polypeptide molecule comprising at least one humanized CD3-binding domain and a second binding domain that binds a tumor antigen, wherein the molecule simultaneously engages the CD3 subunit of a T-cell receptor complex on T-cells and tumor antigen-expressing cells to induce target-dependent T-cell cytotoxicity, activation, and proliferation.", "source_patent_id": "11352426", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11352426"], "ground_truth": {"tier1_relevant_docs": {"11168125": 1, "10858417": 2, "W2086567342": 2, "11591400": 2, "10961311": 2, "W2094360210": 1, "10323099": 1, "W1783606365": 1, "W1976174066": 3, "W2118672177": 1, "W2007497663": 1, "W2032185672": 3, "W2160989461": 1, "10183992": 2, "10239938": 2, "10308688": 2, "9315567": 2, "W2149776121": 3, "W185479028": 2, "W2418555221": 1, "W2107806760": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN088", "text": "A combination therapy for cancer treatment comprising an anti-AXL antibody-drug conjugate (ADC) administered together with a secondary therapeutic agent, wherein the anti-AXL ADC targets the AXL receptor tyrosine kinase to deliver a cytotoxic payload to tumor cells.", "source_patent_id": "10544223", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10544223"], "ground_truth": {"tier1_relevant_docs": {"W2124514746": 1, "W2083670340": 1, "W2152976222": 1, "W2061537048": 1, "W2615326416": 1, "W2132089284": 1, "W2104998312": 1, "W2100314556": 1, "W2314837202": 1, "W2136750953": 1, "W2587678059": 1, "W1999146917": 1, "W2403458189": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN089", "text": "Antibodies that specifically bind to sclerostin (a TGF-beta binding protein) to interfere with the interaction between sclerostin and bone morphogenetic proteins (TGF-beta superfamily members), thereby increasing bone mineral density for treatment of conditions such as osteoporosis and osteopenia.", "source_patent_id": "9011856", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9011856"], "ground_truth": {"tier1_relevant_docs": {"8563271": 3, "8992911": 3, "9657095": 3, "7868134": 3, "W2075010531": 2, "W2073558178": 2, "W2112292482": 1, "W2087560312": 1, "W2016251348": 1, "W2339561542": 2, "W2032956576": 2, "W1970864109": 1, "10273293": 2, "11091537": 2, "9089553": 2, "W2108403721": 2, "W2039302262": 2, "W2160306549": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN090", "text": "Heteroaryl-substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-b]pyrimidine compounds that selectively modulate Janus kinase (JAK) activity, useful for treating immune-related diseases, skin disorders, myeloid proliferative disorders, and cancer by inhibiting JAK signaling pathways.", "source_patent_id": "9814722", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9814722"], "ground_truth": {"tier1_relevant_docs": {"10398699": 3, "10639310": 3, "11331320": 3, "8946245": 3, "9206187": 3, "9662335": 3, "9974790": 3, "11213528": 2, "10370387": 1, "11161855": 1, "9216984": 2, "9623029": 2, "10899736": 2, "9221845": 2, "9487521": 3, "9714233": 2, "9718834": 2, "10513522": 1, "11214573": 1, "9611269": 1, "9193733": 2, "10640506": 2, "9249145": 1, "9334274": 2, "10695337": 1, "11285140": 1, "9464088": 1, "9999619": 1, "10329299": 1, "9828377": 1, "W2019402966": 2, "W114839291": 1, "W1982421421": 1, "W4299639679": 1, "W2167617907": 1, "W2044086940": 1, "W2141032550": 1, "W2566221528": 1, "W2316411171": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN091", "text": "A method of inducing or modulating reward- or aversive-related behaviors in an animal by expressing light-responsive opsins in neurons projecting to the ventral tegmental area and selectively activating or inhibiting those neural inputs using optical stimulation to control dopaminergic circuit activity.", "source_patent_id": "9636380", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9636380"], "ground_truth": {"tier1_relevant_docs": {"9238150": 1, "W2416279662": 1, "10046174": 1, "W1980737345": 2, "W2083932518": 1, "W1990894640": 1, "W2165706889": 2, "W2013927030": 1, "10568307": 1, "W1980604666": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "NOVEL", "google": "NOVEL"}}}
{"statement_id": "RN092", "text": "A glucose sensor system that monitors a continuous data stream to detect transient non-glucose-related signal artifacts of higher amplitude than electronic or diffusion noise, and selectively replaces corrupted data by applying distinct signal estimation algorithms or distinct parameter sets to a single algorithm based on detected artifact severity, to minimize the impact of ischemia, pH changes, and temperature changes on reported glucose values.", "source_patent_id": "9750460", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9750460"], "ground_truth": {"tier1_relevant_docs": {"8346338": 3, "11589823": 3, "7998071": 3, "8010174": 3, "8073519": 3, "8073520": 3, "8128562": 3, "8150488": 3, "8167801": 3, "8195265": 3, "8229536": 3, "8292810": 3, "8412301": 3, "8435179": 3, "8491474": 3, "8790260": 3, "8795177": 3, "8812073": 3, "8821400": 3, "8843187": 3, "9149219": 3, "9649069": 3, "9724045": 3, "8777853": 3, "9420968": 3, "9510782": 3, "9585607": 3, "11564602": 1, "7927274": 1, "8282550": 1, "9538946": 1, "10898113": 2, "8005524": 2, "8216139": 2, "8233958": 2, "8251906": 2, "8257259": 2, "8265725": 2, "8290561": 2, "8374667": 2, "8469886": 2, "8657745": 2, "8747315": 2, "8801610": 2, "9107623": 2, "9192328": 2, "9351668": 2, "9364173": 2, "9498155": 2, "9750441": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN093", "text": "Antibodies or antigen-binding fragments thereof that immunospecifically bind to B Lymphocyte Stimulator (BLyS) protein, wherein these antibodies are used to prevent, treat, or ameliorate diseases or disorders associated with aberrant BLyS expression or inappropriate BLyS function by administering an effective amount to an animal.", "source_patent_id": "7879328", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7879328"], "ground_truth": {"tier1_relevant_docs": {"8101181": 3, "9187548": 3, "8062906": 3, "W2088324610": 1, "W2095460138": 2, "W1920115643": 1, "W1536748279": 3, "W2043971353": 1, "W2060208115": 3, "W2165056939": 1, "W2097129513": 1, "W2014956545": 2, "W1987554279": 1, "W212723289": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN094", "text": "A chimeric light-responsive membrane protein is created by modifying a rhodopsin nucleotide sequence with one or more heterologous adrenergic receptor subunits, enabling expression in a cell to produce secondary messengers (such as cAMP or IP3) in response to light stimulation rather than chemical ligands.", "source_patent_id": "8962589", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8962589"], "ground_truth": {"tier1_relevant_docs": {"9453215": 3, "10018695": 1, "10371776": 1, "10914803": 1, "9271674": 1, "9615789": 1, "10350430": 1, "W2034751180": 1, "W2165408978": 1, "9855442": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN095", "text": "A chimeric receptor comprising a cytoplasmic domain containing a 4-1BB stimulatory signaling domain that enables simultaneous signaling of both a primary activation pathway and a co-stimulatory pathway, allowing activation of the co-stimulatory pathway independently of binding to the natural 4-1BB ligand, expressed in T cells or NK cells.", "source_patent_id": "9856322", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9856322"], "ground_truth": {"tier1_relevant_docs": {"9834590": 3, "W2147051992": 1, "W1987891097": 1, "W1656949393": 1, "W2155754472": 1, "W2306413099": 2, "W2074129424": 1, "W2020646453": 3, "W2032803186": 3, "W1635113215": 1, "W1842126375": 3, "W2097765486": 1, "W1524274652": 1, "W83880277": 2, "W2789892520": 1, "W2564777138": 3, "W1514625873": 1, "W2050386410": 2, "W2036644325": 3, "W1499068539": 1, "W1943676235": 1, "W2159537998": 3, "W2053440339": 2, "W2099241614": 1, "W2144436556": 2, "W1574443686": 2, "W2556167380": 3, "W1834335942": 1, "W2161958391": 2, "W2176708322": 1, "W2406035635": 1, "W1615039363": 1, "W2165580475": 3, "W1596693997": 1, "W2111429442": 3, "10525083": 2, "W1989523156": 2, "W2131609628": 3, "W2014154395": 1, "W2160520392": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN096", "text": "A DNA sequencing method in which the four nucleotide bases are supplied individually and serially to a microfluidic reaction cell containing a DNA template and primer, with real-time detection of DNA polymerase-catalyzed incorporation events using fluorescence, chemiluminescence, or microcalorimetric measurement of heat generated during each nucleotide incorporation step.", "source_patent_id": "9957561", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9957561"], "ground_truth": {"tier1_relevant_docs": {"10214774": 3, "9096898": 3, "9212393": 3, "9540689": 3, "9725764": 3, "W2137348240": 2, "W2082631942": 2, "W2132341951": 1, "W2155466304": 1, "W2001590540": 1, "W1969628353": 1, "W2029297547": 1, "W80436974": 1, "W4234937123": 2, "W1987739795": 1, "W1964558738": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN097", "text": "Combined treatment of EGFR-mediated cancer using anti-EGFR monoclonal antibody mAb806 in combination with a src kinase inhibitor, wherein simultaneous or sequential inhibition of both EGFR and src pathways produces a therapeutic effect against cancer.", "source_patent_id": "9023356", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9023356"], "ground_truth": {"tier1_relevant_docs": {"9090693": 1, "W2087381093": 1, "W1969391810": 1, "W2052370726": 1, "W1991541715": 1, "W2032264569": 1, "W2267868684": 1, "W2144368667": 1, "W1556788203": 1, "W2143536404": 1, "W2139819066": 1, "W2099805317": 1}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "override", "tier3_individual": {}}}
{"statement_id": "RN098", "text": "A continuous analyte sensor comprising a sensing membrane that includes at least one surface-active group-containing polymer configured as a bioprotective layer that substantially blocks the effect of non-constant noise-causing species on the sensing mechanism while permitting analyte transport to the sensor.", "source_patent_id": "10143410", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10143410"], "ground_truth": {"tier1_relevant_docs": {"11147483": 3, "8583204": 3, "8682408": 3, "8954128": 3, "9173606": 3, "9173607": 3, "9549699": 3, "9566026": 3, "9572523": 3, "9693721": 3, "8229535": 1, "8277713": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN099", "text": "An implantable arrangement for stimulating target cells in vivo comprising an electrical light-generation means coupled to a biological portion containing a photosensitive bio-molecular arrangement, wherein the photosensitive bio-molecular arrangement responds to generated light by directly stimulating target cells within a living organism.", "source_patent_id": "10569099", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10569099"], "ground_truth": {"tier1_relevant_docs": {"10052497": 3, "10046174": 2, "10426970": 3, "10434327": 3, "9238150": 2, "9084885": 3, "9394347": 2, "W2037645743": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN100", "text": "A method of sequencing low-complexity amplicon libraries arrayed at high density on a surface, wherein amplicons are prepared using primer sets designed to ensure that initial sequencing-by-synthesis signals are evenly distributed among different nucleotides across different amplicons, thereby enabling accurate base calling in high-density random arrays where signal imbalance from low-complexity sequences would otherwise confound detection.", "source_patent_id": "10385475", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10385475"], "ground_truth": {"tier1_relevant_docs": {"W2318103124": 1, "W2060226894": 1, "W2027589602": 2, "W2143153669": 1, "W2168585454": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN101", "text": "A system and method for detecting rare mutations and copy number variations in cell-free polynucleotides extracted from bodily fluids, combining sample preparation, sequencing of cell-free polynucleotides, and bioinformatics analysis against a reference database of disease-specific rare mutation and copy number variation profiles to enable genetic profiling of disease states.", "source_patent_id": "11434523", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11434523"], "ground_truth": {"tier1_relevant_docs": {"11447813": 3, "11434531": 2, "W2128537944": 1, "W2740452569": 1, "W2161063963": 2, "W2064543601": 2, "W2008599012": 1, "W2549958142": 2, "W2809244864": 3, "W2143297413": 1, "W2125888786": 1, "W2103145701": 1, "W2092203068": 1, "W2765912584": 2, "W2303585199": 2, "W2096837288": 3, "W2094718447": 1, "W2754300385": 1, "W2110501857": 1, "W2101342813": 1, "W1512274012": 1, "W2768442191": 1, "W2047042799": 1, "W2968565225": 1, "W2095332077": 2, "W2154361640": 1, "W2107751484": 1, "W1994678797": 1, "W1003942541": 2, "W2006288875": 1, "W1926851645": 1, "W2090428736": 1, "10061889": 2, "10061890": 2, "10216896": 2, "10522242": 2, "W2133174470": 1, "W2124873881": 1, "W2128477255": 1, "W2143362349": 1, "11365447": 1, "W2143799706": 1, "W2057379745": 1, "10081839": 1, "10083273": 1, "10260096": 1, "10266893": 1, "11111543": 1, "11111544": 1, "W1957977360": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN102", "text": "Compositions and methods for identifying human papillomavirus (HPV) by combining nucleic acid amplification with molecular mass or base composition analysis to enable precise identification of HPV types from biological samples.", "source_patent_id": "8084207", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8084207"], "ground_truth": {"tier1_relevant_docs": {"8026084": 2, "8551738": 2, "W2142400988": 1, "7741036": 3, "8017322": 3, "8017358": 3, "8017743": 3, "8265878": 3, "W1950764552": 1, "W2129266910": 1, "9249456": 1, "W2041898143": 2, "7666592": 2, "8187814": 2, "9447462": 2, "8182992": 1, "W2154944147": 2, "W2100538295": 1, "9149473": 1, "W2082346918": 1, "W282255597": 1, "W1986432875": 2, "W4235693387": 1, "W2410036530": 1, "W2097579293": 1, "W1977942351": 1, "8046171": 2, "W2010790628": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN103", "text": "A method of assembling transcription activator-like effector (TALE) repeat domain arrays by sequentially ligating nucleic acid fragments encoding TALE repeat domains through compatible ligatable ends created by specific enzymes, wherein the ligated nucleic acid product is linked to a solid support, enabling construction of a polypeptide comprising multiple TALE repeat domain sets.", "source_patent_id": "11472849", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11472849"], "ground_truth": {"tier1_relevant_docs": {"10273271": 3, "W2037566247": 2, "W2098238343": 2, "W2089510176": 1, "W2026871784": 1, "11046948": 1, "W2124408367": 3, "W2002302294": 2, "W2165917029": 1, "W2315792854": 1, "W2029135592": 1, "W1990319434": 1, "W2140494588": 3, "W2029425876": 1, "11072789": 1, "W2168245648": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN104", "text": "A method for in vitro evolution that compartmentalizes individual genetic elements into microcapsules and sorts those expressing a gene product with desired activity, where at least one of the compartmentalization or sorting steps is controlled by a microfluidic system, enabling iterative mutagenesis and selection of nucleic acids and proteins.", "source_patent_id": "9186643", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9186643"], "ground_truth": {"tier1_relevant_docs": {"8871444": 3, "9029083": 3, "9839890": 2, "9925504": 2, "W2071086763": 1, "W2404312007": 1, "9498759": 2, "W2007353701": 1, "10982208": 1, "7943384": 1, "W2035734647": 2, "W2091368700": 2, "W2123687265": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN105", "text": "A method for simultaneously amplifying multiple nucleic acid target loci in a single reaction volume using a library of primers designed to minimize formation of primer dimers and non-target amplicons, wherein the primer library is selected through a computational process that evaluates and excludes primer pairs with cross-reactivity or self-complementarity above defined thresholds.", "source_patent_id": "11519035", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11519035"], "ground_truth": {"tier1_relevant_docs": {"10316362": 3, "10351906": 3, "10526658": 3, "10538814": 3, "10557172": 3, "10597708": 3, "10597709": 3, "10597723": 3, "10655180": 3, "10731220": 3, "10793912": 3, "11111545": 3, "11286530": 3, "11312996": 3, "11332793": 3, "11390916": 3, "11525162": 3, "W2137167287": 3, "W2062837212": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN106", "text": "Cyclic purine dinucleotide (CDN) compositions comprising substantially pure Rp,Rp or Rp,Sp thiophosphate diastereomers that activate the STING (Stimulator of Interferon Genes) cytoplasmic receptor to induce STING-dependent TBK1 activation, wherein the defined stereochemistry at the phosphorothioate linkages distinguishes these CDN immune stimulators from mixed diastereomeric preparations.", "source_patent_id": "10414789", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10414789"], "ground_truth": {"tier1_relevant_docs": {"9695212": 3, "10653774": 3, "9724408": 3, "9549944": 1, "10189873": 1, "W2099489128": 1, "W2027163190": 1, "9770467": 2, "W2105894358": 2, "W2331783064": 1, "W2135783899": 1, "W1967034968": 1, "W2003034886": 2, "W1945887236": 1, "W2165793295": 1, "W3023454987": 1, "W2016263096": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN107", "text": "A fertile transgenic maize plant containing an integrated phosphinothricin acetyltransferase (PAT) gene at a specific chromosomal locus where the integration event is correlated with increased yield, and a method of transferring this increased yield phenotype to other maize lines by crossing with the transgenic plant.", "source_patent_id": "6395966", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6395966"], "ground_truth": {"tier1_relevant_docs": {"W2091843088": 2, "W2163621988": 2, "W1993612910": 1, "W2170434347": 1, "W1976290254": 1, "6329574": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN108", "text": "A method for targeted modification of endogenous genes in eukaryotic cells using large DNA targeting vectors (LTVECs) derived from cloned genomic DNA fragments larger than those used in conventional homologous recombination approaches, combined with a quantitative detection method to identify correctly targeted cells for generating genetically modified organisms.", "source_patent_id": "9376699", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9376699"], "ground_truth": {"tier1_relevant_docs": {"10526630": 3, "9371553": 3, "10344299": 3, "10227625": 3, "9528136": 3, "9353394": 3, "9388446": 3, "10378037": 3, "9708635": 3, "10378038": 3, "10378040": 3, "10584364": 3, "10378039": 3, "W1846243202": 1, "W3106428088": 2, "W2167530391": 2, "W1536706018": 1, "W1984592727": 1, "W1975453246": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN109", "text": "A droplet-based digital PCR method that forms sample droplets containing on average a single target nucleic acid, amplifies the target within droplets, and selectively excludes droplets containing both amplicon from the target and amplicon from a variant of the target, thereby enabling analysis of target amplicons independently from variant amplicons.", "source_patent_id": "8535889", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8535889"], "ground_truth": {"tier1_relevant_docs": {"11254968": 3, "9074242": 3, "9228229": 3, "9366632": 3, "W2151606724": 2, "W2063789994": 1, "W2026125236": 2, "10647981": 1, "W2107551413": 1, "W1968579293": 2, "W2074905581": 1, "W3002095616": 1, "W2109397680": 2, "11453906": 1, "W2095490768": 1, "W2128839883": 2, "W2055245741": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN110", "text": "A method for determining fetal chromosome copy number non-invasively by analyzing SNP microarray data from maternal serum containing mixed fetal and maternal DNA together with parental genomic data, wherein the combined analysis of fetal-maternal mixed genetic material and both biological parents' genotypes enables ploidy calling for clinical prenatal diagnosis decisions.", "source_patent_id": "10061889", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10061889"], "ground_truth": {"tier1_relevant_docs": {"10061890": 3, "10216896": 3, "10522242": 3, "10174369": 3, "11322224": 3, "11332785": 3, "11339429": 3, "11482300": 3, "11306357": 3, "W2162212132": 1, "W2128146847": 1, "W2152673489": 1, "W2156283009": 1, "W2089486503": 1, "W2161063963": 1, "W2149390514": 2, "W2080501218": 1, "10113196": 1, "W2100618987": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN111", "text": "A device comprising multivolume analysis regions of different discrete volumes that supports nucleic acid amplification and detection, enabling digital quantification of nucleic acids or other analytes by distributing a sample across multiple partitions of varying sizes to extend the dynamic range of detection beyond what is achievable with uniform-volume partitioning.", "source_patent_id": "10196700", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10196700"], "ground_truth": {"tier1_relevant_docs": {"9493826": 3, "9464319": 3, "W1979899105": 3, "10370705": 3, "9447461": 3, "W2123793021": 3, "W2087828704": 1, "W2035285327": 1, "W2066346928": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN112", "text": "A sperm cell suspension formulation comprising a motility inhibitor that preserves cell viability during flow cytometric sorting processes, resulting in post-sort compositions with increased numbers of viable or motile sperm enriched for either X or Y chromosome-bearing cells.", "source_patent_id": "7838210", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7838210"], "ground_truth": {"tier1_relevant_docs": {"W2013024192": 1, "W1969635765": 1, "W2035411444": 2, "W1966630596": 2, "W2142049694": 1, "W1997808069": 2, "W2039698632": 1, "W2021376347": 2, "W1971118791": 1, "W2091260390": 2, "W2017828817": 1, "W2056020032": 1, "W243725899": 1, "W2157648764": 1, "W2339361287": 2, "W1966146263": 1, "7833147": 1, "W2097104987": 1, "W1985707686": 1, "11104880": 2, "W2084476179": 1, "W2404912082": 2, "W82918339": 2, "W2097317907": 3, "W2416111859": 1, "7892725": 2, "W2409566824": 2, "W2076453557": 2, "W2032991801": 1, "W2055566539": 1, "W2536170555": 2, "W2073893214": 2, "W4253147399": 1, "W47713270": 2, "W1993721938": 1, "W2033412811": 1, "W2032478581": 1, "W1979546260": 2, "W1497818460": 2, "W1503789934": 2, "W2110066165": 1, "W2074554430": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN113", "text": "A short double-stranded RNA of less than 49 nucleotides in length, having a nucleotide sequence complementary to at least a part of a target gene, used to specifically inhibit expression of that target gene in mammals for treating diseases including cancer, viral diseases, or neurodegenerative diseases.", "source_patent_id": "8114851", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8114851"], "ground_truth": {"tier1_relevant_docs": {"8729037": 3, "10508277": 2, "W2002200554": 1, "9994853": 2, "W1906181797": 2, "W2324865838": 2, "8283329": 2, "8580754": 2, "9102939": 2, "W2083014834": 2, "W2008161734": 2, "W147652200": 2, "W1993883459": 1, "W1984251559": 1, "W2116899346": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN114", "text": "A non-human donor animal (swine) genetically engineered to lack wild-type surface glycan epitopes and having its swine leukocyte antigen (SLA) sequences replaced with synthetic nucleotides based on a specific human recipient's HLA reference sequence, thereby generating personalized, immunologically matched transplantable cells, tissues, and organs tailored to an individual human recipient.", "source_patent_id": "11473062", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11473062"], "ground_truth": {"tier1_relevant_docs": {"10883084": 3, "11028371": 3, "11155788": 3, "W2794269584": 2, "W2893918473": 1, "W2953479887": 2, "10799614": 2, "10905799": 2, "11129922": 2, "W1636346635": 2, "W2171543957": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN115", "text": "A genetically modified mouse engineered to express human M-CSF (macrophage colony-stimulating factor) protein, wherein the mouse is engrafted with human hematopoietic cells to create a humanized immune system model that supports human hematopoietic cell development and activity in vivo.", "source_patent_id": "10785966", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10785966"], "ground_truth": {"tier1_relevant_docs": {"W2067114333": 2, "10278374": 2, "11051499": 2, "W2101758099": 2, "W2003466425": 2, "W2216567752": 2, "W1997090313": 3, "10785968": 2, "9901082": 2, "9986724": 2, "W2010519150": 1, "W49329161": 1, "W1973127853": 2, "W2163065691": 1, "W1979345147": 2, "W2114530568": 1, "W2767177385": 2, "W2168248700": 2, "W2149929061": 2, "W1744293511": 1, "W1920235745": 1, "W2495415429": 1, "W2038672919": 1, "W2024123171": 2, "W2141950800": 2, "W2009655979": 1, "W2748538138": 1, "W2947989483": 2, "11259510": 1, "W1976701849": 1, "W2146145483": 1, "W2071110704": 1, "W2108454894": 1, "W2281522309": 1, "W2169009227": 1, "W2557596611": 1, "W2095022753": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN116", "text": "A non-invasive prenatal paternity testing method that determines biological paternity by extracting fetal DNA from maternal plasma and comparing its genetic fingerprint to that of an alleged father using an informatics-based approach, while accounting for maternal genetic contributions through separate maternal genetic measurements.", "source_patent_id": "11408031", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11408031"], "ground_truth": {"tier1_relevant_docs": {"10113196": 3, "10590482": 3, "11326208": 3, "10774380": 3, "10061889": 1, "10061890": 1, "10216896": 1, "10522242": 2, "W2149390514": 2, "W2131081514": 2, "W1512274012": 1, "W1972580334": 2, "W2099601546": 1, "W2089486503": 1, "W2080501218": 1, "W2104083677": 1, "W2096027381": 1, "W110191290": 1, "W2152673489": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN117", "text": "A scaffold device in which a bioactive composition is incorporated into or coated onto a scaffold composition to actively recruit host cells into the scaffold, modify the recruited cells, and control the egress of those resident cells or their progeny from the material, thereby mediating in vivo cell programming and release without requiring ex vivo cell manipulation.", "source_patent_id": "10149897", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10149897"], "ground_truth": {"tier1_relevant_docs": {"10137184": 3, "11096997": 3, "8932583": 3, "9132210": 3, "9446107": 3, "10695468": 2, "9770535": 2, "W2102842575": 2, "W1862959882": 1, "W4231516524": 2, "W2031776886": 1, "W2049593971": 1, "W2084849128": 1, "W2135022648": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN118", "text": "A method for preparing a nucleic acid sequencing library by amplifying a template nucleic acid using dNTPs combined with dUTP and random hexamer primers to incorporate occasional uracil bases into complementary strands, then treating with a dUTP-excising enzyme to introduce nicks at uracil sites, in the presence of bead-bound oligonucleotide adapter sequences.", "source_patent_id": "10221436", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10221436"], "ground_truth": {"tier1_relevant_docs": {"10557158": 3, "11414688": 3, "9598724": 1, "W2034189827": 1, "9890408": 1, "W2171640958": 1, "W2153430939": 1, "W2163379946": 2, "10647981": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN119", "text": "T cells engineered to be deficient in T-cell receptor (TCR) expression while simultaneously expressing a functional non-TCR receptor, wherein the TCR deficiency prevents graft-versus-host disease and the non-TCR receptor redirects cytotoxic activity toward a target disease.", "source_patent_id": "9821011", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9821011"], "ground_truth": {"tier1_relevant_docs": {"W1976400767": 3, "W1989523156": 1, "W2047205338": 2, "W2009597900": 1, "W2155575072": 1, "W2108080895": 1, "W1924656799": 1, "W2033839702": 1, "W1839053269": 3, "11377637": 3, "W2160989461": 2, "W2406035635": 1, "W1984927242": 1, "10689616": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN120", "text": "A method for synthesizing nucleic acid or peptide sequences on a substrate surface by selectively exposing regions bearing photoremovable protecting groups to light to activate those regions, then coupling monomers that also carry photoremovable protecting groups, and iteratively repeating this light-directed deprotection and monomer addition process to build up combinatorial arrays of sequences of defined length.", "source_patent_id": "6403957", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6403957"], "ground_truth": {"tier1_relevant_docs": {"6646243": 3, "6630308": 3, "6660234": 3, "6747143": 3, "6491871": 3, "6566495": 3, "W2071451059": 3, "W2157215461": 3, "W2140361413": 2, "W2159511216": 3, "W2003681056": 1, "W2032429811": 3, "W2029911544": 2, "W2086464766": 3, "W2278101460": 1, "W1970057367": 1, "W2116586215": 1, "W2029209483": 1, "W2054716367": 1, "W2012878989": 2, "W2048223863": 1, "W2010630649": 1, "W2058560506": 1, "W1977205611": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN121", "text": "Use of INT131, a selective PPARγ agonist, alone or in combination with vitamin E, to treat nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and/or lipodystrophic syndromes associated with insulin resistance, where the selective PPARγ partial agonism distinguishes it from full PPARγ agonists such as thiazolidinediones.", "source_patent_id": "11400072", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11400072"], "ground_truth": {"tier1_relevant_docs": {"10555929": 3, "10772865": 3, "W2059109343": 2, "W1975353500": 1, "W2047257800": 1, "W34154047": 1, "W2005046746": 2, "W2045050366": 1, "W1971077317": 1, "W2025699570": 1, "W2049060679": 2, "W2072059059": 1, "W2782009042": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN122", "text": "A modified Caspase-9 polypeptide engineered to have reduced basal apoptotic activity in the absence of a chemical inducer while retaining inducible apoptotic activity upon inducer addition, for use as a controllable safety switch in adoptive cell therapy applications.", "source_patent_id": "9932572", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9932572"], "ground_truth": {"tier1_relevant_docs": {"9434935": 3, "W1499340810": 3, "W2060670004": 1, "W2152826290": 1, "W2050386410": 2, "W2152943305": 2, "W2097175022": 3, "W2038248457": 1, "W2122465970": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN123", "text": "A method for determining fetal chromosome copy number non-invasively by analyzing SNP microarray data from maternal serum containing mixed fetal and maternal DNA in combination with parental genomic data, wherein the allelic distribution patterns at single-nucleotide polymorphisms are used to distinguish fetal ploidy status from the maternal background signal.", "source_patent_id": "10522242", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10522242"], "ground_truth": {"tier1_relevant_docs": {"10061889": 3, "10061890": 3, "10216896": 3, "11482300": 3, "10174369": 3, "11322224": 3, "11332785": 3, "11339429": 3, "11306357": 3, "W2128146847": 1, "W2100618987": 2, "W2156283009": 1, "10591391": 2, "W323772999": 1, "W2155632863": 1, "W2164298293": 1, "10155984": 1, "9017942": 1, "9273355": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN124", "text": "A method for determining fetal chromosome copy number non-invasively by analyzing SNP microarray data from maternal serum containing mixed fetal and maternal DNA together with parental genomic data, wherein the combined analysis of SNP allele distributions from both biological parents and the mixed maternal-fetal sample enables ploidy calling for clinical decision-making.", "source_patent_id": "10061890", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10061890"], "ground_truth": {"tier1_relevant_docs": {"10061889": 3, "10216896": 3, "10522242": 3, "11482300": 3, "10174369": 3, "11322224": 3, "11332785": 3, "11339429": 3, "11306357": 3, "10155984": 1, "9017942": 1, "9273355": 1, "9347100": 1, "W2128146847": 1, "10591391": 2, "W2068248569": 2, "W2161063963": 1, "W2133344765": 1, "W2005155830": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN125", "text": "An oligonucleotide adjuvant with antitumor activity comprising 2-4 CpG motifs (5'-X1CpGX2-3') within a 14-32 nucleotide sequence, wherein the nucleic acids at both the 3' and 5' termini are S-type (stereospecific) nucleotides connected by phosphorothioate linkages, the 3' end side of at least two CpG motifs contains phosphorothioate linkages, and the oligonucleotide contains at least one nucleotide lacking phosphorothioate modification, creating a chimeric backbone with defined stereochemistry.", "source_patent_id": "10149905", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10149905"], "ground_truth": {"tier1_relevant_docs": {"10322173": 2, "10144933": 3, "W1917892434": 2, "W2085575509": 1, "9617547": 3, "W1588809288": 1, "W2109137574": 1, "W2418558714": 1, "W1992875583": 1, "W2069381859": 2, "W146125631": 1, "W1984703936": 1, "W2149484379": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN126", "text": "A non-naturally occurring microbial organism engineered with a muconate biosynthetic pathway comprising exogenous nucleic acids encoding specific enzymes—including beta-ketoadipyl-CoA hydrolase, muconolactone isomerase, muconate cycloisomerase, and muconate cis/trans isomerase among others—that enable biological production of muconic acid (muconate), which can subsequently be chemically converted to terephthalic acid via Diels-Alder cycloaddition with ethylene followed by oxidation, yielding a semi-synthetic route to a key polymer precursor.", "source_patent_id": "10041093", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10041093"], "ground_truth": {"tier1_relevant_docs": {"10415063": 3, "9562241": 3, "W2067582881": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN127", "text": "A template composition comprising a diverse plurality of synthetic oligonucleotide templates in substantially equimolar amounts that serve as a calibration standard for measuring and correcting differential amplification efficiencies among multiplexed PCR primer sets targeting rearranged T cell receptor or immunoglobulin gene sequences, enabling bias correction in quantitative high-throughput sequencing of lymphoid cell DNA.", "source_patent_id": "10894977", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10894977"], "ground_truth": {"tier1_relevant_docs": {"10214770": 3, "9150905": 3, "9371558": 3, "9824179": 3, "W2162578061": 1, "10150996": 3, "11248253": 3, "W2156465688": 1, "W2318103124": 1, "W2055181847": 1, "W2095707035": 2, "W2147008415": 1, "W2027956702": 1, "W2060226894": 1, "W2070479548": 1, "W2564951402": 1, "W2184822132": 1, "W2142686163": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN128", "text": "A synthetic antibody library designed by rational analysis of public human antibody sequence databases to replicate the preimmune repertoire, wherein the library incorporates directed sequence diversity and directed length diversity in complementarity-determining regions rather than random mutagenesis.", "source_patent_id": "8691730", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8691730"], "ground_truth": {"tier1_relevant_docs": {"10189894": 3, "11008383": 3, "10196635": 3, "11008568": 3, "8877688": 3, "W2138136760": 2, "W2068310820": 1, "W2051126826": 1, "W1998522293": 1, "W2169812461": 1, "W2058246832": 2, "W2116006352": 1, "W2033701042": 2, "W2001875799": 3, "W2130393856": 1, "W2157792089": 1, "W2009545641": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN129", "text": "An optical coherence tomography system that performs spectral analysis by interfering backscattered radiation from a sample structure with reference radiation to generate spectroscopic data, and then computationally reduces scattering effects within that spectroscopic data to extract tissue-specific spectral characteristics for classifying tissue type.", "source_patent_id": "9795301", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9795301"], "ground_truth": {"tier1_relevant_docs": {"W1982095576": 2, "W2030900817": 2, "W2065812668": 2, "W1972463508": 2, "W2034325033": 1, "W2107562630": 1, "W2132887753": 1, "7843572": 1, "8149418": 1, "8760663": 1, "9513276": 1, "9226665": 1, "8018598": 1, "7859679": 1, "10058250": 1, "9668652": 1, "W2063446460": 3, "7725169": 2, "W2109924778": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN130", "text": "RNA-guided FokI nucleases (RFNs) comprising FokI nuclease domain fused to catalytically inactive dCas9 (or Cas9) require dimerization of two RFN monomers guided by paired sgRNAs to cleave DNA, thereby increasing genome editing specificity by reducing off-target cleavage that occurs when CRISPR-Cas nucleases tolerate up to five mismatches.", "source_patent_id": "10011850", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10011850"], "ground_truth": {"tier1_relevant_docs": {"10544433": 3, "10138476": 3, "9567603": 3, "W1981160614": 3, "W2025280731": 2, "W2128758977": 1, "W2039316426": 1, "W2156319424": 3, "W2035986309": 1, "10119133": 1, "W2460406567": 2, "W2116534141": 1, "W2032453905": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN131", "text": "A self-inactivating HIV-derived lentiviral vector comprising the EF1α promoter and a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) configured for high-efficiency transgene expression in human hematopoietic stem cells and their blood cell derivatives for gene therapy of lympho-hematological disorders.", "source_patent_id": "8551773", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8551773"], "ground_truth": {"tier1_relevant_docs": {"10226538": 3, "9476062": 3, "9731033": 3, "W2160587796": 3, "9023646": 3, "8748169": 3, "9340798": 3, "9260725": 2, "W2073905027": 2, "W2027122999": 2, "W1769569140": 2, "W1987483457": 2, "W2150922307": 1, "W2011847596": 1, "W1544190956": 2, "W2167523976": 2, "W2062826915": 1, "W2071460884": 1, "W2039273383": 1, "W1985964771": 1, "W2041709256": 1, "W2089579355": 1, "W2411589290": 1, "W2112824117": 1, "W2053601402": 1, "W1972576862": 1, "W2107483168": 1, "W2052150955": 2, "W2409470631": 1, "W2162361061": 1, "W2033839702": 1, "W1994413761": 2, "W2027296526": 1, "W2044474105": 1, "W2114205243": 1, "W1938107912": 2, "W2028418295": 1, "W1591189766": 2, "W2323826662": 1, "W1963143659": 1, "W2303820367": 1, "W1982765182": 2, "W2137516788": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN132", "text": "Stable genetic transformation of maize cells is achieved by introducing the Streptomyces bar gene into embryogenic maize suspension culture cells via microprojectile bombardment, followed by selection of transformed cells using the herbicide bialaphos, and subsequent regeneration of fertile transgenic maize plants from the transformed cells.", "source_patent_id": "6025545", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6025545"], "ground_truth": {"tier1_relevant_docs": {"6329574": 3, "6399861": 3, "6803499": 3, "7705215": 3, "6777589": 3, "5990390": 3, "W2163621988": 3, "W2091843088": 2, "W1976290254": 1, "W2063673708": 1, "W2052839443": 1, "W1993993130": 1, "W2170434347": 1, "W4243845639": 3, "W1538806497": 1, "W2125582909": 2, "W2138079061": 1, "W1506529854": 1, "6395966": 2, "W2012129665": 2, "W2087496933": 1, "W1993612910": 1, "W2150374064": 1, "W2041667041": 1, "W2046982378": 1, "W2020440778": 1, "W1969095754": 1, "W4298877105": 2, "W2092238474": 2, "W198223601": 1, "W1561127009": 1, "W2153346606": 1, "W1977091294": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN133", "text": "A scaffold device incorporating or coated with a bioactive composition that actively recruits host cells into the scaffold, modifies them in situ, and controls the egress of the resident cells or their progeny back into the host, enabling cell transplantation without prior ex vivo cell manipulation.", "source_patent_id": "11096997", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11096997"], "ground_truth": {"tier1_relevant_docs": {"10137184": 3, "10149897": 3, "8932583": 3, "9132210": 3, "9446107": 3, "10695468": 1, "9770535": 1, "W2102842575": 2, "W2031776886": 1, "W1994573333": 1, "W2434370524": 1, "W2011426439": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN134", "text": "A transgenic non-human vertebrate engineered to express fully human antibodies comprising both human variable and human constant regions, wherein the antibodies undergo in vivo recombination, junctional diversification, affinity maturation, and isotype class switching within the non-human vertebrate host, thereby enabling selection of antigen-specific fully human antibodies without in vitro humanization of constant regions.", "source_patent_id": "10251377", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10251377"], "ground_truth": {"tier1_relevant_docs": {"11297811": 3, "10667501": 2, "9963716": 2, "W2782220244": 2, "W2029380472": 1, "W49329161": 3, "10881085": 1, "W2161511521": 1, "11111314": 2, "9938358": 2, "W2157160711": 3, "W1543809928": 1, "W2463062642": 1, "9504236": 2, "W1985997318": 1, "W185071820": 3, "9783618": 2, "W2133159579": 2, "W2060208115": 1, "W2006098333": 1, "W2044609128": 2, "W1978470109": 3, "9924705": 2, "W1985837387": 1, "W1480660253": 1, "W1982800306": 2, "W2087327314": 3, "W32155772": 1, "W2021547240": 1, "W2044485065": 3, "9447177": 2, "W2143222772": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN135", "text": "Opioid antagonists, including peripherally restricted opioid antagonists, inhibit or reduce endothelial cell proliferation and migration associated with angiogenesis.", "source_patent_id": "8524731", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8524731"], "ground_truth": {"tier1_relevant_docs": {"9662325": 3, "9662390": 3, "9675602": 3, "8518962": 3, "9717725": 3, "W2031848709": 1, "W2127881618": 1, "W2735739709": 3, "W2074925725": 1, "10383869": 2, "8685995": 2, "9526723": 2, "W2172074189": 1, "W1878450525": 1, "W2406688330": 1, "W2156405505": 1, "W2552328241": 3, "W1530480820": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN136", "text": "A method for simultaneously amplifying multiple nucleic acid target loci in a single reaction volume using a library of primers designed to minimize formation of primer dimers and non-target amplicons, wherein primer selection criteria are applied across the entire primer library to ensure compatible co-amplification of all target regions.", "source_patent_id": "10597709", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10597709"], "ground_truth": {"tier1_relevant_docs": {"10316362": 3, "10351906": 3, "10526658": 3, "10538814": 3, "10557172": 3, "10597708": 3, "10597723": 3, "10655180": 3, "10731220": 3, "10793912": 3, "11111545": 3, "11286530": 3, "11312996": 3, "11332793": 3, "11390916": 3, "11519035": 3, "11525162": 3, "W2137167287": 3, "W2120504051": 1, "11072789": 1, "10647981": 1, "W2033609627": 2, "W2062837212": 1, "W2075922438": 2, "W2120335901": 2, "W2168585454": 2, "W2142448093": 1, "W2157463520": 2, "W2171719398": 2, "W2412513069": 2, "W2046001839": 1, "W2149897099": 1, "W2118555972": 2, "W2106888005": 2, "W2144175569": 1, "W2098956446": 1, "10077473": 2, "10526650": 2, "9708657": 2, "W1572117680": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "NOVEL", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN137", "text": "A dual-mode ultrasound system that uses real-time image data to iteratively solve an optimization problem for selecting excitation waveforms for a transducer array, wherein user-selected control points within the imaging field of view define focusing gain targets, and the optimized waveforms are cascaded through virtual sub-arrays to adaptively refocus ultrasound energy for therapy delivery.", "source_patent_id": "11458337", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11458337"], "ground_truth": {"tier1_relevant_docs": {"11076836": 3, "11116474": 2, "W2081085597": 1, "W2641856058": 1, "W2111035192": 2, "W2026225029": 2, "W2168471456": 1, "9532769": 1, "W2156830265": 2, "11596812": 1, "W2089328310": 1, "W2171716661": 2, "W2064315631": 2, "W2093035114": 2, "W2195438994": 2, "W1980963921": 1, "W1996006850": 1, "W2139050512": 1, "W2127116397": 1, "W2111589632": 1, "W2138029450": 3, "W1968832397": 1, "W2169019908": 2, "W2110462557": 1, "W2088043908": 1, "W1984780645": 1, "W2013326714": 1, "W1972736234": 2, "W2070793639": 1, "W2153805182": 1, "W2141668541": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN138", "text": "A method for modifying endogenous genes in eukaryotic cells using large DNA targeting vectors (LTVECs) derived from cloned genomic DNA fragments larger than those used in conventional homologous recombination approaches, combined with a quantitative detection method to identify cells in which the LTVEC has correctly targeted the desired chromosomal locus via homologous recombination.", "source_patent_id": "10227625", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10227625"], "ground_truth": {"tier1_relevant_docs": {"9528136": 3, "10344299": 3, "10378039": 3, "10378038": 3, "10378040": 3, "10584364": 3, "9353394": 3, "9376699": 3, "9388446": 3, "10378037": 3, "9708635": 3, "10526630": 3, "9371553": 3, "W2102654270": 1, "W1984592727": 1, "W3106428088": 2, "W2168504426": 2, "W1975453246": 1, "W1846243202": 1, "W2027640038": 1, "W4245545847": 1, "W2005259996": 1, "W2001488804": 1, "W1951800697": 1, "W2167530391": 1, "W2092806325": 2, "W2124293910": 1, "W2115330624": 1, "W4245734014": 1, "W2133872029": 1, "W275152028": 2, "W2024123713": 1, "W1845461494": 1, "W1982482797": 1, "W2015015564": 1, "W2180906670": 1, "W25811119": 1, "W1536706018": 1, "W2148828002": 1, "W2155995453": 1, "W2087180482": 1, "W2015713400": 1, "W2093788916": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN139", "text": "A method for simultaneously amplifying multiple nucleic acid target loci in a single reaction volume using a library of primers specifically selected to minimize formation of primer dimers and non-target amplicons, wherein the primer library selection process evaluates inter-primer interactions across all primer pairs to achieve high-specificity multiplex amplification.", "source_patent_id": "10655180", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10655180"], "ground_truth": {"tier1_relevant_docs": {"10316362": 3, "10351906": 3, "10526658": 3, "10538814": 3, "10557172": 3, "10597708": 3, "10597709": 3, "10597723": 3, "10731220": 3, "10793912": 3, "11111545": 3, "11286530": 3, "11312996": 3, "11332793": 3, "11390916": 3, "11519035": 3, "11525162": 3, "W2137167287": 3, "W2120335901": 1, "W2075922438": 2, "W2033609627": 1, "W2171719398": 2, "W2062837212": 1, "W2052383391": 2, "W2118555972": 2, "10647981": 1, "W2168585454": 2, "W2157683435": 2, "W2157463520": 2, "W2318103124": 2, "W2127442514": 1, "W2120504051": 1, "W2144175569": 1, "W2046001839": 1, "W2127082697": 1, "W2106888005": 1, "W2095707035": 1, "W2142448093": 2, "W2412513069": 2, "W2115767337": 2, "W59602671": 1, "10077473": 2, "10526650": 2, "9708657": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN140", "text": "A method of co-culturing mammalian skeletal muscle cells and spinal motoneurons on carriers coated with a covalently bonded monolayer of trimethoxysilylpropyl diethylenetriamine (DETA) in a serum-free medium system, where muscle cells are plated first followed by motoneurons, and the co-culture is maintained in a mixture of two defined serum-free medium compositions.", "source_patent_id": "10266804", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10266804"], "ground_truth": {"tier1_relevant_docs": {"8815584": 3, "9650606": 3, "10160953": 2, "9163216": 2, "8828721": 1, "9952204": 2, "8835168": 3, "9267936": 3, "W2047219005": 2, "W2057393201": 2, "W2109184588": 1, "W1994104218": 2, "W2061558355": 1, "W1964988197": 2, "W2025829879": 1, "W2014829573": 1, "W2090197816": 3, "W2283638088": 2, "W1985247565": 1, "W1973157651": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN141", "text": "A method for synthesizing templated molecules in which a scaffold functional entity and a building block functional entity are each equipped with complementary dimerization domains that bring the two functional entities into close proximity upon interaction, thereby directing covalent bond formation between them while the synthesized molecule remains attached to the template that directed its synthesis.", "source_patent_id": "10731151", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10731151"], "ground_truth": {"tier1_relevant_docs": {"8808984": 3, "9121110": 2, "10730906": 3, "8722583": 1, "8466277": 1, "8932992": 2, "11118215": 1, "W2142916432": 1, "9096951": 1, "W2132476130": 1, "10669538": 3, "W2028254012": 1, "W1986413545": 2, "W2128882353": 1, "W2118598894": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN142", "text": "A method for synthesizing a bifunctional complex comprising a display molecule part and a coding part, wherein a nascent bifunctional complex having both a chemical reaction site and a priming site is simultaneously reacted at the chemical reaction site with one or more chemical reactants while enzymatically adding nucleotide or oligonucleotide tags to the priming site that encode the identity of the reacted reactant(s).", "source_patent_id": "9284600", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9284600"], "ground_truth": {"tier1_relevant_docs": {"10077440": 3, "9574189": 3, "11225655": 2, "W2029097469": 1, "W2094850820": 2, "9096951": 1, "W2017423606": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN143", "text": "A method for quantifying enzyme molecules by distributing them into a plurality of discrete fluid partitions such that a subset of partitions each contain individual enzyme molecules, performing an enzyme-catalyzed reaction within those partitions, detecting the number of reaction-positive partitions, and determining the absolute amount of enzyme based on the counted partition number using digital quantification principles.", "source_patent_id": "11187702", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11187702"], "ground_truth": {"tier1_relevant_docs": {"10533998": 3, "W1976045759": 3, "11168353": 1, "W2037826246": 1, "11135584": 1, "W2043127660": 3, "W2046183278": 3, "W2119278037": 1, "11313856": 1, "11193176": 2, "W2087828704": 1, "W2138709542": 1, "W1990211442": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN144", "text": "An antigen-binding molecule engineered to exhibit weaker antigen-binding activity at early endosomal pH (approximately pH 5.5-6.0) compared to plasma pH (approximately pH 7.4), enabling a single antibody molecule to repeatedly bind and release multiple antigen molecules in vivo, thereby extending plasma half-life and prolonging the duration of antigen-binding capacity.", "source_patent_id": "10472623", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10472623"], "ground_truth": {"tier1_relevant_docs": {"11371039": 3, "9868948": 3, "9890377": 3, "11359194": 3, "10253100": 2, "10618965": 1, "W2042858467": 3, "W2095421286": 2, "W2905274775": 2, "W2211283619": 3, "W2068651607": 1, "W2093117233": 3, "W1996045402": 1, "W2149725620": 1, "W1821450386": 3, "9376495": 1, "W2094308406": 1, "W2050286659": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN145", "text": "An acellular mammalian tooth-shaped scaffold incorporating at least one bioactive compound that is chemotactic, osteogenic, dentinogenic, amelogenic, or cementogenic, configured for implantation into a tooth socket to recruit endogenous cells and regenerate tooth structures without pre-seeding with exogenous cells.", "source_patent_id": "8979534", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8979534"], "ground_truth": {"tier1_relevant_docs": {"W2140031359": 2, "W2014437426": 1, "10695468": 1, "9770535": 1, "W1967017841": 1, "10137184": 2, "10149897": 2, "11096997": 2, "8932583": 2, "9132210": 2, "9446107": 2, "9809633": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN146", "text": "A combination therapy composition comprising triciribine (an AKT inhibitor) and trastuzumab (a HER2-targeting monoclonal antibody) that exhibits reduced toxicity compared to monotherapy while treating tumors and cancers associated with abnormal cell proliferation.", "source_patent_id": "9186403", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9186403"], "ground_truth": {"tier1_relevant_docs": {"8623834": 3, "9486522": 3, "8691779": 1, "9101641": 1, "9498492": 1, "8865666": 1, "9192645": 1, "9486492": 1, "8673867": 1, "9655914": 1, "8673868": 1, "9211299": 1, "9486470": 1, "W2159750196": 1, "11225509": 2, "8435959": 2, "9115162": 2, "9518079": 2, "W2105196235": 3, "W2022160610": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN147", "text": "An implantable device membrane system comprising a polymer formed from a high oxygen soluble material disposed adjacent to an oxygen-utilizing source, configured to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits in the surrounding biological environment, enabling improved performance of enzyme-based electrochemical sensors or cell transplantation devices under low oxygen conditions.", "source_patent_id": "8255033", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8255033"], "ground_truth": {"tier1_relevant_docs": {"10610140": 3, "8255030": 3, "9597027": 3, "9993186": 3, "W2002941644": 2, "W2131625224": 1, "W1965785192": 1, "W2149357652": 1, "8840552": 1, "W2106771243": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN148", "text": "T-bet, a transcription factor encoded by an isolated nucleic acid molecule, regulates T helper cell differentiation, and compositions including T-bet polypeptides, antisense nucleic acids, recombinant expression vectors, and anti-T-bet antibodies can be used to modulate T-bet expression and/or activity in cells and to identify agents that alter Th1/Th2 immune responses.", "source_patent_id": "8048672", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8048672"], "ground_truth": {"tier1_relevant_docs": {"7745581": 3, "W2011754426": 2, "W2102810679": 2, "W2020975034": 2, "10308702": 1, "10590183": 1, "7807786": 1, "8674076": 1, "7368554": 1, "8354513": 1, "9399052": 1, "W2115024315": 1, "W1911902366": 1, "7968689": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN149", "text": "Small molecule compounds that modulate the activity of both receptor protein tyrosine kinases c-kit and c-fms, useful for treating diseases mediated by one or both of these kinase receptors.", "source_patent_id": "8461169", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8461169"], "ground_truth": {"tier1_relevant_docs": {"7846941": 3, "7893075": 3, "8404700": 3, "8722702": 3, "9169250": 3, "9487515": 3, "7947708": 2, "W2084612167": 1, "W1485350399": 2, "W2037263805": 1, "W2134094496": 1, "W1522716655": 1, "10329299": 1, "9828377": 1, "W1999015953": 1, "W1992388470": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN150", "text": "A combination therapy using a 4-anilino-3-cyanoquinoline compound (such as HKI-272, SKI-606, or EKB-569) together with capecitabine for the treatment of neoplasms including metastatic breast cancer and lung cancer, wherein the two agents are co-administered as an antineoplastic regimen optionally combined with additional anti-neoplastic or immunomodulatory agents.", "source_patent_id": "9265784", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9265784"], "ground_truth": {"tier1_relevant_docs": {"10111868": 2, "9511063": 2, "10729672": 2, "W155262670": 1, "W2312696895": 3, "W1989245824": 1, "W2108400228": 1, "W2085327953": 1, "W4213281733": 1, "W2016506024": 2, "W2052370726": 1, "W2068868056": 1, "W2114159573": 1, "W2074908331": 1, "W2004114072": 2, "W2027814079": 1, "W2115847479": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN151", "text": "Recombinational cloning using engineered recombination sites that direct site-specific recombination proteins to exchange DNA segments between molecules, enabling directional and sequence-specific transfer of DNA inserts into destination vectors in vitro and in vivo to produce chimeric DNA molecules with defined characteristics.", "source_patent_id": "6720140", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6720140"], "ground_truth": {"tier1_relevant_docs": {"W1986508375": 3, "8883988": 3, "7670823": 3, "8241896": 3, "W129885521": 1, "W2006443975": 1, "W2124408385": 1, "8304189": 3, "9534252": 3, "W1967287827": 2, "W1976657584": 1, "W2414556878": 1, "W568144879": 1, "W1678580492": 2, "W2114759215": 1, "W2079482933": 1, "W1570672028": 1, "W2100521872": 1, "W2027264255": 1, "W2039040205": 1, "W2050537059": 2, "W1776030351": 2, "W2084231562": 2, "W1601944560": 2, "W2306598616": 2, "W1507245927": 2, "W2146532328": 2, "W2042278007": 1, "W2089223300": 2, "W2067801473": 1, "W2019713900": 1, "W1985634042": 2, "W2068514032": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN152", "text": "Novel derivatives of oleanolic acid, a pentacyclic triterpenoid, that function as dual antioxidant and anti-inflammatory modulators for treating cancer, neurological disorders, and oxidative stress-related pathologies through chemical modifications to the oleanolic acid scaffold.", "source_patent_id": "8338618", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8338618"], "ground_truth": {"tier1_relevant_docs": {"8071632": 3, "9889143": 3, "10398711": 3, "10898499": 3, "11406648": 3, "8440854": 3, "10501489": 3, "8124799": 3, "9102681": 3, "9670147": 3, "10093614": 3, "10556858": 3, "11091430": 3, "7943778": 3, "8394967": 3, "9249089": 3, "7915402": 3, "8124656": 3, "8440820": 3, "RE45288": 3, "RE45325": 3, "8067394": 1, "W4245283474": 1, "W1966060541": 3, "W2080450475": 2, "W2116830932": 3, "W2033694990": 2, "W18402349": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN153", "text": "A kit for detecting human telomerase reverse transcriptase (hTRT) nucleic acids comprising oligonucleotide probes or primers specifically designed to hybridize to hTRT polynucleotide sequences encoding the catalytic protein subunit of human telomerase, enabling diagnostic detection of telomerase activity in biological samples for cancer diagnosis and prognosis.", "source_patent_id": "8222392", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8222392"], "ground_truth": {"tier1_relevant_docs": {"W2036594498": 1, "W2101511757": 1, "W2102313667": 3, "8709995": 2, "W1965743650": 1, "8236774": 3, "7879609": 3, "7750121": 2, "W2004561527": 1, "W2110727184": 2, "W2163231075": 1, "W2114551234": 2, "W2079378073": 2, "W2143983456": 2, "W2140295594": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN154", "text": "A mass spectrometry method for characterizing large analytes such as biomolecules that applies a digital thresholding process to selectively filter singly- or multiply-charged ions based on signal intensity, enabling molecular mass analysis by discriminating target ions from background noise or interfering species.", "source_patent_id": "9449802", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9449802"], "ground_truth": {"tier1_relevant_docs": {"7714275": 3, "8987660": 3, "W1970766963": 3, "W2077214112": 1, "W1946407936": 1, "W2073292063": 1, "W2080212641": 1, "W2086502504": 1, "W1973486893": 1, "W2108632817": 1, "W2031919469": 2, "W1980069844": 1, "W2083991421": 1, "W2010004076": 1, "W2127071500": 2, "W2156731279": 1, "W1981316765": 1, "W2031498259": 1, "W2034003757": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN155", "text": "A directed evolution method for obtaining novel binding proteins wherein DNA molecules encoding a family of similar potential binding domains fused to a bacterial or phage surface display signal are introduced into a genetic package (bacterial cell, spore, or phage), the displayed binding domains are screened against a target molecule, successful binders are isolated and used as templates to design a new family of potential binding domains, and the iterative selection-redesign cycle is repeated until a binding domain with desired affinity is obtained, exemplified using bovine pancreatic trypsin inhibitor variants displayed on M13 phage via the gene III protein transport signal.", "source_patent_id": "6979538", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6979538"], "ground_truth": {"tier1_relevant_docs": {"5223409": 3, "5571698": 3, "5837500": 3, "7893007": 3, "W2163753017": 3, "W2169619592": 2, "W2055661888": 2, "W1972762198": 1, "W2140239020": 1, "W1906285808": 2, "W2094361895": 2, "W2148160352": 1, "W2084071030": 1, "W4245525145": 2, "W2002637160": 3, "W2170706863": 2, "W2020558940": 1, "W2013435976": 1, "W2010781281": 1, "W2025827008": 2, "W1988388495": 1, "W1999994305": 1, "W1973612810": 1, "W2040865345": 1, "W2413408041": 2, "W2156023245": 2, "W2081399278": 2, "W1988835409": 1, "W2066353338": 1, "W2041659572": 2, "W2039175545": 2, "W2008312694": 1, "7413537": 2, "W2106949912": 1, "W2022742484": 3, "W2086843403": 1, "W2035650745": 1, "W2030189518": 1, "W2051541338": 1, "W1973019272": 1, "W2128113908": 1, "5198346": 1, "W2001958777": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN156", "text": "Double-stranded short interfering nucleic acid (siNA) molecules capable of mediating RNA interference (RNAi) to inhibit target gene expression, wherein the siNA molecules comprise chemically modified nucleotides that enhance stability and efficacy compared to unmodified RNA duplexes.", "source_patent_id": "9970005", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9970005"], "ground_truth": {"tier1_relevant_docs": {"10000754": 3, "10351852": 3, "10662428": 3, "10889815": 3, "9181551": 3, "9657294": 3, "9732344": 3, "9738899": 3, "9771588": 3, "9957517": 3, "9260471": 3, "9994853": 2, "10508277": 2, "W2045653120": 2, "W2052355985": 3, "10633656": 2, "8329463": 2, "8362231": 2, "8372968": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN157", "text": "An oligonucleotide composition comprising at least 2 different oligonucleotides each targeted to distinct regions of the same target gene, wherein the combination of oligonucleotides provides enhanced inhibition of protein synthesis in a cell compared to individual oligonucleotides used alone.", "source_patent_id": "10196640", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10196640"], "ground_truth": {"tier1_relevant_docs": {"10036025": 3, "10626398": 3, "9777275": 3, "W2015646343": 2, "W1752221293": 2, "W2140505271": 2, "W2007404424": 1, "W2101583297": 1, "W2074215343": 1, "W1530096785": 2, "W1824700770": 1, "W2129932149": 1, "W2019766860": 1, "W2124860623": 1, "W2313533040": 1, "W594893089": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN158", "text": "Adeno-associated viral (AAV) vectors encoding small interfering RNA (siRNA) molecules targeting the SOD1 gene are used to silence SOD1 expression as a therapeutic approach for treating amyotrophic lateral sclerosis (ALS).", "source_patent_id": "10597660", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10597660"], "ground_truth": {"tier1_relevant_docs": {"10920227": 3, "11542506": 3, "11603542": 3, "W2035943396": 2, "W2504888830": 3, "W1986086455": 2, "11434502": 3, "W2128701198": 2, "W2038354221": 2, "W2148592148": 1, "W2297831727": 2, "W1995148334": 2, "W2073419755": 2, "W2118778532": 3, "W2159275688": 3, "W2200333324": 2, "W3041917243": 2, "W2007035942": 1, "W1512307340": 1, "W2801208090": 3, "W2154549928": 1, "W2157890177": 2, "W2135522980": 1, "W2068666140": 1, "W2093478697": 1, "W2032611006": 1, "W1983913371": 1, "W2166155593": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN159", "text": "A cancer immunotherapy composition combining cyclic-di-nucleotide (CDN) STING agonists with allogeneic human tumor cell lines engineered to secrete GM-CSF, wherein the CDN activates dendritic cells via the STING cytoplasmic receptor while the GM-CSF-secreting tumor cells provide tumor-associated antigens and promote dendritic cell recruitment and proliferation.", "source_patent_id": "9770467", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9770467"], "ground_truth": {"tier1_relevant_docs": {"10414789": 2, "9695212": 2, "10653774": 2, "9724408": 2, "W2331783064": 3, "W1493941926": 1, "W1995729706": 1, "W2088009031": 1, "W2041747503": 1, "W2410879014": 2, "W2116286338": 1, "W2162252268": 1, "W1975739500": 1, "W2016263096": 1, "W1932326519": 1, "W2087057703": 1, "W1969976769": 2, "W2126043466": 1, "W2010144429": 1, "W2135783899": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN160", "text": "A method of manufacturing ASTM-compliant renewable diesel and jet fuel by fermenting genetically engineered oil-bearing microbes on carbohydrate feedstocks including cane bagasse, sugar beet pulp, or corn stover to produce triglyceride oils, followed by hydrotreating, hydrocracking, and isomerization of the microbially-derived triglyceride oils to convert them into alkane-based fuels.", "source_patent_id": "10138435", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10138435"], "ground_truth": {"tier1_relevant_docs": {"9464304": 2, "W2153366067": 1, "W1878214092": 2, "9499845": 2, "8951777": 2, "9279136": 2, "W2071089582": 1, "10006034": 2, "9255282": 2, "W1536483915": 2, "10100341": 2, "9249436": 2, "W1576129734": 1, "W2059476617": 1, "W2099395427": 1, "W2087885742": 1, "W2128403342": 1, "W2025097672": 1, "W2156778513": 1, "8852885": 2, "W2105503244": 1, "W1991490949": 2, "W2035556650": 1, "W2090574238": 1, "W2120244994": 1, "W2139466075": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN161", "text": "Small molecule compounds that dually modulate the activity of both c-kit and c-fms receptor protein tyrosine kinases, useful for treating diseases mediated by one or both of these kinase receptors.", "source_patent_id": "7893075", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7893075"], "ground_truth": {"tier1_relevant_docs": {"7846941": 3, "8404700": 3, "8722702": 3, "9169250": 3, "9487515": 3, "8461169": 3, "7947708": 2, "W2134094496": 1, "W1485350399": 1, "W2084612167": 1, "W2171405465": 2, "W1864739484": 1, "W2093635574": 3, "W2037263805": 1, "W2041415161": 1, "W188422528": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN162", "text": "Adeno-associated viral (AAV) vectors encoding small interfering RNA (siRNA) molecules targeting the SOD1 gene are used to deliver and express SOD1-silencing siRNA for the treatment of amyotrophic lateral sclerosis (ALS).", "source_patent_id": "11542506", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11542506"], "ground_truth": {"tier1_relevant_docs": {"10597660": 3, "10920227": 3, "11603542": 3, "W1986086455": 2, "W2035943396": 2, "W2504888830": 3, "11434502": 3, "W2118778532": 3, "W2038544294": 1, "W2070693578": 1, "W2068666140": 1, "W2801208090": 3, "W2159275688": 3, "W2073419755": 2, "W2038354221": 2, "W2117258523": 1, "W2409984167": 1, "W2093478697": 1, "W1995148334": 2, "W2157890177": 2, "W1988142389": 1, "W2297831727": 2, "W2323826662": 1, "W2114205243": 1, "W2161465550": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN163", "text": "Isolated antibodies and binding fragments thereof that specifically bind to DR3 (Death Domain Containing Receptor 3) or DR3-V1 polypeptides, which are members of the tumor necrosis factor receptor family containing a death domain, wherein said antibodies can be used to identify agonists or antagonists of DR3 and DR3-V1 signaling activity.", "source_patent_id": "7708996", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7708996"], "ground_truth": {"tier1_relevant_docs": {"7357927": 3, "8105589": 3, "6713061": 3, "W1995871393": 1, "W2162490282": 2, "W2165554836": 1, "W2104857626": 1, "10906982": 1, "7824675": 1, "W2124489451": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN164", "text": "Non-naturally occurring microbial organisms engineered with a fatty alcohol, fatty aldehyde, or fatty acid biosynthetic pathway combined with select gene disruptions or enzyme attenuations that enable selective production of fatty alcohols, fatty aldehydes, or fatty acids of a specified carbon chain length, optionally coupled with an acetyl-CoA pathway to increase precursor availability and product yield.", "source_patent_id": "11186853", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11186853"], "ground_truth": {"tier1_relevant_docs": {"10513716": 3, "W2123529118": 1, "W2012716766": 1, "W2019486445": 1, "8048661": 1, "W2010436846": 1, "W2120701931": 1, "W2061266858": 1, "W1991490949": 2, "10087470": 1, "8445244": 2, "8637286": 1, "W2036311907": 2, "W2046015775": 2, "W1549786776": 1, "W1528270170": 1, "W2138058365": 2, "W1975327876": 1, "W2009692251": 1, "W2087404650": 1, "W1550508606": 1, "W2150882201": 1, "W2099395427": 1, "W4234588618": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN165", "text": "Synthetic polyamides containing N-methylpyrrole and N-methylimidazole amino acids that bind the minor groove of B-form double helical DNA with subnanomolar affinity to any predetermined DNA sequence, governed by a defined pairing code in which imidazole/pyrrole heterocyclic pairs distinguish G·C from C·G and A·T base pairs, enabling rational design of molecules that recognize specific DNA sequences with affinities and specificities comparable to transcription factors.", "source_patent_id": "6506906", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["6506906"], "ground_truth": {"tier1_relevant_docs": {"6555692": 3, "W1995041448": 3, "W2030489075": 3, "W2072791365": 2, "W2005611394": 2, "W1969171231": 2, "W4239029593": 2, "W1964916975": 3, "W1970252085": 3, "W1973988374": 3, "W1987571328": 3, "W2597403574": 2, "W1969494211": 2, "W2001005528": 2, "W4253249247": 1, "W1976180993": 3, "W2019793833": 1, "W2047289523": 1, "W2012823408": 2, "W2153626821": 2, "W1517561105": 1, "W2046226908": 2, "W2951932269": 3, "W2008019194": 2, "W2147909833": 1, "W2018996043": 2, "W2115997423": 1, "W2045489285": 2, "W2038114355": 3, "W1988112394": 2, "W2004607245": 1, "W1968614822": 2, "W2476639948": 2, "W2053439913": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN166", "text": "Substituted pyrazolo[1,5-a]pyrimidine compounds that selectively inhibit Trk (tropomyosin receptor kinase) kinases, useful for treating pain, cancer, inflammation, neurodegenerative diseases, and infectious diseases mediated by Trk kinase activity.", "source_patent_id": "10758542", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10758542"], "ground_truth": {"tier1_relevant_docs": {"10647730": 1, "10774085": 3, "11267818": 3, "W1971831559": 2, "10590139": 1, "W2835158150": 1, "W1979778155": 1, "10655186": 1, "10724102": 1, "10907215": 1, "W2012556542": 2, "W2169013957": 1, "W2620626563": 1, "W2110795584": 1, "10329299": 1, "9828377": 1, "W2065098417": 1, "7863327": 1, "8034955": 1, "W2006371036": 2, "W2154727263": 1, "W2771786250": 1, "W2020244870": 1, "10668072": 2, "11484535": 2, "W2125894112": 1, "W2009850072": 1, "W2500669545": 1, "W2338990099": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN167", "text": "T-bet is a T-box transcription factor whose isolated nucleic acid sequence and protein are provided, enabling recombinant expression vectors, transgenic animal models, fusion proteins, and anti-T-bet antibodies for modulating T-bet transcriptional activity in immune cells and identifying agents that alter T-bet function.", "source_patent_id": "7745581", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7745581"], "ground_truth": {"tier1_relevant_docs": {"8048672": 3, "W2011754426": 2, "W1911902366": 1, "W2020975034": 1, "W2102810679": 2, "W2115024315": 1, "W2077116159": 1, "W2072780211": 1, "W2136488866": 1, "W1987735044": 3, "7709218": 1, "W2147448501": 1, "6518063": 1, "W2103930786": 1, "W586119499": 1, "10973842": 1, "W1527011538": 1, "7968689": 1, "W2172044251": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN168", "text": "A sequencing method that assigns a unique identifier (UID) to each individual DNA template molecule prior to PCR amplification, then groups sequencing reads sharing the same UID into families and calls a true variant only when ≥95% of reads within a UID-family contain the identical mutation, thereby distinguishing true rare mutations from PCR and sequencing errors in massively parallel sequencing.", "source_patent_id": "11459611", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11459611"], "ground_truth": {"tier1_relevant_docs": {"W2238713843": 3, "11180803": 3, "W2152241467": 3, "11453913": 3, "W2143197030": 2, "W1957977360": 3, "W1944987775": 3, "W2303585199": 2, "W2163576465": 3, "W2153577928": 1, "W2133385595": 2, "W2161332321": 2, "W2106562836": 1, "W2168156874": 1, "W2143799706": 1, "W2009039142": 1, "W2024237661": 1, "W2734327409": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN169", "text": "A sequencing method that assigns a unique identifier (UID) to each individual DNA template molecule, amplifies each uniquely tagged molecule to create UID-families, and then performs redundant sequencing of the amplification products, wherein PCR fragments sharing the same UID are classified as true mutations only when ≥95% of the family members contain the identical sequence variant, thereby enabling confident detection of rare mutations present in a small fraction of DNA templates using massively parallel sequencing instruments.", "source_patent_id": "11453913", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11453913"], "ground_truth": {"tier1_relevant_docs": {"11180803": 3, "W2152241467": 3, "11459611": 3, "W2238713843": 2, "W2143197030": 2, "W2161332321": 2, "W2303585199": 3, "W2106562836": 1, "W1957977360": 3, "W2734327409": 2, "W2110501857": 1, "W2163576465": 2, "W1997020783": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN170", "text": "Antibodies or antigen-binding fragments thereof that immunospecifically bind to B Lymphocyte Stimulator (BLyS) protein, wherein said antibodies neutralize aberrant BLyS expression or function and are used to prevent, treat, or ameliorate diseases or disorders associated with dysregulated BLyS activity.", "source_patent_id": "9187548", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9187548"], "ground_truth": {"tier1_relevant_docs": {"7879328": 3, "8101181": 3, "8062906": 3, "W2088324610": 2, "W2095460138": 3, "W1920115643": 2, "W2043971353": 1, "W1536748279": 3, "W2060208115": 3, "W2097129513": 1, "W212723289": 2, "W2165056939": 1, "W1987554279": 1, "W2014956545": 2, "W2007998723": 1, "W2158631566": 1, "W2152330468": 1, "W2024372250": 2, "W2119170361": 1, "W2012030976": 1, "W2019990958": 1, "W2021932553": 1, "W2037237748": 1, "W2086765333": 1, "W2166397226": 2, "W2071141476": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN171", "text": "A method for regulating polypeptide association to promote heterodimer formation by modifying amino acid residues at the polypeptide interface to carry the same type of charge, thereby electrostatically disfavoring homodimer formation and favoring heterodimer formation for producing bispecific antibodies.", "source_patent_id": "11168344", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11168344"], "ground_truth": {"tier1_relevant_docs": {"10011858": 3, "W2021855052": 3, "W2118499907": 2, "W2026422641": 1, "W2053211371": 1, "11124576": 3, "W2166777850": 2, "10851178": 2, "11142587": 2, "W2033232429": 2, "W2409808339": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN172", "text": "A triblock brush copolymer having an ABC or ABA block configuration where each block bears polymer side chains (brush architecture) that provide steric properties enabling rapid self-assembly into morphologies distinct from those of conventional non-brush block copolymers, while imparting tunable mechanical, elastic, ionic, or electronic properties through selection of the side chain polymer groups.", "source_patent_id": "10153513", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10153513"], "ground_truth": {"tier1_relevant_docs": {"10608280": 3, "W2042386599": 2, "W2172949807": 1, "W2111839013": 2, "W1975562526": 2, "W4235024652": 2, "W2573340532": 1, "W2480003646": 1, "W2321768266": 3, "W2050714343": 1, "11053356": 2, "W2056456952": 1, "W2042537919": 1, "W2076174949": 1, "W2310993694": 2, "W2063996379": 1, "W1987596173": 1, "W2006358916": 1, "W2145232299": 1, "W2034697976": 1, "W1973724964": 1, "7943703": 1, "W2041862937": 1, "W2063763957": 1, "W2010857112": 1, "W1989214143": 1, "W2074782914": 2, "W2001299122": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN173", "text": "Antibodies or antigen-binding fragments thereof that immunospecifically bind to B Lymphocyte Stimulator (BLyS) protein, wherein said antibodies are used to prevent, treat, or ameliorate diseases associated with aberrant BLyS expression or inappropriate BLyS function by administering an effective amount of the antibody to an animal.", "source_patent_id": "8101181", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8101181"], "ground_truth": {"tier1_relevant_docs": {"7879328": 3, "9187548": 3, "8062906": 3, "W2088324610": 2, "W2095460138": 3, "W1920115643": 1, "W2060208115": 3, "W2043971353": 1, "W1536748279": 3, "W2097129513": 1, "W2165056939": 1, "W1987554279": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN174", "text": "Monomethylauristatin E (MMAE) and monomethylauristatin F (MMAF) peptide compounds are conjugated to targeting ligands via a maleimidocaproyl-valine-citrulline-p-aminobenzyloxycarbonyl (mc-val-cit-PAB) linker to form ligand-drug conjugates that retain cytotoxic activity both in vitro and in vivo.", "source_patent_id": "8557780", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8557780"], "ground_truth": {"tier1_relevant_docs": {"W2136101268": 3, "W2146480092": 2, "W2167463450": 2, "10414826": 3, "10808039": 3, "8703714": 3, "W2159744123": 2, "W1604721988": 1, "W2129901781": 2, "W2115292116": 3, "W2124532648": 2, "W2104998312": 2, "W2106529185": 3, "W2589361793": 2, "W2131478662": 2, "W2089197481": 3, "W2030177226": 1, "W2171368669": 2, "W2073429992": 2, "W2132696220": 2, "W2044708833": 1, "W2316400334": 1, "W2126183505": 2, "W2002228258": 2, "W2150694237": 2, "W2072725781": 2, "W2794923942": 2, "W2158346246": 3, "W2060882819": 1, "W2049348498": 1, "W1537235822": 1, "W2314837202": 2, "W2060213126": 1, "W1967808511": 3, "W1977241343": 2, "W1984007340": 1, "W2621591331": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN175", "text": "An antibody-drug conjugate (IMMU-140) comprising SN-38 attached via a CL2A linker to the anti-HLA-DR humanized antibody hL243, administered at dosages of 3-18 mg/kg, which reduces solid tumor size, eliminates metastases, and treats HLA-DR-positive hematologic cancers including AML, ALL, and multiple myeloma that are resistant to standard radiation, chemo-, or immunotherapy.", "source_patent_id": "10709701", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10709701"], "ground_truth": {"tier1_relevant_docs": {"10206918": 3, "10130718": 1, "10653793": 1, "10849986": 1, "9492566": 1, "10130626": 3, "10682347": 3, "9475884": 3, "9493573": 3, "9493574": 3, "9522959": 3, "10744129": 1, "10137196": 2, "10058621": 2, "10751420": 2, "10195175": 1, "10799597": 2, "W2614143574": 2, "W1498832526": 1, "W2597848588": 1, "W2599330662": 1, "W2767499153": 2, "W1970700504": 2, "W2083670340": 1, "W2163235231": 1, "W2065920777": 1, "W2112245386": 1, "W2143892831": 1, "W2061537048": 1, "W1486001319": 1, "W2030692610": 1, "W2951188632": 1, "W2012347946": 1, "W2002228258": 1, "W1996802281": 1, "W2950560291": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN176", "text": "Humanized monoclonal antibodies and antigen-binding fragments thereof that specifically bind sphingosine-1-phosphate (S1P), wherein the antibodies comprise humanized framework regions grafted with complementarity-determining regions reactive to S1P, for use in treating diseases associated with aberrant S1P levels.", "source_patent_id": "8222373", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8222373"], "ground_truth": {"tier1_relevant_docs": {"8067549": 3, "7956173": 3, "8025877": 3, "W2240331751": 1, "W1593737248": 1, "7829674": 3, "8026342": 3, "W2055609042": 1, "W2052150715": 1, "8614103": 3, "W1590584281": 1, "W2070205845": 1, "W2091609940": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN177", "text": "An albumin fusion protein comprising a therapeutic protein genetically fused to human serum albumin or a fragment thereof, wherein the fusion extends the half-life of the therapeutic protein in vivo while maintaining biological activity, encoded by a recombinant nucleic acid molecule expressible in a host cell.", "source_patent_id": "8252739", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8252739"], "ground_truth": {"tier1_relevant_docs": {"10711050": 3, "W2564128381": 3, "W1967723796": 3, "W2288562919": 3, "W2087865968": 2, "W2159330187": 1, "W2168950405": 3, "W1974752399": 3, "W1982267707": 3, "W2070027483": 1, "W2174253635": 3, "6686179": 3, "W2111254012": 1, "W2055454792": 1, "W2039993654": 2, "W1986377826": 3, "W2088696708": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN178", "text": "A method of inducing myelination of isolated motoneurons in vitro by co-culturing isolated motoneurons deposited on a non-biological substrate with a covalently attached DETA monolayer together with isolated Schwann cells in a defined serum-free medium supplemented with L-ascorbic acid, until the motoneurons form Nodes of Ranvier indicative of myelination.", "source_patent_id": "8828721", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8828721"], "ground_truth": {"tier1_relevant_docs": {"10266804": 2, "8815584": 2, "9650606": 2, "W2057393201": 2, "9952204": 1, "W1973157651": 2, "8835168": 1, "9267936": 1, "10160953": 2, "9163216": 2, "W1517125774": 1, "W1989407054": 1, "W2090284288": 1, "W1994452959": 1, "W1964988197": 1, "W1905071397": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN179", "text": "A method of culturing mixotrophic microorganisms wherein phototrophic and heterotrophic metabolic activities are balanced such that CO2 produced by heterotrophic respiration is consumed by phototrophic photosynthesis and O2 produced by photosynthesis is consumed by heterotrophic respiration, thereby minimizing or eliminating the need for externally supplied gases.", "source_patent_id": "10240120", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10240120"], "ground_truth": {"tier1_relevant_docs": {"9758756": 2, "W3209173973": 1, "W2089553643": 2, "W2050590108": 1, "W1821330830": 1, "W1968605375": 1, "W1999755624": 1, "W1988506059": 2, "W2088006774": 2, "W1997332981": 1, "W2024862111": 2, "W2469632292": 2, "W2129451156": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN180", "text": "A chimeric antigen receptor (CAR) comprising an endodomain that incorporates both MyD88-derived and CD40-derived polypeptide sequences as costimulatory elements, wherein T cells expressing this CAR construct receive costimulatory signaling through the MyD88 and CD40 pathways upon antigen recognition to enhance immune activation against target antigens.", "source_patent_id": "10918705", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10918705"], "ground_truth": {"tier1_relevant_docs": {"10888608": 3, "W2124513722": 1, "W2161958391": 1, "W2076991609": 1, "10934346": 3, "W2651055861": 3, "W2131714126": 2, "W1987504267": 1, "W2017390384": 1, "W2133298966": 1, "11377637": 1, "W2141410122": 1, "W2340862784": 1, "W2130011407": 1, "W1607012924": 1, "W2025271699": 1, "W1991890073": 1, "W2182307605": 1, "W2109947795": 1, "W1541573460": 2, "W2212773922": 1, "W2036644325": 1, "W2142312775": 1, "W1966747978": 1, "W1991339665": 1, "W2165580475": 1, "W2008686180": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN181", "text": "An aptamer-based colorimetric sensor system comprising oligonucleotide-functionalized particles assembled into an aggregate via a linker, wherein binding of a target analyte to the aptamer causes disaggregation of the particle assembly, producing a detectable colorimetric signal change that indicates the presence and concentration of the analyte.", "source_patent_id": "8470532", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8470532"], "ground_truth": {"tier1_relevant_docs": {"7892734": 3, "W2083612572": 1, "W1997511581": 1, "W2013753213": 2, "W1988214044": 2, "W2016431195": 1, "W1977125458": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN182", "text": "An endoprosthesis such as a drug-eluting stent incorporating hollow elements integrated within a porous surface coating, where the hollow elements are structurally embedded in the coating to enable controlled drug elution from the stent surface.", "source_patent_id": "8449603", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8449603"], "ground_truth": {"tier1_relevant_docs": {"8002823": 1, "7981150": 2, "8029554": 1, "7942926": 1, "W2162303835": 3, "W2153845471": 1, "8287937": 1, "8067054": 1, "W2115563538": 1, "W1970046408": 1, "W1991929264": 1, "7938855": 1, "W2062510776": 1, "8221822": 2, "W2070310408": 2, "W2086490706": 1, "8216632": 1, "W2133944580": 1, "W2034189742": 1, "W2062790747": 1, "8066763": 2, "8070797": 2, "W2148307855": 1, "8071156": 2, "W2062360485": 1, "W2432067349": 1, "W2014620182": 1, "W2398742502": 1, "W2017193291": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "NOVEL"}}}
{"statement_id": "RN183", "text": "A combination therapy comprising a leukocyte redirecting bispecific antibody (specifically anti-CD3×anti-CD19) formed as a dock-and-lock (DNL) complex, co-administered with one or more of interferon-α, checkpoint inhibitor antibodies, or antibody-drug conjugates, wherein the bispecific antibody redirects effector T cells, NK cells, monocytes, or neutrophils to mediate cytotoxicity against cancer or infectious disease cells expressing the targeted disease antigen.", "source_patent_id": "10111954", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10111954"], "ground_truth": {"tier1_relevant_docs": {"9682143": 3, "10245321": 2, "10662252": 2, "9382329": 2, "9670286": 2, "9879088": 2, "10183992": 3, "10239938": 3, "10308688": 3, "9315567": 3, "W1979077811": 1, "W2280299758": 1, "W2086146164": 1, "W1984385913": 1, "W1840766718": 2, "W4246309265": 1, "W1972848082": 1, "W2032185672": 2, "W2595360873": 2, "W2059410948": 2, "10717778": 1, "W2750085077": 1, "W1977743020": 1, "W2026969187": 1, "W2068482302": 1, "W2104844588": 1, "11072666": 1, "W2051944033": 1, "W1985561195": 1, "W2038444690": 2, "W185479028": 1, "W1770942365": 1, "W2139691488": 1, "W1513397279": 1, "10266605": 1, "W2410709360": 1, "W1973284926": 1, "W2111742915": 2, "W2149656692": 2, "W2108446685": 1, "W1553387109": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN184", "text": "A method for synthesizing templated molecules wherein the synthesized molecules remain covalently or non-covalently linked to the nucleic acid template that directed their synthesis, enabling the generation of screenable libraries in which each molecule is physically associated with the genetic information encoding its structure.", "source_patent_id": "10669538", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10669538"], "ground_truth": {"tier1_relevant_docs": {"8932992": 3, "8808984": 3, "10731151": 3, "10730906": 3, "W2106562836": 1, "9096951": 2, "W2096216335": 3, "W2028254012": 1, "9121110": 1, "W1968995375": 3, "W2033597631": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN185", "text": "An angle-resolved Fourier-domain optical coherence tomography system that simultaneously detects signals from a plurality of backscattered electromagnetic radiations returned from a sample at multiple angles outside the illumination solid angle, wherein depth information at multiple sample depths is independently extractable from each individual angular channel without requiring combination with other angular channels.", "source_patent_id": "7982879", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["7982879"], "ground_truth": {"tier1_relevant_docs": {"RE46412": 3, "8174702": 2, "8559012": 2, "8081316": 1, "9226665": 2, "9226660": 1, "W1967985611": 3, "W2168669080": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN186", "text": "A medical device integrating stretchable or flexible circuitry with arrays of active sensing and therapeutic elements on a single substrate that conforms to curved biological tissue surfaces such as cardiac, neural, or luminal walls, enabling simultaneous conformal sensing and therapy delivery through direct tissue contact.", "source_patent_id": "8097926", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8097926"], "ground_truth": {"tier1_relevant_docs": {"8536667": 3, "8886334": 3, "10918298": 3, "10052066": 1, "10357201": 1, "9554484": 1, "10441185": 2, "9289132": 3, "7881763": 1, "W2132275340": 1, "8666471": 2, "W2033375037": 2, "10374072": 2, "11088268": 1, "7982296": 1, "8440546": 1, "8664699": 2, "9450043": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN187", "text": "A robotic limb controller that uses a neuromuscular model comprising a muscle model, muscle geometry, and reflex feedback loop to generate torque or impedance commands for joint control, where model parameters governing the relationship between sensory feedback and muscle activation are dynamically adjusted based on data from intrinsic and/or extrinsic sensors.", "source_patent_id": "9975249", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9975249"], "ground_truth": {"tier1_relevant_docs": {"9221177": 3, "10307272": 3, "9539117": 3, "W2104865505": 2, "W2146555215": 1, "W2097511884": 1, "W1990924208": 1, "W1904546907": 1, "W2121441566": 3, "W2064657462": 1, "W2147809815": 2, "W1583686703": 2, "W2095661097": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN188", "text": "A reproducible high-yield method for producing neuromodulatory oligomers of amyloid-β(1-42) protein, wherein the oligomers are used to generate oligomer-specific antibodies that selectively recognize amyloid-β(1-42) oligomeric forms as distinct from monomers and fibrils for diagnostic and therapeutic applications in Alzheimer's disease.", "source_patent_id": "10464976", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10464976"], "ground_truth": {"tier1_relevant_docs": {"9176150": 3, "W2015068992": 1, "W2104878642": 1, "W2078212921": 2, "W2040721710": 2, "W2167425173": 1, "W2594587078": 1, "W2056092494": 3, "W2168025729": 2, "W2148809657": 1, "W2133631618": 2, "W2121963977": 2, "W1996037698": 3, "W2130288893": 1, "W2129412868": 1, "W2055733182": 1, "W2160770834": 3, "W2437755512": 1, "W1964741226": 2, "W2028826941": 1, "W2097033620": 2, "W2046974636": 2, "W2012814922": 1, "W2610995516": 1, "W2043110867": 1, "W2141827210": 1, "W2057012035": 1, "W2058819008": 1, "W2076968916": 2, "W1677883125": 2, "W2124929769": 1, "W1990975951": 2, "W1506853129": 1, "W1986139836": 1, "W1613451007": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN189", "text": "A lipid composition comprising triacylglycerol in which docosapentaenoic acid (DPA) and/or docosahexaenoic acid (DHA) are preferentially esterified at the sn-2 position of the glycerol backbone, along with processes for producing such positionally-specific long-chain polyunsaturated fatty acid triacylglycerols.", "source_patent_id": "10793507", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10793507"], "ground_truth": {"tier1_relevant_docs": {"10005713": 3, "8951514": 1, "10190073": 2, "10800729": 2, "9725399": 2, "9119826": 1, "W2143901058": 1, "W1996358681": 1, "W2007678655": 1, "W2091974362": 2, "W2084588202": 1, "W2142038669": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN190", "text": "A robotic limb controller that uses a neuromuscular model comprising a muscle model, muscle geometry, and reflex feedback loop to generate torque or impedance commands, where model parameters governing the relationship between sensory feedback and muscle activation are dynamically adjusted based on data from intrinsic and/or extrinsic sensors to control joint position, torque, and impedance.", "source_patent_id": "9221177", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9221177"], "ground_truth": {"tier1_relevant_docs": {"9975249": 3, "10307272": 3, "9539117": 3, "W2104865505": 2, "W2146555215": 1, "W2097511884": 2, "W2121441566": 3, "W2171246493": 1, "W1549114171": 1, "W2147809815": 2, "W2064657462": 1, "W1976912497": 1, "W1904546907": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN191", "text": "Albumin fusion proteins comprising a therapeutic protein genetically fused to human serum albumin or a fragment thereof, wherein the fusion extends the half-life of the therapeutic protein in vivo, encoded by recombinant nucleic acid molecules expressible in host cells.", "source_patent_id": "9221896", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9221896"], "ground_truth": {"tier1_relevant_docs": {"10711050": 2, "8287859": 3, "W2159330187": 1, "W1982267707": 2, "W1974752399": 3, "W1967723796": 3, "7977306": 3, "W2564128381": 3, "8211439": 3, "W2088696708": 2, "W2087865968": 1, "6686179": 3, "7482013": 3, "6926898": 3, "6946134": 3, "6994857": 3, "7507413": 3, "7521424": 3, "7592010": 3, "7785599": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN192", "text": "Heterocyclic prolinamide derivatives that function as inhibitors of HTRA1 serine protease activity, wherein the compounds are designed to prevent or treat age-related macular degeneration (including dry-AMD, wet-AMD, and geographic atrophy), diabetic retinopathy, and related retinal degenerative diseases by inhibiting HTRA1-mediated pathological processes in the eye.", "source_patent_id": "11377439", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11377439"], "ground_truth": {"tier1_relevant_docs": {"11267803": 2, "W2154106629": 1, "W1708491780": 1, "W2015439810": 2, "W2106901733": 2, "W3183892691": 1, "W2117906875": 1, "W2145027167": 1, "W2041777777": 1, "W2165027720": 1, "W1993028247": 1, "W2672043438": 1, "W2581382563": 1, "W2116211129": 1, "W2057633567": 2, "W1779648250": 1, "W2171845476": 1, "W158938192": 1, "W2122067959": 1, "W2791884494": 2, "W2008901562": 1, "W2133556048": 1, "W1985386407": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN193", "text": "Alvocidib prodrug compounds having a modified chemical structure where at least one of three defined substituent groups (R1, R2, R3) is not hydrogen, designed to be converted in vivo to the active CDK inhibitor alvocidib for treating diseases associated with overexpression of cyclin-dependent kinases.", "source_patent_id": "11279694", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11279694"], "ground_truth": {"tier1_relevant_docs": {"10259835": 3, "10562925": 3, "W2134428146": 1, "W2907710146": 1, "W3177873443": 1, "W2085648789": 1, "W3083373021": 2, "W2074695805": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN194", "text": "A bifunctional fusion antibody comprising an anti-human insulin receptor antibody conjugated to α-L-Iduronidase enzyme, administered systemically to deliver therapeutic α-L-Iduronidase across the blood-brain barrier via insulin receptor-mediated transcytosis for treating CNS α-L-Iduronidase deficiency, with dosing based on quantified CNS uptake characteristics of the fusion construct.", "source_patent_id": "11512145", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11512145"], "ground_truth": {"tier1_relevant_docs": {"10202467": 3, "9567400": 3, "W2057915227": 1, "9975955": 1, "W1965298106": 3, "W2021565098": 3, "W1980379909": 2, "W2055422281": 2, "W2090764193": 2, "W2014004221": 2, "W2002851710": 3, "W1974491241": 2, "11028156": 1, "W1551220004": 1, "W2023959423": 2, "W2088565055": 2, "W1973213662": 3, "W2097778362": 3, "W2126567630": 2, "W2071588157": 2, "W1574043141": 3, "W2009312492": 2, "W2135418827": 1, "W4255653564": 2, "W2171636653": 2, "W2035885897": 1, "W2094665624": 1, "W2027373998": 3, "W2083284350": 2, "W2100174615": 1, "W2132851377": 1, "W2416436748": 1, "W2058733470": 2, "W2048428129": 2, "W2109699895": 2, "W2152944721": 2, "W2043482793": 1, "W1966885906": 1, "W2157986686": 3, "W1969749348": 1, "W1987561860": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN195", "text": "A conformable brain-surface electrode array comprising a flexible substrate supporting an actively multiplexed electronic circuit and a barrier layer, wherein high-density electrodes provide electrical contact with brain tissue to enable simultaneous monitoring and actuation of spatio-temporal electrical waveforms at high spatial and temporal resolution over large cortical surface areas.", "source_patent_id": "8934965", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8934965"], "ground_truth": {"tier1_relevant_docs": {"10349860": 3, "10925543": 2, "10953225": 1, "W2163532909": 1, "11229789": 1, "10052066": 1, "10357201": 1, "9554484": 1, "W1984750744": 3, "W2122482341": 1, "W2111937020": 1, "W2542395004": 1, "W1990283232": 2, "10918298": 3, "W2170459269": 1, "W2003418830": 1, "W2127718543": 1, "W2077854881": 1, "W2009578021": 2, "8840552": 1, "W2122276783": 1, "10441185": 1, "W2047881676": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN196", "text": "A method for treating tracheobronchomalacia (TBM) in a patient diagnosed with hypophosphatasia (HPP) by administering a soluble alkaline phosphatase (sALP), thereby addressing the TBM as a clinical manifestation of the underlying HPP condition.", "source_patent_id": "11116821", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11116821"], "ground_truth": {"tier1_relevant_docs": {"11065306": 2, "11400140": 1, "10898549": 2, "11224637": 2, "W2582923639": 1, "W2739051205": 1, "W1899890323": 1, "W2012850243": 1, "W2334055315": 1, "10449236": 1, "11224638": 1, "W1810382110": 1, "W1993776289": 1, "W2144827667": 1, "W1975386252": 1, "11229686": 2, "W2426439845": 2, "W2290672512": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN197", "text": "Monoclonal antibodies 10F4 and 3C5 that selectively bind to Abeta globulomer conformers, distinguishing them from Abeta monomers and fibrils, for use in the treatment and diagnosis of Alzheimer's Disease.", "source_patent_id": "9359430", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9359430"], "ground_truth": {"tier1_relevant_docs": {"8877190": 3, "9394360": 3, "9951125": 3, "W2176365163": 1, "W2120096591": 2, "8497072": 2, "W2100610042": 1, "W2061385106": 1, "W2139606533": 1, "W1996037698": 2, "W1987398071": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN198", "text": "A continuous glucose measurement system configured for direct insertion into a host's vascular system, comprising a vascular access device integrated with an analyte sensor and sensor electronics to enable continuous real-time glucose monitoring within the circulatory system.", "source_patent_id": "8886273", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8886273"], "ground_truth": {"tier1_relevant_docs": {"10349873": 3, "11000215": 3, "11020031": 3, "8287453": 3, "9451908": 3, "11382539": 3, "8229535": 1, "11564602": 1, "7927274": 1, "8282550": 1, "9538946": 1, "11102306": 1, "9020572": 1, "9143569": 1, "10278580": 1, "10403012": 1, "10966609": 1, "11373347": 1, "8562558": 1, "8808228": 1, "9741139": 1, "8591455": 1, "W2101919013": 1, "W2021289280": 1, "10653835": 1, "10835672": 1, "W2144664632": 2, "W2045397747": 1, "W2174424607": 1, "W4299649886": 1, "W1831881013": 1, "10610135": 1, "10610136": 1, "10610137": 1, "10617336": 1, "10709364": 1, "10716498": 1, "10743801": 1, "10856787": 1, "10898114": 1, "10918316": 1, "10918317": 1, "10918318": 1, "10925524": 1, "11000213": 1, "11051726": 1, "7920906": 1, "8560037": 1, "8579816": 1, "8611978": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN199", "text": "Blocking the interaction between thrombospondin-1 (TSP1) and CD47 in blood vessels causes vasodilation and increases blood flow and tissue perfusion, thereby preventing tissue ischemia and damage under conditions of reduced blood flow caused by injury or atherosclerosis.", "source_patent_id": "8557788", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8557788"], "ground_truth": {"tier1_relevant_docs": {"10370439": 3, "8865672": 3, "8236313": 3, "W2153948972": 3, "W2040261887": 3, "W30165372": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN200", "text": "An anti-VISTA antibody antagonist that blocks the immune checkpoint protein VISTA to activate anti-tumor immune responses in vivo, wherein combining the VISTA antagonist with a PD-L1 antagonist produces an additive reduction in tumor burden compared to either agent alone.", "source_patent_id": "11529416", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11529416"], "ground_truth": {"tier1_relevant_docs": {"11180557": 3, "W2786903500": 1, "11123426": 2, "W2126259300": 2, "W2566255135": 1, "W2166932124": 2, "W2558584963": 2, "W2097288420": 2, "W2549739020": 2, "W2020090293": 1, "10370455": 2, "W2134644618": 2, "11525000": 2, "10933115": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN201", "text": "A microfluidic cartridge configured to accept a plurality of biological samples and perform PCR amplification on each sample individually or on multiple samples simultaneously within discrete microfluidic channels, enabling parallel polynucleotide amplification and detection in a single integrated device.", "source_patent_id": "11085069", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["11085069"], "ground_truth": {"tier1_relevant_docs": {"10900066": 3, "11142785": 3, "W2089922757": 3, "11266987": 3, "11135584": 2, "11549959": 2, "11453906": 2, "W2035285327": 2, "W1975763728": 3, "W2096250619": 2, "W2094691790": 2, "W2042181447": 2, "10632466": 3, "10875022": 3, "W2010790628": 2, "10821446": 2, "11141734": 2, "W1983770680": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN202", "text": "Antibodies or antigen binding fragments that simultaneously bind to globo H, SSEA-3, and SSEA-4 glycan antigens on cancer cell surfaces, enabling both therapeutic targeting and diagnostic detection of carcinomas including breast, ovarian, lung, pancreatic, and prostate cancers.", "source_patent_id": "9975965", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9975965"], "ground_truth": {"tier1_relevant_docs": {"10150818": 3, "9982041": 2, "W2317274483": 2, "W1968196198": 2, "W2111442531": 2, "W2123834367": 2, "W2113408598": 1, "W2741768127": 1, "W2488118245": 1, "W1994745314": 1, "W2152916164": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN203", "text": "Maleate salt forms of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide, including specific crystalline polymorphs thereof, prepared as pharmaceutical compositions for treating cancers driven by epidermal growth factor receptor family kinases.", "source_patent_id": "9630946", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9630946"], "ground_truth": {"tier1_relevant_docs": {"10035788": 3, "9139558": 3, "W2053015255": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN204", "text": "Methods and compositions for selecting patients for treatment with a complement factor D inhibitor based on prognostic or predictive biomarkers comprising polymorphisms in complement factor H (CFH) and complement factor I (CFI) genes, wherein the presence of specific CFH/CFI polymorphisms predicts patient responsiveness to anti-factor D antibody treatment for age-related macular degeneration (AMD).", "source_patent_id": "10093978", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10093978"], "ground_truth": {"tier1_relevant_docs": {"10947591": 3, "W2028283509": 1, "9212212": 1, "W2113784410": 2, "W1993028247": 1, "W3145351529": 1, "W2117386992": 1, "10654932": 1, "10961313": 1, "W2147166769": 1, "W1760485743": 1, "10179821": 2, "W2097474764": 1, "W2107356267": 1, "W2037699290": 1, "W2089709236": 2, "W2171110632": 1, "W1989747234": 2, "W2036826501": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN205", "text": "Synthetic combinations of agricultural plant seeds or seedlings with heterologous seed-derived bacterial endophytes, wherein purified populations of seed-origin bacterial endophytes isolated from cereal seeds are applied to confer agronomic benefits to the seed, seedling, or resulting plant.", "source_patent_id": "10499652", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10499652"], "ground_truth": {"tier1_relevant_docs": {"10499653": 3, "11166465": 3, "10492497": 3, "10499654": 3, "10912303": 3, "W2117231950": 2, "10750711": 2, "10271554": 2, "11254908": 2, "W2110590767": 1, "10212940": 2, "11064702": 2, "W2143817628": 2, "10212944": 2, "W2053035894": 3, "W2147981185": 2, "W2150260278": 2, "W2136322518": 2, "10306890": 3, "11119086": 3, "W2165287641": 1, "W2119276271": 1, "W2067462638": 1, "W1989107764": 2, "W1593139763": 1, "W2040494523": 1, "W2163268872": 1, "W2130817835": 2, "10375966": 1, "10813359": 1, "W2110482520": 1, "W1998567999": 1, "W1970419776": 1, "W2160716612": 1, "W2620421631": 1, "W3159376780": 1, "W2025071115": 1, "W2086333404": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN206", "text": "A CR2-FH fusion molecule comprising a complement receptor 2 (CR2) portion linked to a factor H (FH) portion, wherein the CR2 portion targets sites of complement activation and the FH portion inhibits the alternative complement pathway, for use in treating diseases such as age-related macular degeneration, rheumatoid arthritis, and ischemia reperfusion injury.", "source_patent_id": "9212212", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9212212"], "ground_truth": {"tier1_relevant_docs": {"W1833364259": 3, "9650447": 2, "W2126578468": 3, "W2082748157": 2, "W2150659072": 2, "W1865120546": 3, "W2133396318": 3, "W2014336891": 3, "W2043761376": 1, "W2110587815": 1, "W1962102239": 1, "W2025576158": 3, "W2136963282": 1, "W2028283509": 1, "W1853339213": 1, "W1588757304": 2, "W1748831834": 1, "W2146429955": 1, "W2125236492": 1, "W2097474764": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN207", "text": "A relatively non-invasive esophageal device configured to induce therapeutic hypothermia in a patient by circulating a temperature-controlled fluid through a catheter placed in the esophagus to transfer heat from the patient's core body, thereby treating ischemic conditions without requiring intravascular access.", "source_patent_id": "8231664", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8231664"], "ground_truth": {"tier1_relevant_docs": {"10568761": 3, "10363162": 3, "10716703": 3, "8444684": 3, "8523929": 3, "8696725": 3, "9301871": 3, "9326890": 3, "9622909": 3, "10413444": 3, "W2149174218": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN208", "text": "Monoclonal antibodies that specifically bind to Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) and inhibit its activity, for use in treating hypercholesterolemia by reducing LDL cholesterol levels through blocking PCSK9-mediated degradation of LDL receptors.", "source_patent_id": "9920134", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9920134"], "ground_truth": {"tier1_relevant_docs": {"9493576": 3, "W1976691226": 3, "W2019703802": 2, "W2054610237": 2, "W2027027250": 2, "W2059664120": 2, "W2019173226": 1, "W2028682402": 2, "W187428942": 3, "W2004032902": 2, "W2015860855": 1, "W2102467926": 3, "W2062062360": 3, "W104809725": 1, "W2978829346": 2, "W2157115489": 2, "W2001314633": 1, "W2136034547": 2, "W2952304415": 3, "W2113442590": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN209", "text": "Blocking the interaction between thrombospondin-1 (TSP1) and CD47 receptor in blood vessels causes vasodilation and increases blood flow and tissue perfusion, thereby preventing tissue ischemia and damage under conditions of reduced blood flow such as those caused by injury or atherosclerosis.", "source_patent_id": "8865672", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8865672"], "ground_truth": {"tier1_relevant_docs": {"10370439": 3, "8557788": 3, "8236313": 3, "W2153948972": 3, "W2040261887": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN210", "text": "A bivalent linker molecule that simultaneously couples two or more chemical entities, specifically connecting targeting ligands such as vitamins to therapeutic drugs or diagnostic/imaging agents, enabling formation of conjugates that retain receptor-binding capability of the vitamin ligand while delivering the attached drug or diagnostic agent.", "source_patent_id": "10647676", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10647676"], "ground_truth": {"tier1_relevant_docs": {"7790860": 1, "W1975556125": 2, "W1517969155": 1, "W2030177226": 1, "10080805": 1, "10765756": 1, "11344623": 1, "W2060213126": 1, "W2083670340": 1, "W1987246672": 1, "W2319778858": 2, "W1604721988": 1, "W2101893838": 1, "W3099031341": 1, "W2012078259": 1, "9555139": 3, "W1990212018": 2, "W2057278101": 1, "W2060537783": 1, "W1967393143": 2, "W2002228258": 1, "W102754497": 2, "10814013": 2, "10925977": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN211", "text": "(2S,3R)-N-(1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide bearing a (3-pyridinyl)methyl substituent at the nitrogen, wherein the specific stereochemical configuration (2S,3R) enables selective binding to and modulation of neuronal nicotinic acetylcholine receptors for treatment of central nervous system disorders.", "source_patent_id": "8901151", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["8901151"], "ground_truth": {"tier1_relevant_docs": {"W1967278587": 1, "W2030117810": 1, "8476296": 3, "9173876": 3, "W2058732759": 1, "W2170194206": 1, "W2104594197": 2, "W2044814300": 1, "W2125605704": 1, "W1998523060": 1, "W2050406169": 1, "W4247556132": 1, "W2161605623": 1, "W2126075813": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN212", "text": "A bifunctional fusion antibody comprising an anti-human insulin receptor antibody conjugated to α-L-Iduronidase enzyme, administered systemically to deliver therapeutically effective concentrations of α-L-Iduronidase across the blood-brain barrier into the CNS by exploiting insulin receptor-mediated transcytosis.", "source_patent_id": "10202467", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10202467"], "ground_truth": {"tier1_relevant_docs": {"9567400": 3, "11512145": 3, "W2057915227": 2, "9975955": 2, "W1574043141": 3, "W2014004221": 2, "W1965298106": 3, "W2090764193": 2, "W1980379909": 2, "W2055422281": 2, "W2088565055": 2, "W2021565098": 2, "W1974491241": 2, "W2002851710": 3, "W2097778362": 3, "W1551220004": 1, "W2035885897": 2, "W1973213662": 3, "W4255653564": 2, "W2135418827": 2, "W2023959423": 2, "11028156": 1, "W2416436748": 1, "W2094665624": 2, "W1969749348": 1, "W2048428129": 2, "W2071588157": 1, "W2069050425": 2, "W2167124686": 1, "W2017668300": 2, "W2083284350": 2, "W1987561860": 1, "W2132851377": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN213", "text": "A pharmaceutical combination comprising a positive allosteric modulator (PAM) or orthosteric agonist of metabotropic glutamatergic receptor subtype 2 (mGluR2) together with a synaptic vesicle protein 2A (SV2A) ligand for therapeutic use.", "source_patent_id": "10537573", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["10537573"], "ground_truth": {"tier1_relevant_docs": {"11103506": 3, "11369606": 3, "W2153645092": 1, "10154988": 1, "W2319496949": 1, "W2335625211": 1, "W2001864260": 1, "W92727290": 1, "W2587036530": 3, "W2116896173": 1, "W2147197593": 1, "9708315": 1, "W2070609048": 1, "W2133179281": 1, "W71748888": 1, "8691813": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN214", "text": "A method of modifying the isoelectric point of an antibody while retaining antigen-binding activity by substituting at least one surface-exposed amino acid residue within the complementarity determining region (CDR) to alter the charge of that residue, enabling purification of multispecific antibodies and improvement of plasma pharmacokinetics.", "source_patent_id": "9828429", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9828429"], "ground_truth": {"tier1_relevant_docs": {"9096651": 3, "11248053": 3, "W2006648563": 1, "10934344": 3, "9670269": 3, "W2033701042": 1, "W2141301556": 2, "W2053887681": 1, "W2011766387": 3, "W2156778410": 1, "W2095793426": 2, "W2085234074": 1, "10450381": 1, "W2404542855": 1, "W2897928030": 2, "W1850124590": 1, "W1986368280": 1, "W2055004986": 1, "W2042430782": 1, "W143149509": 1, "W2073799384": 1, "W2008130732": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN215", "text": "A catheter balloon incorporating stretchable active integrated circuits and sensor arrays on its outer surface that maintain electrical functionality when the balloon is inflated, enabling direct contact measurement and therapy delivery against the inner wall of a body lumen.", "source_patent_id": "9289132", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9289132"], "ground_truth": {"tier1_relevant_docs": {"8097926": 3, "8536667": 3, "8886334": 3, "10052066": 1, "10357201": 1, "9554484": 1, "W2138094826": 2, "W2047881676": 1, "W2007705351": 1, "W2030699080": 2, "W1973543540": 1, "9023037": 1, "9757193": 1, "9827041": 1, "W2085834391": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN216", "text": "Optical systems comprising printable single-crystalline semiconductor elements assembled onto flexible or stretchable substrates via printing-based transfer techniques, achieving performance characteristics comparable to conventional high-temperature processed single-crystalline semiconductor devices while enabling flexible, conformable, and stretchable form factors not accessible by traditional fabrication methods.", "source_patent_id": "9601671", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "both", "num_citing_patents": 0, "patent_ids": ["9601671"], "ground_truth": {"tier1_relevant_docs": {"10374072": 3, "11088268": 3, "7982296": 3, "8440546": 3, "8664699": 3, "9450043": 3, "9761444": 3, "9768086": 3, "10361180": 3, "10424572": 3, "10504882": 3, "11309305": 3, "7972875": 3, "8722458": 3, "9117940": 3, "7799699": 3, "8039847": 3, "W2142404795": 3, "8372726": 2, "W2132275340": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN217", "text": "Crystalline polymorphic solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one, a PI3 kinase inhibitor, including specific processes for their preparation and pharmaceutical compositions thereof for treating diseases associated with PI3 kinase activity.", "source_patent_id": "9840505", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9840505"], "ground_truth": {"tier1_relevant_docs": {"10160761": 3, "11247995": 3, "9481667": 2, "10550122": 3, "10329299": 2, "9828377": 2, "8809349": 3, "9290497": 3, "RE46621": 3, "9522146": 2, "9206182": 2, "9738644": 2, "10919914": 2, "11541059": 1, "8785470": 2, "8940742": 2, "8969363": 2, "9056877": 2, "9255108": 2, "9359365": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN218", "text": "An electrochemical analyte sensor comprising a substrate with a recessed channel formed therein and conductive material disposed within the recessed channel to form a working electrode, coupled to a wearable sensor control unit having conductive contacts that mate with corresponding contact pads on the sensor and a wireless transmitter that sends analyte measurement data to a separate display unit receiver for real-time analyte level indication.", "source_patent_id": "8226555", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8226555"], "ground_truth": {"tier1_relevant_docs": {"8612159": 3, "10231654": 3, "10478108": 3, "10952652": 3, "11103165": 3, "11272867": 3, "11399748": 3, "7869853": 3, "7885699": 3, "8162829": 3, "8175673": 3, "8177716": 3, "8224413": 3, "8226557": 3, "8226558": 3, "8231532": 3, "8235896": 3, "8255031": 3, "8260392": 3, "8265726": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN219", "text": "A method of diagnosing inflammatory bowel disease (including Crohn's Disease, Ulcerative Colitis, and Medically Refractive Ulcerative Colitis) by detecting expression levels of RNASET2, TL1A, and/or IFN-γ as biomarkers, wherein the method further enables patient stratification and selection of therapeutically effective treatment agents based on the detected biomarker profiles.", "source_patent_id": "11186872", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11186872"], "ground_truth": {"tier1_relevant_docs": {"W1984189215": 1, "W2112449462": 1, "9580752": 2, "W1997677936": 1, "W1981714996": 1, "W2097875133": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN220", "text": "A voice input processing system that identifies the speaking user and selects a personalized subset of a speech recognition vocabulary library based on that user's profile—including media items stored on the device, contact names, and frequently used applications—so that speech recognition is performed against this reduced, user-specific word subset rather than the full vocabulary library.", "source_patent_id": "10049675", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10049675"], "ground_truth": {"tier1_relevant_docs": {"9633660": 3, "9190062": 3, "10049663": 1, "11069347": 1, "10102359": 1, "9262612": 1, "9972304": 1, "8903716": 2, "10079014": 2, "9959870": 1, "9865280": 1, "9697822": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN221", "text": "A continuous analyte sensor system that uses one or more additional electrodes to measure a secondary analyte to obtain baseline or sensitivity measurements, which are then used to calibrate the primary continuous analyte sensor and can trigger events such as digital filtering or suspension of data display.", "source_patent_id": "8428678", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8428678"], "ground_truth": {"tier1_relevant_docs": {"8160671": 3, "8249684": 3, "11399745": 3, "10610135": 1, "10610136": 1, "10610137": 1, "10617336": 1, "10709364": 1, "10716498": 1, "10743801": 1, "10856787": 1, "10898114": 1, "10918316": 1, "10918317": 1, "10918318": 1, "10925524": 1, "11000213": 1, "11051726": 1, "7920906": 1, "8560037": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN222", "text": "An electrochemical analyte sensor comprising a substrate with a recessed channel formed therein and conductive material disposed within the recessed channel to form a working electrode, coupled to a skin-worn sensor control unit having conductive contacts that mate with contact pads on the sensor and a transmitter that wirelessly transmits sensor data to a remote display unit receiver.", "source_patent_id": "8366614", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8366614"], "ground_truth": {"tier1_relevant_docs": {"8612159": 3, "10231654": 3, "10478108": 3, "10952652": 3, "11103165": 3, "11272867": 3, "11399748": 3, "7869853": 3, "7885699": 3, "8162829": 3, "8175673": 3, "8177716": 3, "8224413": 3, "8226555": 3, "8226557": 3, "8226558": 3, "8231532": 3, "8235896": 3, "8255031": 3, "8260392": 3, "8265726": 3, "8273022": 3, "8275439": 3, "8287454": 3, "8306598": 3, "8346336": 3, "8353829": 3, "8357091": 3, "8372005": 3, "8380273": 3, "8409131": 3, "8473021": 3, "8480580": 3, "8597189": 3, "8617071": 3, "8622906": 3, "8641619": 3, "8649841": 3, "8652043": 3, "8660627": 3, "8666469": 3, "8668645": 3, "8670815": 3, "8672844": 3, "8734346": 3, "8734348": 3, "8738109": 3, "8744545": 3, "8774887": 3, "8880137": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN223", "text": "A method for renal neuromodulation wherein thermal energy is applied directly or indirectly to renal neural fibers or their supplying vasculature to achieve neuromodulation, with sensor-based monitoring of neural fiber parameters, non-target tissue parameters, or thermal energy delivery element parameters to control the modulation, combined with protective elements that selectively reduce thermal damage to non-target tissues while preserving therapeutic effect on renal nerves.", "source_patent_id": "8728137", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8728137"], "ground_truth": {"tier1_relevant_docs": {"10034708": 3, "10441356": 3, "8626300": 3, "10124195": 3, "8728138": 3, "8986294": 3, "8845629": 3, "10293190": 3, "9186198": 3, "8684998": 3, "10537385": 2, "10561460": 2, "9131978": 2, "9265558": 2, "9320561": 2, "9456869": 2, "10179235": 2, "10850091": 2, "8150519": 2, "9486270": 2, "9814873": 2, "9138281": 1, "8175711": 2, "9308044": 2, "9439726": 2, "9636174": 2, "9895195": 2, "8145317": 2, "8150520": 2, "9474563": 2, "10179027": 2, "8774922": 1, "8551069": 1, "10039596": 1, "10194979": 2, "10194980": 2, "9980766": 2, "9364280": 1, "8774913": 3, "8433423": 1, "10537734": 1, "9108040": 1, "9402992": 1, "9950161": 1, "8768470": 1, "9308043": 1, "9327122": 1, "9468497": 1, "9707035": 1, "10111707": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN224", "text": "A method for treating ulcerative colitis comprising administering a pharmaceutical composition comprising live non-pathogenic fecal bacteria at least three times per week for at least 8 weeks to a subject with a Mayo endoscopy score of 3 or lower, without concomitant or immediately prior corticosteroid use.", "source_patent_id": "10195235", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10195235"], "ground_truth": {"tier1_relevant_docs": {"10561690": 3, "11071759": 3, "11166990": 2, "10064900": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN225", "text": "A method for identifying compounds that bind to or modulate a target by compartmentalizing individual compounds together with the target into microcapsules such that only a subset of the compound repertoire is represented in multiple copies within any single microcapsule, enabling screening of large molecular repertoires for drug lead identification.", "source_patent_id": "9448172", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9448172"], "ground_truth": {"tier1_relevant_docs": {"9857303": 3, "9498759": 3, "7927791": 1, "9925504": 2, "9839890": 2, "8460864": 1, "W2111017461": 1, "10052605": 3, "W2055723836": 1, "W2040809710": 1, "9328344": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN226", "text": "A balloon catheter apparatus for renal neuromodulation that delivers energy at multiple lengthwise and angularly offset positions within a renal artery to create overlapping less-than-full circumferential treatment zones that together define a non-continuous circumferential treatment pattern without forming a continuous circumferential lesion.", "source_patent_id": "9023037", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9023037"], "ground_truth": {"tier1_relevant_docs": {"9757193": 3, "9827041": 3, "8721637": 3, "8740896": 3, "8454594": 3, "10420606": 3, "9314630": 1, "9743983": 1, "9757192": 1, "9907611": 1, "8880186": 1, "10561460": 1, "10537385": 1, "10179028": 1, "10105180": 1, "10376311": 1, "10179027": 1, "8774922": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN227", "text": "A method of reducing remnant lipoprotein cholesterol (RLP-C) in a subject comprising administering a pharmaceutical composition comprising eicosapentaenoic acid (EPA) or a derivative thereof, wherein the EPA treatment selectively lowers remnant lipoprotein particle cholesterol levels to reduce cardiovascular disease risk.", "source_patent_id": "10561631", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10561631"], "ground_truth": {"tier1_relevant_docs": {"10966968": 1, "10383840": 2, "10555924": 2, "10555925": 2, "10568861": 2, "10576054": 2, "10792270": 2, "10894028": 2, "10668042": 2, "10786478": 2, "11000499": 2, "11116742": 2, "11116743": 2, "11298333": 2, "11369582": 2, "11052063": 3, "10166209": 2, "10265290": 2, "10610508": 2, "10973797": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN228", "text": "A system where a DNS-like IP address lookup request for a second device's identifier triggers a name service to simultaneously return the requested IP address, an availability indication for a secure communications service, and provisioning information for establishing an encrypted communication link, enabling the requesting device to use the lookup response itself to configure and initiate the encrypted connection.", "source_patent_id": "9077695", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9077695"], "ground_truth": {"tier1_relevant_docs": {"10511573": 3, "9374346": 3, "8850009": 3, "8868705": 3, "9038163": 3, "10187387": 2, "8843643": 3, "9413766": 2, "8904516": 3, "9819649": 3, "9027115": 3, "9769128": 1, "9077694": 2, "9860283": 2, "9037713": 2, "9967240": 2, "9100375": 2, "8943201": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN229", "text": "An implantable medical device coating comprising a first layer containing a therapeutic agent and an optional polymer, combined with a second layer containing a metallic material, wherein both layers are applied to a substrate such as an intravascular stent for localized drug delivery to body tissue.", "source_patent_id": "8815275", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8815275"], "ground_truth": {"tier1_relevant_docs": {"8920491": 3, "8431149": 2, "8070797": 2, "8932346": 2, "8840552": 1, "8900292": 2, "8187620": 3, "8815273": 2, "8066763": 3, "8118877": 1, "8067054": 2, "7713544": 1, "7942926": 2, "9265844": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN230", "text": "An electrochemical analyte sensor comprising a substrate with a recessed channel formed therein and conductive material disposed within the recessed channel to form a working electrode, combined with a skin-worn sensor control unit having conductive contacts that couple to contact pads on the sensor and a transmitter that wirelessly transmits analyte data to a remote display unit receiver.", "source_patent_id": "8880137", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8880137"], "ground_truth": {"tier1_relevant_docs": {"8612159": 3, "10231654": 3, "10478108": 3, "10952652": 3, "11103165": 3, "11272867": 3, "11399748": 3, "7869853": 3, "7885699": 3, "8162829": 3, "8175673": 3, "8177716": 3, "8224413": 3, "8226555": 3, "8226557": 3, "8226558": 3, "8231532": 3, "8235896": 3, "8255031": 3, "8260392": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN231", "text": "A method for treating cancer by first administering a Btk inhibitor to cause an increase or appearance of a specific lymphocyte subpopulation in blood (identified by immunophenotyping), then measuring biomarker expression profiles from that subpopulation, and selecting a second therapeutic agent based on the determined expression profile.", "source_patent_id": "10751342", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10751342"], "ground_truth": {"tier1_relevant_docs": {"10004745": 3, "10004746": 3, "10016435": 3, "10478439": 3, "10653696": 3, "9814721": 3, "W2548523404": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN232", "text": "A continuous analyte sensor calibration system that uses reference data from a short-term implanted continuous analyte sensor to initially calibrate or update sensor data from a long-term implanted continuous analyte sensor, and alternatively uses pre-insertion benchtop testing reference data to provide initial calibration of sensor data, employing matched sensor-reference data pairs evaluated for clinical acceptability and calibration quality.", "source_patent_id": "10918316", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10918316"], "ground_truth": {"tier1_relevant_docs": {"10610135": 3, "10610136": 3, "10610137": 3, "10617336": 3, "10709364": 3, "10716498": 3, "10743801": 3, "10856787": 3, "10898114": 3, "10918317": 3, "10918318": 3, "10925524": 3, "11000213": 3, "11051726": 3, "7920906": 3, "8560037": 3, "8579816": 3, "8611978": 3, "9078608": 3, "9314196": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN233", "text": "A pre-connected analyte sensor assembly comprising a sensor carrier permanently attached to an analyte sensor prior to end-use deployment, wherein the sensor carrier includes both a substrate configured for mechanical coupling to testing, calibration, or wearable equipment and conductive contacts that electrically couple sensor electrodes to such equipment.", "source_patent_id": "11350862", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11350862"], "ground_truth": {"tier1_relevant_docs": {"11160926": 3, "11331022": 3, "11382540": 3, "10231654": 2, "10478108": 2, "10952652": 2, "11103165": 2, "11272867": 2, "11399748": 2, "7869853": 2, "7885699": 2, "8162829": 2, "8175673": 2, "8177716": 2, "8224413": 2, "8226555": 2, "8226557": 2, "8226558": 2, "8231532": 2, "8235896": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN234", "text": "A laser control system employing multiphoton intrapulse interference phase scan (MIIPS) to characterize and compensate spectral phase distortions in ultrafast laser pulses, wherein a pulse shaper is positioned between a laser oscillator and the output of a laser amplifier to correct pulse distortions before amplification output.", "source_patent_id": "8300669", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8300669"], "ground_truth": {"tier1_relevant_docs": {"8265110": 2, "8311069": 2, "8208504": 2, "8630322": 3, "8861075": 2, "8675699": 2, "8633437": 1, "8208505": 1, "9018562": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN235", "text": "1,2,4-triazolo[4,3-a]pyridine derivatives that function as positive allosteric modulators of metabotropic glutamate receptor subtype 2 (mGluR2), useful for treating neurological and psychiatric disorders associated with glutamate dysfunction.", "source_patent_id": "9012448", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9012448"], "ground_truth": {"tier1_relevant_docs": {"9271967": 3, "8946205": 3, "8691813": 1, "8716480": 3, "8993591": 3, "9085577": 3, "10071095": 3, "9737533": 3, "9226930": 3, "8937060": 3, "9708315": 3, "8697689": 1, "8785486": 2, "9067891": 1, "8691849": 2, "8841323": 2, "9266834": 2, "8906939": 2, "8722894": 1, "9132122": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN236", "text": "A glucose monitoring system that awards scores or rewards to users based on interactions with the monitoring system interface—such as initiating displays, downloading data, and setting operational parameters—independently of the user's actual glucose measurement values, to incentivize engagement with the system.", "source_patent_id": "10675405", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10675405"], "ground_truth": {"tier1_relevant_docs": {"10537678": 3, "10610642": 3, "9446194": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN237", "text": "An integrated device combining a continuous glucose sensor receiver with a hand-held medicament injection pen, wherein the receiver electronics automatically calculate a bolus dose from continuous glucose sensor data and programmatically set that dose on the injection pen, which the user then manually administers, with the receiver and pen being either integrally formed or detachably connected via mutually engaging electrical contacts or wireless communication.", "source_patent_id": "10403012", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10403012"], "ground_truth": {"tier1_relevant_docs": {"10278580": 3, "10966609": 3, "11373347": 3, "8562558": 3, "8808228": 3, "9741139": 3, "11564602": 2, "7927274": 2, "8282550": 1, "9538946": 1, "11246990": 3, "7976492": 3, "8721585": 3, "8882741": 3, "8920401": 3, "8926585": 3, "9050413": 3, "9155843": 3, "9937293": 3, "10653835": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN238", "text": "A blood clot filter delivery system comprising an introducer and a push rod with a spline member having a main body and first and second boss portions longitudinally spaced apart to define a gap that retains an anchor member of the filter during intravascular delivery through the introducer.", "source_patent_id": "11517415", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11517415"], "ground_truth": {"tier1_relevant_docs": {"10492898": 3, "8430903": 3, "9387063": 3, "11141257": 3, "9326842": 3, "8690906": 2, "10813738": 1, "9017367": 1, "9351821": 1, "9615909": 1, "8613754": 1, "8574261": 1, "9498318": 1, "10842608": 1, "9131999": 1, "10729527": 1, "11554006": 1, "10512531": 2, "7794473": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN239", "text": "A first electronic device that, upon sampling audio input through its microphone, sends stop instructions to a second external electronic device instructing it to forgo responding to audio input received through its own microphone, thereby coordinating which of multiple competing voice-triggered devices processes and responds to a detected audio input.", "source_patent_id": "10311871", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10311871"], "ground_truth": {"tier1_relevant_docs": {"9721566": 3, "10567477": 1, "10089072": 2, "11587559": 2, "11087759": 1, "9886953": 1, "10223066": 1, "10789041": 1, "11133008": 1, "9715875": 1, "10354011": 1, "10170123": 1, "11257504": 1, "10199051": 1, "10978090": 1, "10791176": 2, "11405466": 2, "10643611": 1, "11348582": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN240", "text": "A flow cytometry particle sorting system comprising a microprocessor-based controller that dynamically varies the fluid delivery rate to the sorting system as a function of measured purity or yield of a target sub-population of particles, enabling real-time optimization of sorting performance through adaptive fluid flow control.", "source_patent_id": "8709817", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8709817"], "ground_truth": {"tier1_relevant_docs": {"7943384": 3, "9040304": 1, "7799569": 1, "W2091260390": 1, "W2067029382": 1, "7758811": 1, "W2066225632": 1, "W2050658916": 1, "9365822": 1, "9422523": 1, "W2091368700": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN241", "text": "A pharmaceutical composition for treating chronic gastrointestinal diseases associated with abnormal microflora distribution, comprising viable non-pathogenic or attenuated pathogenic Clostridia combined with one or more additional viable microorganisms selected from Bacteroides, Eubacteria, Fusobacteria, Propionibacteria, Lactobacilli, anaerobic cocci, Ruminococcus, E. coli, Gemmiger, Desulfomonas, Peptostreptococcus, and fungi, formulated to recolonize the gastrointestinal tract of a mammalian host.", "source_patent_id": "10369175", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10369175"], "ground_truth": {"tier1_relevant_docs": {"10772919": 3, "9867858": 3, "9901604": 3, "9962414": 3, "11357801": 1, "10064900": 2, "11185562": 1, "11433102": 1, "10973861": 2, "10195235": 2, "10561690": 2, "11071759": 2, "11040073": 2, "11529375": 2, "10092601": 2, "11026978": 2, "10772918": 1, "11213549": 2, "W2126295648": 1, "W2328149919": 1, "W1970665287": 1, "W2203727677": 1, "W2169567609": 1, "W2993557262": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN242", "text": "A method for transmitting 10 kW or more of laser energy through a deep borehole while suppressing nonlinear optical phenomena that would otherwise degrade the high-power laser beam, enabling laser-based rock removal and borehole formation at depth within the earth.", "source_patent_id": "8757292", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8757292"], "ground_truth": {"tier1_relevant_docs": {"8936108": 3, "8869914": 3, "8511401": 3, "8997894": 3, "8826973": 3, "8820434": 2, "8636085": 2, "9244235": 1, "8424617": 2, "9284783": 2, "9138786": 1, "9562395": 2, "9347271": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN243", "text": "A method for determining fetal chromosome ploidy status from a mixed maternal-fetal DNA sample by constructing a joint distribution model that generates expected allele distributions for each possible fetal ploidy state conditioned on parental genotypic data, then selecting the ploidy state whose expected allelic distribution pattern most closely matches the measured allelic distributions observed across a plurality of polymorphic loci in the mixed sample, wherein the sample is preferentially enriched at those polymorphic loci in a manner that minimizes allelic bias.", "source_patent_id": "11306357", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11306357"], "ground_truth": {"tier1_relevant_docs": {"10174369": 3, "11322224": 3, "11332785": 3, "11339429": 3, "11482300": 3, "11525159": 1, "10061889": 3, "10061890": 3, "10216896": 3, "10522242": 3, "10081839": 2, "10083273": 2, "10260096": 2, "10266893": 2, "11111543": 2, "11111544": 2, "W2100618987": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN244", "text": "An integrated system combining a continuous glucose sensor with a medicament delivery device, where an operable connection between components enables automated or semi-automated control of medicament delivery based on continuous glucose sensor data, reducing or eliminating required user input for determining the amount, type, and timing of medicament delivery.", "source_patent_id": "11246990", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11246990"], "ground_truth": {"tier1_relevant_docs": {"7976492": 3, "8721585": 3, "8882741": 3, "8920401": 3, "8926585": 3, "9050413": 3, "9155843": 3, "9937293": 3, "10278580": 3, "10403012": 3, "10966609": 3, "11373347": 3, "8562558": 3, "8808228": 3, "9741139": 3, "10653835": 3, "10835672": 3, "11564602": 1, "7927274": 1, "8282550": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN245", "text": "A glucose sensor monitoring system that detects transient non-glucose-related signal artifacts in a continuous glucose sensor data stream, determines artifact severity, and selectively applies distinct signal estimation algorithms or distinct parameter sets to replace corrupted data segments, thereby distinguishing and compensating for ischemia-, pH-, or temperature-induced noise from normal electronic or diffusion-related system noise.", "source_patent_id": "11589823", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11589823"], "ground_truth": {"tier1_relevant_docs": {"8346338": 3, "7998071": 3, "8010174": 3, "8073519": 3, "8073520": 3, "8128562": 3, "8150488": 3, "8167801": 3, "8195265": 3, "8229536": 3, "8292810": 3, "8412301": 3, "8435179": 3, "8491474": 3, "8790260": 3, "8795177": 3, "8812073": 3, "8821400": 3, "8843187": 3, "9149219": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN246", "text": "An electrochemical analyte sensor comprising a substrate with a recessed channel formed therein and conductive material disposed within the recessed channel to form a working electrode, coupled to a skin-mounted sensor control unit having conductive contacts that interface with corresponding contact pads on the sensor and a transmitter that wirelessly transmits sensor data to a remote display unit receiver for real-time analyte level indication.", "source_patent_id": "8175673", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8175673"], "ground_truth": {"tier1_relevant_docs": {"8612159": 3, "10231654": 3, "10478108": 3, "10952652": 3, "11103165": 3, "11272867": 3, "11399748": 3, "7869853": 3, "7885699": 3, "8162829": 3, "8177716": 3, "8224413": 3, "8226555": 3, "8226557": 3, "8226558": 3, "8231532": 3, "8235896": 3, "8255031": 3, "8260392": 3, "8265726": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN247", "text": "A method of treating hypertriglyceridemia by administering a pharmaceutical composition comprising eicosapentaenoic acid (EPA) or a derivative thereof as the sole active ingredient, without docosahexaenoic acid (DHA), to reduce triglyceride levels in a subject in need thereof.", "source_patent_id": "8293727", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8293727"], "ground_truth": {"tier1_relevant_docs": {"10537544": 3, "10632094": 3, "11291643": 3, "8293728": 3, "8314086": 3, "8324195": 3, "8357677": 3, "8367652": 3, "8377920": 3, "8399446": 3, "8415335": 3, "8426399": 3, "8431560": 3, "8440650": 3, "8518929": 3, "8524698": 3, "8546372": 3, "10966968": 2, "10561631": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN248", "text": "A continuous analyte sensor calibration system that uses reference data from a short-term implanted continuous analyte sensor to initially calibrate or update sensor data from a separately implanted long-term continuous analyte sensor, and that also uses pre-insertion benchtop testing reference data to provide initial calibration of in vivo sensor data.", "source_patent_id": "11000213", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11000213"], "ground_truth": {"tier1_relevant_docs": {"10610135": 3, "10610136": 3, "10610137": 3, "10617336": 3, "10709364": 3, "10716498": 3, "10743801": 3, "10856787": 3, "10898114": 3, "10918316": 3, "10918317": 3, "10918318": 3, "10925524": 3, "11051726": 3, "7920906": 3, "8560037": 3, "8579816": 3, "8611978": 3, "9078608": 3, "9314196": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "NOVEL", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN249", "text": "An electrochemical analyte sensor comprising a substrate with a recessed channel formed therein and conductive material disposed within the recessed channel to form a working electrode, coupled to a wearable sensor control unit having conductive contacts that mate with contact pads on the sensor and a transmitter that wirelessly transmits sensor data to a remote display unit receiver showing analyte levels.", "source_patent_id": "8480580", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8480580"], "ground_truth": {"tier1_relevant_docs": {"8612159": 3, "10231654": 3, "10478108": 3, "10952652": 3, "11103165": 3, "11272867": 3, "11399748": 3, "7869853": 3, "7885699": 3, "8162829": 3, "8175673": 3, "8177716": 3, "8224413": 3, "8226555": 3, "8226557": 3, "8226558": 3, "8231532": 3, "8235896": 3, "8255031": 3, "8260392": 3, "8265726": 3, "8273022": 3, "8275439": 3, "8287454": 3, "8306598": 3, "8346336": 3, "8353829": 3, "8357091": 3, "8366614": 3, "8372005": 3, "8380273": 3, "8409131": 3, "8473021": 3, "8597189": 3, "8617071": 3, "8622906": 3, "8641619": 3, "8649841": 3, "8652043": 3, "8660627": 3, "8666469": 3, "8668645": 3, "8670815": 3, "8672844": 3, "8734346": 3, "8734348": 3, "8738109": 3, "8744545": 3, "8774887": 3, "8880137": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN250", "text": "An implantable medical device such as an intravascular stent having a coating with increased surface area that includes at least one coating composition with both an exposed abluminal surface and an exposed luminal surface or exposed side surface, configured to enhance therapeutic agent delivery to body tissue.", "source_patent_id": "8900292", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8900292"], "ground_truth": {"tier1_relevant_docs": {"8070797": 2, "8771343": 2, "8815275": 2, "8431149": 2, "8216632": 2, "8187620": 2, "8287937": 2, "8449603": 2, "8920491": 2, "8221822": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN251", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with an enzymatically inactive Cas9 polypeptide, enables site-specific modulation of transcription at a target DNA locus without cleaving the DNA, wherein the RNA-directed targeting specificity is determined by the targeting sequence complementarity to the target DNA.", "source_patent_id": "11008590", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11008590"], "ground_truth": {"tier1_relevant_docs": {"10301651": 3, "10752920": 3, "10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10400253": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN252", "text": "A guided wave launcher system with dynamic impedance matching wherein a mismatch probe detects impedance mismatch from an output RF signal, and a controller adjusts one or more variable circuit elements in an impedance matching circuit to reduce the mismatch, enabling a guided electromagnetic wave to propagate along a transmission medium surface at a non-optical carrier frequency without requiring an electrical return path.", "source_patent_id": "9973940", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9973940"], "ground_truth": {"tier1_relevant_docs": {"10727599": 2, "10819035": 2, "10312567": 2, "9793955": 1, "9871558": 2, "9960808": 2, "9893795": 1, "9954286": 1, "9911020": 1, "10135145": 1, "9927517": 1, "10020844": 1, "10069535": 1, "9820146": 1, "9705610": 2, "9876587": 2, "9847566": 2, "9831912": 1, "9998870": 1, "10797781": 1, "10812174": 1, "10916969": 1, "9912381": 1, "9912382": 1, "9967002": 1, "9749053": 2, "9806818": 2, "10326494": 1, "10755542": 1, "10530505": 2, "9876570": 1, "9876571": 1, "9793954": 1, "9997819": 1, "10439675": 1, "9973416": 1, "9917341": 2, "10547348": 1, "10050697": 1, "9866309": 1, "9935703": 1, "9876264": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN253", "text": "A distributed-input distributed-output (DIDO) system employing M spatially distributed transmit antennas that uses block diagonalization (BD) precoding with channel state information (CSI) to simultaneously create up to (M−1) spatial nulls of zero RF energy at specific receiver locations, where the CSI is either fed back from receivers or computed at the transmitter via channel reciprocity.", "source_patent_id": "10200094", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10200094"], "ground_truth": {"tier1_relevant_docs": {"10749582": 2, "10886979": 2, "10333604": 2, "10985811": 2, "11190246": 2, "11190247": 2, "11196467": 2, "11394436": 2, "11451275": 2, "10547358": 2, "11146313": 2, "11581924": 2, "10277290": 2, "10243623": 2, "9819403": 1, "10349417": 2, "9826537": 2, "10727907": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN254", "text": "A variegated nucleic acid library comprising multiple nucleic acid sequences each encoding a predetermined variant of at least one reference nucleic acid sequence, wherein the variants encode scaffold proteins comprising a GLP1R (glucagon-like peptide-1 receptor) binding domain, enabling systematic exploration of sequence space for GLP1R-binding protein engineering.", "source_patent_id": "11492727", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11492727"], "ground_truth": {"tier1_relevant_docs": {"11407837": 3, "11492728": 1, "10894959": 1, "10907274": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN255", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with a site-specific modifying polypeptide (Cas9), directs site-specific modification of a target DNA, wherein an enzymatically inactive Cas9 polypeptide complexed with the DNA-targeting RNA modulates transcription of a target nucleic acid without cleaving the DNA.", "source_patent_id": "10676759", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10676759"], "ground_truth": {"tier1_relevant_docs": {"10301651": 3, "10752920": 3, "10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10400253": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN256", "text": "A topical nerve stimulator system comprising a dermal patch with an integrated electrical signal generator, a wireless signal receiver for activating the generator, and an on-patch power source, enabling transcutaneous neurological stimulation without implanted components.", "source_patent_id": "10918853", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10918853"], "ground_truth": {"tier1_relevant_docs": {"10016600": 3, "10307591": 3, "11291828": 3, "11077301": 3, "W2135015966": 1, "10953225": 3, "11458311": 2, "11229789": 3, "W2109813077": 1, "W2071533986": 1, "W2149323526": 1, "W2048445715": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN257", "text": "A method for renal neuromodulation using monopolar pulsed electric field delivery via intravascular catheters with expandable treatment members to effectuate irreversible electroporation of renal neural fibers, optionally performed bilaterally on both renal arteries simultaneously.", "source_patent_id": "9445867", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9445867"], "ground_truth": {"tier1_relevant_docs": {"10111707": 3, "9308043": 3, "9468497": 3, "10376312": 3, "8131371": 3, "9327122": 3, "9707035": 3, "9138281": 3, "10179027": 3, "8774922": 2, "8852163": 2, "8768470": 3, "10245429": 3, "11033328": 3, "8934978": 3, "9125661": 3, "9289255": 3, "9675413": 3, "8433423": 3, "8548600": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN258", "text": "A broadcast communication system that transmits an outage status signal to user devices via guided electromagnetic waves along a transmission medium in response to detecting a power outage, where the waves propagate without utilizing an electrical return path.", "source_patent_id": "10020844", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10020844"], "ground_truth": {"tier1_relevant_docs": {"10916969": 1, "9820146": 1, "9927517": 1, "9847566": 1, "9911020": 1, "9998870": 1, "9893795": 1, "10135145": 1, "10547348": 2, "10439675": 1, "9973416": 1, "10326494": 1, "10727599": 1, "10819035": 1, "10312567": 1, "9705610": 1, "9876587": 1, "10797781": 2, "10812174": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "NOVEL", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN259", "text": "A device that receives a personal identifier from an RFID tag via a first wireless signal, then re-transmits that identifier combined with location information as electromagnetic waves coupled into a transmission medium at a first physical interface, where the waves propagate without requiring an electrical return path and are guided to a receiving device at a second physical interface of the transmission medium.", "source_patent_id": "9911020", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9911020"], "ground_truth": {"tier1_relevant_docs": {"9998870": 1, "10326494": 1, "9820146": 1, "10916969": 1, "9893795": 1, "9749053": 1, "9806818": 1, "10205655": 1, "10020844": 1, "10069535": 1, "9705610": 1, "9876587": 1, "9742521": 1, "9749083": 1, "9793955": 1, "10547348": 1, "9853342": 1, "9865911": 2, "10135145": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN260", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with an enzymatically inactive Cas9 polypeptide, provides site-specific modulation of transcription of a target DNA without cleaving the DNA, enabling RNA-directed transcriptional regulation at a sequence-specific genomic locus.", "source_patent_id": "10301651", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10301651"], "ground_truth": {"tier1_relevant_docs": {"10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10400253": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3, "10519467": 3, "10526619": 3, "10533190": 3, "10550407": 3, "10563227": 3, "10570419": 3, "10577631": 3, "10597680": 3, "10612045": 3, "10626419": 3, "10640791": 3, "10669560": 3, "10676759": 3, "10774344": 3, "10793878": 3, "10900054": 3, "10982231": 3, "10988780": 3, "10988782": 3, "11001863": 3, "11008590": 3, "11028412": 3, "11186849": 3, "11242543": 3, "11274318": 3, "11293034": 3, "11332761": 3, "11401532": 3, "11473108": 3, "11479794": 3, "11549127": 3, "10752920": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN261", "text": "Methods and compositions for delivering iRNA agents (interfering RNA) specifically to neural cells to treat neurological diseases, wherein the iRNA agents silence disease-associated gene expression in the nervous system.", "source_patent_id": "9914924", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9914924"], "ground_truth": {"tier1_relevant_docs": {"8969295": 1, "8058068": 1, "8822663": 1, "9181319": 1, "9447164": 1, "9937233": 1, "W2068666140": 1, "8202845": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN262", "text": "A multilayer stretchable electronic device in which a neutral mechanical surface is positioned coincident or proximate to a functional device layer susceptible to strain-induced failure by incorporating one or more layers with spatially inhomogeneous properties achieved through patterning, thereby providing strain isolation to the functional layer during stretching, compression, or flexing.", "source_patent_id": "10064269", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10064269"], "ground_truth": {"tier1_relevant_docs": {"10292261": 3, "8552299": 3, "8905772": 3, "9159635": 1, "10052066": 1, "10357201": 1, "9554484": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN263", "text": "A system that directs electromagnetic waves to an interface of a transmission medium to induce propagation of electromagnetic waves having at least a dominant non-fundamental wave mode, as opposed to the fundamental TEM mode, along the transmission medium.", "source_patent_id": "10069185", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10069185"], "ground_truth": {"tier1_relevant_docs": {"9787412": 3, "9865911": 3, "9893795": 2, "9705610": 2, "9876587": 2, "10135145": 2, "9871558": 2, "9960808": 2, "9954286": 3, "10650940": 2, "10326494": 2, "10069535": 3, "9871282": 1, "9927517": 1, "9742521": 3, "9749083": 3, "10020844": 1, "10547348": 1, "9853342": 2, "9876570": 3, "9876571": 3, "9882257": 3, "9847566": 2, "9998870": 1, "9887447": 1, "10044409": 1, "9749053": 2, "9806818": 2, "9911020": 1, "9820146": 1, "9917341": 2, "10755542": 1, "9954287": 1, "10530505": 3, "10797781": 1, "10812174": 1, "9793955": 2, "9973416": 1, "9769020": 2, "9997819": 2, "10916969": 1, "10439675": 2, "10205655": 2, "10727599": 2, "10819035": 1, "9838078": 1, "10312567": 1, "10355367": 1, "10938108": 2, "10050697": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "NOVEL", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN264", "text": "A microfluidic method for manipulating droplet size in real-time by dynamically adjusting the pressure exerted on either the aqueous fluid or the immiscible carrier fluid during the droplet formation step, enabling active control of droplet volume without changing channel geometry or fluid flow rates.", "source_patent_id": "8658430", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8658430"], "ground_truth": {"tier1_relevant_docs": {"W2136074922": 1, "W2541163117": 1, "11084036": 1, "W2107731965": 1, "W1980221373": 1, "10603662": 1, "8772046": 1, "9017623": 1, "9440232": 1, "11268887": 2, "8528589": 2, "W2088617194": 1, "W2033906622": 1, "W2026725821": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN265", "text": "A non-naturally occurring microbial organism engineered with at least one exogenous nucleic acid encoding pathway enzymes that enable conversion of syngas (CO, CO2, H2) as a carbon and energy source to isopropanol, 4-hydroxybutyrate, or 1,4-butanediol through heterologous metabolic pathways expressed at sufficient levels to produce these target chemicals.", "source_patent_id": "8129155", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8129155"], "ground_truth": {"tier1_relevant_docs": {"8048661": 2, "10087470": 2, "8445244": 2, "8637286": 2, "8715971": 2, "11371046": 2, "8357520": 2, "8969054": 2, "9487803": 2, "10550411": 2, "7803589": 2, "8323950": 2, "8691553": 2, "9051552": 2, "9885064": 2, "8993285": 2, "8268607": 1, "8697421": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN266", "text": "A method for differentiating pluripotent stem cells into pancreatic endoderm cells expressing PDX1, NKX6.1, and HB9 by culturing Stage 4 to Stage 6 cells with a thyroid hormone (T3), an ALK5 inhibitor, or a combination of both to promote pancreatic endocrine differentiation.", "source_patent_id": "10138465", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10138465"], "ground_truth": {"tier1_relevant_docs": {"10947511": 3, "10344264": 1, "10006006": 2, "10870832": 2, "10456424": 2, "8785185": 2, "9096832": 2, "9725699": 2, "9744195": 2, "9752126": 1, "9969982": 2, "9752125": 2, "9150833": 2, "W2043915076": 1, "9133439": 2, "9181528": 1, "9458430": 1, "W1503301779": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN267", "text": "A blood clot filter delivery system comprising a push-rod with a spline member having first and second boss portions spaced apart along a longitudinal axis to define a gap that retains filter anchor members during delivery, enabling the same single delivery system to introduce the filter into a vein from either femoral or jugular access without modification. The filter includes first and second filter structures diverging in opposite directions, connected by a link that allows each structure to be independently collapsed into a generally cylindrical shape for retrieval.", "source_patent_id": "11141257", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11141257"], "ground_truth": {"tier1_relevant_docs": {"9326842": 3, "10492898": 3, "11517415": 3, "8430903": 3, "9387063": 3, "9204956": 1, "8690906": 2, "9351821": 1, "9615909": 1, "8613754": 1, "10813738": 2, "9017367": 2, "8574261": 2, "9498318": 2, "10729527": 1, "11554006": 1, "8372109": 1, "7704267": 1, "10512531": 2, "7794473": 2, "8992562": 2, "9131999": 1, "W24979439": 1, "8628556": 1, "9144484": 1, "11103339": 1, "W2477380386": 1, "W2008308998": 1, "W2057504171": 1, "W2072251047": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN268", "text": "A DNA-targeting RNA comprising a targeting sequence that, together with an enzymatically inactive Cas9 polypeptide, enables site-specific modification of a target DNA or modulation of transcription at a specific genomic locus without cleaving the DNA, where the targeting sequence directs the Cas9 polypeptide to the target site via RNA-directed sequence complementarity.", "source_patent_id": "10988780", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10988780"], "ground_truth": {"tier1_relevant_docs": {"10400253": 3, "10000772": 3, "10113167": 3, "10227611": 3, "10266850": 3, "10308961": 3, "10337029": 3, "10351878": 3, "10358658": 3, "10358659": 3, "10385360": 3, "10407697": 3, "10415061": 3, "10421980": 3, "10428352": 3, "10443076": 3, "10487341": 3, "10513712": 3, "10519467": 3, "10526619": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN269", "text": "A method for identifying trending terms absent from or underrepresented in a speech recognizer vocabulary by monitoring electronic data sources (social networks, news feeds, search queries) for candidate terms, then searching archived speech audio using open-vocabulary spoken term detection to find phonetic matches, and generating notifications with usage statistics and context when candidates are confirmed in live speech traffic.", "source_patent_id": "10431204", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10431204"], "ground_truth": {"tier1_relevant_docs": {"9818400": 3, "9697822": 1, "10079014": 1, "9502031": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN270", "text": "A method that receives speech input containing a word, determines a first phonetic representation using a speech recognition phonetic alphabet, then maps that first set of phonemes to a second set of phonemes from a speech synthesis phonetic alphabet, and stores the resulting second phonetic representation in association with the word's text string to enable user-specified pronunciation for both speech recognition and synthesis.", "source_patent_id": "9620104", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9620104"], "ground_truth": {"tier1_relevant_docs": {"9966060": 3, "10079014": 1, "10446141": 1, "9711141": 2, "10134385": 1, "8903716": 1, "9646609": 1, "9502031": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN271", "text": "A DNA-based digital information storage device comprising addressable sidewall electrodes that locally control polynucleotide synthesis steps—including deprotection, extension, and cleavage—to enable spatially selective writing of digital information into DNA sequences at high storage density.", "source_patent_id": "10936953", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10936953"], "ground_truth": {"tier1_relevant_docs": {"W2246279215": 1, "W2512345221": 1, "W2025383314": 1, "W2114487425": 1, "W2471091339": 1, "W4231505808": 1, "11550939": 1, "W2592122940": 1, "11208684": 1, "11365442": 1, "11371086": 1, "11384386": 1, "11401545": 1, "11479810": 1, "11519022": 1, "11549138": 1, "11560587": 1, "11263354": 2, "11562103": 2}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN272", "text": "A process for differential functionalization of a surface to support biopolymer synthesis that uses lamps, lasers, and/or microcontact printing to selectively add functional groups to defined regions of a surface, enabling efficient and uniform oligonucleic acid synthesis on the functionalized substrate.", "source_patent_id": "10987648", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10987648"], "ground_truth": {"tier1_relevant_docs": {"6660234": 2, "6747143": 2, "W2032816497": 1, "W1994573288": 1, "8691754": 1, "W2029127959": 1, "6403957": 2, "6646243": 2, "W4232837145": 1, "W2008535631": 1, "6630308": 2, "10844373": 1, "11512347": 1, "W2149482213": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN273", "text": "A method for remodeling Factor VIII by enzymatically adding, deleting, or modifying glycosyl groups on the protein and conjugating a modifying group (such as PEG or therapeutic agent) to Factor VIII through glycosyl linkages to alter its pharmacological properties.", "source_patent_id": "8076292", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8076292"], "ground_truth": {"tier1_relevant_docs": {"8008252": 2, "7795210": 3, "7696163": 1, "8716240": 1, "8716239": 1, "7473680": 3, "7439043": 2, "7399613": 2, "7265084": 3, "7265085": 3, "8063015": 3, "8853161": 3, "7416858": 3, "8791070": 1, "8911967": 2, "8916360": 1, "9029331": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN274", "text": "Gel beads are functionalized with barcode molecules generated through two or more sequential ligation reactions in a combinatorial fashion, where each barcode molecule comprises a barcode sequence and a functional sequence, enabling a single bead to carry two or more different barcode molecules for multi-analyte analysis including nucleic acids, proteins, and perturbation agents.", "source_patent_id": "10745742", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10745742"], "ground_truth": {"tier1_relevant_docs": {"10876147": 3, "11168353": 2, "11162132": 1, "11299774": 1, "11390912": 1, "11613773": 1, "10829815": 1, "W2303585199": 1, "W2037780745": 1, "W2102718644": 1, "W2104148521": 1, "W3093065675": 1, "W2038344809": 1, "W2951068818": 1, "W2096218114": 1, "W4241821763": 1, "W2029209483": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN275", "text": "Methods for B-cell reduction using a synergistic combination of CD37-specific binding molecules and CD20-specific binding molecules, wherein the co-administration of these two distinct B-cell surface antigen-targeting agents achieves greater B-cell depletion than either agent alone for treatment of diseases involving aberrant B-cell activity.", "source_patent_id": "10143748", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10143748"], "ground_truth": {"tier1_relevant_docs": {"10307481": 3, "W2143154854": 1, "W2164777386": 1, "9101609": 2, "W1851879139": 1, "W2142611256": 1, "W2091057822": 1, "W2127214162": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN276", "text": "An analyte monitoring device comprising an electrochemical sensor with a substrate having a recessed channel containing conductive material forming a working electrode, coupled to a skin-mountable sensor control unit that wirelessly transmits analyte data via conductive contacts mating with sensor contact pads to a remote display unit.", "source_patent_id": "8612159", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8612159"], "ground_truth": {"tier1_relevant_docs": {"10231654": 3, "10478108": 3, "10952652": 3, "11103165": 3, "11272867": 3, "11399748": 3, "7869853": 3, "7885699": 3, "8162829": 3, "8175673": 3, "8177716": 3, "8224413": 3, "8226555": 3, "8226557": 3, "8226558": 3, "8231532": 3, "8235896": 3, "8255031": 3, "8260392": 3, "8265726": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN277", "text": "A vector delivering a light-activated ion channel or pump molecule comprising a nucleic acid sequence encoding a modified light-activated molecule, wherein the modification is located near the all-trans retinal Schiff base to extend the duration of the open state of the channel relative to the wild-type molecule.", "source_patent_id": "9309296", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9309296"], "ground_truth": {"tier1_relevant_docs": {"10064912": 3, "10071132": 3, "9458208": 3, "9249200": 2, "10350430": 2, "9878176": 1, "9394347": 2, "9757587": 2, "9284353": 2, "9855442": 2, "W2058488568": 1, "W2051956840": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN278", "text": "Specific salt forms of the FGFR inhibitor compound 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[4,3-d]pyrimidin-2-one, including their methods of preparation, wherein these salts are useful for treating FGFR-mediated diseases such as cancer.", "source_patent_id": "11174257", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["11174257"], "ground_truth": {"tier1_relevant_docs": {"11466004": 3, "10611762": 1, "11472801": 1, "11407750": 1, "11566028": 2, "11607416": 2, "10947230": 2, "11530214": 2, "11053246": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN279", "text": "A non-naturally occurring microbial organism engineered with a complete biosynthetic pathway for 1,4-butanediol production from α-ketoglutarate, comprising exogenous nucleic acids encoding α-ketoglutarate decarboxylase, 4-hydroxybutanoate dehydrogenase, 4-hydroxybutyryl-CoA transferase or butyrate kinase/phosphotransbutyrylase, aldehyde dehydrogenase, and alcohol dehydrogenase, enabling anaerobic fermentative production of 1,4-BDO via a 4-hydroxybutanoic acid intermediate.", "source_patent_id": "8889399", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["8889399"], "ground_truth": {"tier1_relevant_docs": {"8067214": 3, "11371046": 3, "8357520": 3, "8969054": 3, "9487803": 3, "10273508": 3, "8129169": 3, "9434964": 3, "8048661": 1, "7858350": 3, "8129156": 3, "8178327": 3, "9175297": 3, "11401534": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN280", "text": "A method for synthesizing oligonucleotides comprising phosphorothiotriester linkages by reacting an H-phosphonate with a silylating reagent to generate a silyloxyphosphonate intermediate, then reacting the silyloxyphosphonate with a thiosulfonate reagent to directly install the phosphorothiotriester linkage, enabling functionalized nucleic acid synthesis without conventional phosphoramidite chemistry.", "source_patent_id": "10280192", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10280192"], "ground_truth": {"tier1_relevant_docs": {"9605019": 3, "W2064699990": 1, "W2013248417": 1, "W2295435346": 1, "W154596074": 1, "9695211": 1, "W1889071327": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN281", "text": "Recombinant oleaginous cells engineered by manipulating genes encoding stearoyl-ACP desaturase, delta-12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase to produce triglyceride oils with specified fatty acid profiles and regiospecific/stereospecific profiles, including saturated-unsaturated-saturated triglyceride enrichment or mid-chain fatty acid enrichment, for applications such as frying oils, shortenings, cocoa butter replacements, and industrial lubricants.", "source_patent_id": "9068213", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9068213"], "ground_truth": {"tier1_relevant_docs": {"10053715": 3, "10683522": 3, "11401538": 3, "9719114": 3, "8945908": 3, "9102973": 3, "10287613": 3, "9551017": 3, "9909155": 3, "9200307": 3, "10100341": 2, "9249436": 2, "9279136": 2, "10006034": 2, "8852885": 2, "10167489": 2, "10344305": 2, "9388435": 2, "9255282": 2, "W2037129260": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN282", "text": "Oleaginous recombinant cells are engineered by manipulating genes encoding stearoyl-ACP desaturase, delta-12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase to produce triglyceride oils with predetermined fatty acid profiles and regiospecific stereospecific arrangements, including saturated-unsaturated-saturated triglyceride enrichment, for use as frying oils, shortenings, cocoa butter replacements, or industrial lubricants.", "source_patent_id": "9200307", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9200307"], "ground_truth": {"tier1_relevant_docs": {"10053715": 3, "10683522": 3, "11401538": 3, "9719114": 3, "8945908": 3, "9102973": 3, "9068213": 3, "10287613": 3, "9551017": 3, "9909155": 3, "10100341": 2, "9249436": 2, "9279136": 2, "10167489": 1, "10344305": 2, "9388435": 1, "10006034": 2, "9255282": 2, "8852885": 2, "W3010135450": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN283", "text": "A diabody molecule comprising two polypeptide chains that associate to form at least two epitope binding sites and are covalently linked through non-peptide bond covalent bonds between cysteine residues within each polypeptide chain, wherein the molecule further comprises an Fc region to confer antibody-like effector functionality.", "source_patent_id": "9296816", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9296816"], "ground_truth": {"tier1_relevant_docs": {"9889197": 3, "10093738": 3, "10093739": 3, "9284375": 3, "9963510": 3, "11168125": 1, "8084026": 2, "8216574": 1, "W2092638671": 1, "8697071": 1, "W2115820004": 1, "W2139212924": 1, "W1973382371": 1, "7960512": 1, "8003774": 1, "8192737": 1, "8217147": 1, "8951517": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN284", "text": "Soluble neutral active hyaluronidase glycoproteins (sHASEGPs) comprising asparagine-linked sugar moieties required for functional neutral active hyaluronidase activity, combined with Factor VIII compositions, wherein pegylated or sialylated forms of sHASEGPs facilitate subcutaneous administration of Factor VIII by degrading hyaluronan in the extracellular matrix to enhance drug dispersion and bioavailability.", "source_patent_id": "9677062", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9677062"], "ground_truth": {"tier1_relevant_docs": {"8431124": 3, "10286044": 3, "10898551": 3, "8450470": 3, "8772246": 3, "9677061": 3, "8765685": 2, "9562223": 1, "7767429": 3, "8202517": 3, "8431380": 3, "10588983": 3, "7871607": 3, "10016491": 3, "7829081": 3, "7846431": 3, "8105586": 3, "8257699": 3, "8580252": 3, "9211315": 3}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN285", "text": "A combination therapy composition comprising triciribine and bortezomib, wherein the combination exhibits synergistic anticancer activity against tumors and abnormal cell proliferation disorders while demonstrating reduced toxicity compared to either agent administered alone.", "source_patent_id": "9192645", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["9192645"], "ground_truth": {"tier1_relevant_docs": {"8623834": 1, "9186403": 1, "9486522": 1, "8691779": 1, "9101641": 1, "9498492": 1, "8865666": 3, "9486492": 3, "8435959": 1, "9115162": 1, "9518079": 1, "8673867": 1, "9655914": 1, "8673868": 1, "9211299": 1, "9486470": 1, "W2015451788": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN286", "text": "Barcoded oligonucleotides bound to gel beads are used to simultaneously characterize multiple analyte types—including cell surface proteins, intracellular proteins, genomic DNA, and RNA—within a single workflow by tagging each analyte with a unique barcode identifier enabling downstream sequencing-based analyte characterization.", "source_patent_id": "10815525", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "patents_only", "num_citing_patents": 0, "patent_ids": ["10815525"], "ground_truth": {"tier1_relevant_docs": {"10550429": 3, "10793905": 3, "10858702": 3, "11180805": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN287", "text": "Cardiosphere-derived cells (CDCs) and exosomes secreted by CDCs, when administered to subjects with heart failure with preserved ejection fraction (HFpEF), improve left ventricular diastolic relaxation, reduce LV end-diastolic pressure, decrease lung congestion, lower arrhythmia risk, and enhance survival, demonstrating therapeutic efficacy in a condition unresponsive to standard heart failure therapies.", "source_patent_id": "11253551", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["11253551"], "ground_truth": {"tier1_relevant_docs": {"W2559270879": 2, "W2310251639": 3}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN288", "text": "A method for selecting thermostabilized membrane protein mutants by exposing candidate mutants within a membrane-containing composition to a membrane-destabilizing agent at a concentration sufficient to destabilize the parent membrane protein in-situ, then selecting mutants that retain structural integrity or biological activity compared to the destabilized parent protein.", "source_patent_id": "9081020", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9081020"], "ground_truth": {"tier1_relevant_docs": {"8703915": 1, "W2013773601": 2, "W1981448996": 1, "10126313": 1, "9260505": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN289", "text": "A prostate cancer prognostic system comprising defined sets of gene transcript sequences whose expression changes correlate with recurrent versus non-recurrent prostate cancer, together with corresponding polynucleotide probes and primers deployable in solution or array format to classify prostate cancer tissue disease states.", "source_patent_id": "10865452", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10865452"], "ground_truth": {"tier1_relevant_docs": {"10422009": 1, "W1590223761": 2, "W2136452881": 1, "W2121940650": 1, "W2104096208": 2, "W2088076795": 2, "W1535417295": 1, "W1935960420": 1, "W40950966": 1, "W2158626602": 1, "W2112856704": 1, "W2108426942": 2, "W2041992343": 1, "W2116232233": 1, "W2140855177": 1, "W2145320380": 1, "W2126245040": 2, "W2159689134": 1, "W2041002214": 2, "W2106779749": 2, "W187930905": 1, "W2136441440": 2, "W2077672512": 1, "W2408089991": 3, "W2047382917": 1, "W2109502519": 2, "W1552193435": 1, "W2094818686": 2, "W2093403502": 1, "W2003624089": 1, "W1963691340": 2, "W2032739457": 3, "W2142565364": 1, "W2601615263": 2, "W2017704176": 1, "W2143650397": 2, "W2077301757": 1, "W2080510044": 1, "W1990749869": 1, "W1977334426": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "NOVEL", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN290", "text": "Antibody molecules that specifically bind to TIM-3 (T-cell immunoglobulin and mucin-domain containing-3) with defined heavy and light chain complementarity-determining regions, capable of modulating TIM-3-mediated immune checkpoint signaling for use in treating cancer or infectious diseases.", "source_patent_id": "10472419", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["10472419"], "ground_truth": {"tier1_relevant_docs": {"W2117973220": 1, "9783618": 1, "W2108026478": 1, "W2173583300": 1, "W2886878155": 2, "7923221": 1, "W2091609940": 1, "W66372243": 1, "W33263437": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "ANTICIPATED", "anthropic": "ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN291", "text": "Expressed Sequence Tags (ESTs) isolated from maize tissue are disclosed as molecular tools for isolating novel plant genes and promoters, identifying and mapping genes involved in developmental and metabolic pathways, and enabling sequence homology analyses for screening agronomic traits.", "source_patent_id": "7919608", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["7919608"], "ground_truth": {"tier1_relevant_docs": {"W2144905501": 1, "W1964235323": 1, "W2147867116": 1, "W2049545916": 1, "W4244413462": 1, "W2140579645": 1, "W2143968834": 2, "W2093280246": 1, "W4213387068": 1, "W2168742355": 1, "W2139977547": 2, "W2115631962": 1, "W2156061481": 1, "W2106429664": 1, "W2171593390": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN292", "text": "A stapled peptide cross-link formed by olefin metathesis between a proline derivative bearing an alkenyl side chain and another amino acid derivative bearing an alkenyl side chain, where the proline derivative functions as a strong nucleator of alpha-helix formation and the resulting macrocyclic staple stabilizes helical secondary structure.", "source_patent_id": "9617309", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["9617309"], "ground_truth": {"tier1_relevant_docs": {"W1965819962": 2, "W2011539303": 2, "W2020091506": 1, "W2085438832": 1, "W2009381692": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED"}}}
{"statement_id": "RN293", "text": "Humanized antibodies that specifically bind TGF-beta, wherein murine anti-TGF-beta antibody complementarity-determining regions are grafted onto human antibody framework regions to produce antibodies with reduced immunogenicity while retaining binding specificity and affinity for TGF-beta, suitable for treating TGF-beta-mediated disorders including cancer.", "source_patent_id": "8012482", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["8012482"], "ground_truth": {"tier1_relevant_docs": {"W1593737248": 1, "W2055609042": 1, "W1590584281": 1, "W2147810684": 1, "W2052150715": 1, "W2240331751": 1, "W2417940201": 1, "W2051541338": 1, "W1613596933": 1, "W2107418859": 1, "W1986368280": 1, "W2070205845": 2, "W2154200023": 1, "W2091609940": 2, "W2130379555": 2, "W1835232554": 1, "W1589664975": 2, "W143149509": 1, "W1893261451": 1}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "NOVEL", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN294", "text": "Human umbilical cord tissue-derived cells, when administered to a patient, promote repair and regeneration of diseased or damaged renal tissue, providing a cell-based therapeutic approach to treating kidney disease that leverages the unique regenerative properties of umbilical cord tissue-derived cells rather than embryonic or adult stem cell sources.", "source_patent_id": "8034329", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "papers_only", "num_citing_patents": 0, "patent_ids": ["8034329"], "ground_truth": {"tier1_relevant_docs": {"8491883": 1, "9585918": 1, "9125906": 1, "W2122735999": 1, "W2019586013": 1, "9592258": 1, "W1969644104": 1, "W2058256440": 2, "W2105647704": 1, "W1988358491": 1, "W2071692347": 1, "W1995001988": 1, "W2032187209": 2, "W2078823349": 1, "W2110000041": 1, "W2417719407": 1, "W2028664457": 1, "10179900": 1, "W2054363978": 1, "W2092839502": 2, "W1976906682": 1, "W2402792895": 1, "W1994586809": 1, "W1966100365": 1, "W1985114641": 1, "9175261": 1, "W2104225093": 2, "W1996395646": 3, "W2135568887": 1, "W1971530777": 1, "W2115363040": 2}, "tier3_novelty_label": "ANTICIPATED", "tier3_agreement": "no_consensus", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "ANTICIPATED"}}}
{"statement_id": "RN295", "text": "A medical endoprosthesis having a surface comprising a catalytic material with a non-fouling material covalently attached thereto, wherein the non-fouling material is releasably bound to the surface via a cleavable chemical bond that allows controlled release of the non-fouling material from the device surface.", "source_patent_id": "9284409", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9284409"], "ground_truth": {"tier1_relevant_docs": {"8187620": 1, "8815275": 1, "W2149307600": 1, "8771343": 1, "8431149": 1, "W2042372239": 1, "W1994232532": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN296", "text": "A digital microfluidic fluid application and extraction interface device comprising a waste reservoir with a fluid trap and a transfer conduit extending through the waste reservoir, wherein the transfer conduit doubles back on itself to hold a fluid sample while allowing excess fluid to pass from the transfer conduit into the waste reservoir where it is trapped within the waste chamber.", "source_patent_id": "11253860", "source_paper_id": "", "source_paper_title": "", "domain": "C07", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["11253860"], "ground_truth": {"tier1_relevant_docs": {"11266987": 1, "W2168721781": 1, "9562837": 1, "10603662": 1, "8772046": 1, "9017623": 1, "9440232": 1, "W2042181447": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN297", "text": "A housing configured to connect with a utility structure that contains two separate wireless devices, each coupled to respective antennas extending outside the housing, with the wireless devices coupled to each other to enable communication relay functionality mounted on utility infrastructure.", "source_patent_id": "10298293", "source_paper_id": "", "source_paper_title": "", "domain": "A61", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["10298293"], "ground_truth": {"tier1_relevant_docs": {"10333604": 1, "11394436": 1, "10340601": 1, "10382976": 1, "9948333": 1, "10103422": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
{"statement_id": "RN298", "text": "A mixing cartridge comprising a body structure defining a cavity with upper and lower portions, wherein a rotatable member extends along a horizontal axis in the upper portion of the cavity and one or more protrusions extend outward from the rotatable member into the lower portion of the cavity to mix fluidic material disposed therein.", "source_patent_id": "8550694", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["8550694"], "ground_truth": {"tier1_relevant_docs": {}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "NOVEL", "anthropic": "NOVEL", "google": "NOVEL"}}}
{"statement_id": "RN299", "text": "A first network device receives software from a second network device, applies a digital signature to the software to indicate receipt, and forwards the digitally-signed software to a third network device, enabling tracking of software distribution across a chain of network devices.", "source_patent_id": "9904535", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9904535"], "ground_truth": {"tier1_relevant_docs": {}, "tier3_novelty_label": "NOVEL", "tier3_agreement": "unanimous", "tier3_individual": {"openai": "NOVEL", "anthropic": "NOVEL", "google": "NOVEL"}}}
{"statement_id": "RN300", "text": "An audio processing system that analyzes incoming audio input to classify it as either music or speech, generates an acoustic fingerprint for audio portions classified as music, and identifies speech utterance endpoints for audio portions classified as speech, thereby applying distinct recognition pathways based on audio content type.", "source_patent_id": "9620105", "source_paper_id": "", "source_paper_title": "", "domain": "C12", "difficulty": "medium", "category": "novel", "num_citing_patents": 0, "patent_ids": ["9620105"], "ground_truth": {"tier1_relevant_docs": {"9697822": 1, "10074360": 1, "10789041": 1, "10747498": 1, "11133008": 1, "9715875": 1}, "tier3_novelty_label": "PARTIALLY_ANTICIPATED", "tier3_agreement": "majority", "tier3_individual": {"openai": "PARTIALLY_ANTICIPATED", "anthropic": "PARTIALLY_ANTICIPATED", "google": "ANTICIPATED"}}}
